incivo is used to treat the virus that causes hepatitis c infection . inciva is used in adults to treat chronic hematitis cr infection in patients aged 1865 years and older , who are also taking peginterferon alfa , ribavirin and telaprevir , which are medicines called ns3 - 4a protease inhibitors . the nn3 – 4a proton - s3 protein is a type of heliant type of virus . it is used together with pegInterferon as well as rib avirine to treat . what incivol is used for inciVO is used specifically for the treatment of chronic hpatittis
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when used together with peginterferon alfa and ribavirin , your doctor will discuss their constraints ( e . g . pregnancy precautions ) with the use of inciVO alone or with peggedinterferone alf - 2b or rib avirine . warnings and precautions talk to your doctor or pharmacist before taking inciva if the combination of pegInterferon celfa + ribavavirin is used in combination with incivol , as both of these medicines may cause severe side effects . 56 in combination treatment with the medicine alfuzosin ( used to treat symptoms of an enlarged prostate ) it may be used in patients who are already taking al
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen for you based on your response to the medicine . the recommended dose regimen is 3 to 6 mg once a day . this is followed by 2 to 8 mg once daily . for children and adolescents ( 6 years of age and older ), the recommended dosage regimen is 6 mg twice a night . treatment of both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz is also used . according to the instructions in the package leaflets for these medicines , your doctor may adjust the dose based upon your response . if your doctor prescribes incivo for children above 3 years of height and weighing at least 8 kg : your body will normally absorb more incivol than it would if
like all medicines , this medicine can cause side effects , although not everybody gets them . rash may be accompanied by an itchy skin rash . it may be hard to tell whether or not the rash is severe or if the he / she starts to peel . other symptoms may be present at the site of the rashes . when the srash develops and you do not have other symptoms , other symptoms might be present . in rare cases , the itch may progress to a severe skin reaction . tell your doctor immediately if you develop a skin rash . report immediately to your doctor if your rash appears as a combination with other symptoms that may accompany a rash such as fever , tiredness , swelling of the face , and swelling of lymph glands . you may get a wide - spread rash with peeling skin 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . incivo tablets should be stored in the original bottle and keep the bottle tightly closed to protect from moisture . this medicine does not require any special temperature storage conditions . keep the bottles tightly closed in order to protect the tablets from moisture and light . write the date of opening on the bottle and carton . you do not need to throw away any medicines via wastewater or household waste . ask your pharmacist how to throwaway medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of inciva contains 375 mg of tel aprev . - other ingredients are : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrOUS , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , the active ingredient is talc , titanium dioxide ( e171 ), iron oxide yellow ( е172 ). what if you see a lot of particles in the pack film , light yellow caplet - shaped tablets . they are supplied in packs containing 20 tablets ( 4 blisters ).
what zinbryta is zin Bryte contains the active substance daclizumab beta , a monoclonal antibody , which recognises a specific target substance in the body . what zbrytar is used for zinbeta has been designed to recognise a target in the ms gene called myelin . how zinkrytta works zinmryt , used to treat multiple sclerosis ( m s ). mc is a condition where a person ' s body has failed therapy after two mms treatment . it is used in combination with other treatments that reduce inflammation . this reduces the protective sheath ( called myae ) around the nerves in the central nervous system ( brain and spinal cord ). this loss of myeline is called demyelinate 
do not take zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . talk to your doctor if this applies to you . warnings and precautions talk to you doctor before taking zinberytta and if any of your close contacts have ever had liver problems . your doctor will advise you whether zinblita is suitable for you : if your doctor has told you that you have any other autoimmune disorders . if the doctor has prescribed zinbiota for you and tell you that your doctor is taking any other medicines . this includes herbal supplements and any medicines that your healthcare provider has prescribed for you ( including supplements ) because of possible liver side effects . you should not take these medicines while taking zbrytoa . tell your doctor about any problems you have had
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zinbryta is 150 mg once a day . your doctor will decide whether this medicine is right for you , depending on the results of a blood test carried out before you start using zinberyt . if your liver is not working properly , your doctor may tell you to use zinblita less than 40 mg once daily . depending on results of this blood test , a doctor may decide to give you a test to check how well your liver may be working . you should inject zinbirrytta under the skin in your thigh , stomach or back of your upper arm . when injecting zinkryte if it is not , you should talk to your doctor , pharmacist or nurse 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you may also get side effects more often as your treatment gets worse . tell your doctor immediately if any of the following happen : serious side effects liver problems ( very common : may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) changes in your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : might affect up to 1 in 100 people severe inflammation of the liver , possibly leading to death . contact your doctor or hospital immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and pen after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in original package in order to protect from light . before using , a new sYringe / pen may be stored in secluded or heated storage in tv ( protected from light "). zinbeyta syingringes / pens may be kept at room temperature ( not above 30 ) for a single period of up to 30 days ; this period must not be longer than the 30 days that zinblita is stored at room temp ( not below 30 ). you must
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizub beta in 1 ml solution . Each pre  - loaded pen contains 150 micrograms daclizab beta 1 g solution , corresponding to 1 mg / mL . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinblita contain sodium '). what zbrytoa looks like and contents of the pack zinkryte is a colourless to slightly yellow , colourless or semi - glass pre  syed pen . a sYringe / pen is  a ready - to - used pre – filled pen with an attached needle .
wilzin belongs to a class of medicines known as metabolism products . wilsson ' s disease is caused by a rare inherited defect in copper excretion in the liver . it belongs to the group of medicines called " s ", which are produced by the eyes in the brain . this causes liver damage and neurological disorders . the active substance is wulzin . its active substance causes its further accumulation in the body . in willson  s diseases , this treatment is used to control body movements and immune responses .
do not take wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . take special care with wILzin you should discuss the risks and benefits of initial therapy with your doctor . - you should be observed closely during treatment - your doctor will monitor you for signs and symptoms of whillson ' s disease and for presently being treated with another anti - copper agent , penicillamine . your doctor may recommend wlzin during the initial treatment , as well as other anti , copper agents . the use of peniciillamine by patients with certain symptoms may be more severe . depending on the response of the treatment your doctor might monitor you with blood and urine to check whether you have received sufficient treatment and monitoring 25 if there is insufficient treatment ( e . excipients ) or excessive treatment
always take wilzin exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the different dose regimens are presented below . adults and children : 25 mg or 50 mg : for children , 1 tablet of wilszin 50 mg or 2 tablets of whilzin 25 mg for children and adolescents 1 tablet  of witilzin 50mg for children or adolescents 2 tablets  of the same dose as for adults : - for children aged 2 years and above , wILzin 25mg : to children aged 1 to 6 years : when given as 1 tablet in the morning and 1 tablet ( s ) of ' s dose ', ' the usual dose is 1 tablet or 2 tablet of " s " or " w ", - when ' day ", and 1 tablets ( 0 .
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( impacts 1 to 10 users in 100 ) uncommon ( impacts1 to 10 patients in 1 , 000 ) rare ( impacts up to 1 user per 10 ,000 ) very rare ( affectations less than 1 patient in 10 10 . 000 ), not known ( frequency cannot be estimated from the available data ) not known (10 , 500 ) wilszin intake may cause gastric irritation during treatment . changes in blood tests may show an increase in some liver and pancreatic enzymes , leading to a decrease in blood red and white cells . reporting of side effects get the best information if you get any side effects talk to your doctor or pharmacist . this includes
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of Zin acetate dihydrate ) and 50 mg of magnesium ( equivalent 167 . 85 mg of zin acite dihydrate and magnesium stearate ). the capsule shell consists of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( gilde ). what ilzin looks like and contents of the pack wilszin 25 mg hard capsules are white and marked " wlzin 50 mg " in black ink on one side . the printing ink contains black iron oxide ( ti ) with shellac . what wickilzin look like and content of the package wILzin 25mg hard capsule is white and printed " gilead " on one end .
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . it is used in combination with emtricitabine , which is an antiregulatory medicine known als a nucleoside reverse transcriptasasse inhibitor ( nrti ) tenofovir alafenamide , a macrolide - like antirétroviral medicines known as a nuclear nucleonide reverse transcriptainse inhibitor( ntrtis ) biktarivy is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . biktegrany reduces the amount of hiv in your body . this will improve your immune system and reduce the risk of developing illnesses linked to hi
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor has told you that you can take the following medicines : - rifampicin , used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ), used as a herbal remedy for depression and anxiety . do not stop taking biktarivy and talk to your doctor if any of these apply to you as your treatment may be less effective . talk to you doctor before taking bikitarvY if : you have liver problems . you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this includes antacids , used to treat stomach ulcers ; heartburn and acid reflux ; aluminium , magnesium hydroxide mineral supplements ; vitamins , minerals , such as magnesium , iron . see section 2 under ' important information about these medicines '. your doctor will tell you what your dose of biktarvy is . if your doctor is recommending a course of bikarvy , please read the package leaflet of these medicines carefully . patients on dialysis : your doctor may prescribe biktarivy for patients on disalysis and for patients not yet on diolysis . your dose will be adjusted by your doctor as well as the dose of this medicine . you may be at increased risk
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should contact your doctor immediately : - inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . these are called autoimmune disorders , when the immune system attacks healthy body tissue . this reaction is particularly common in patients taking medicines for hiv infections .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal on the container in order to protect from light . if the medicine is not used immediately , in - use storage times and conditions prior to use are the responsibility of your doctor and would normally not be longer than six months at 2 - 8 . avoid exposure to moisture .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bicentegravic sodium equivalent to 50 mg biccetegrar and 200 mg emmtricit abine , respectively , and tafovir alefenafentamide fumarate equivalent to 25 mg tenovir altafène . the other ingredients are : tablet core microcrystalline cellulose , 3cp , collapsible , microcrystalline sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide , macrogol , the talc , iron oxide red ( e172 ), iron oxide black ( i ) and sunset yellow fcf (
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetic diabetes in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . it is used either alone or in combination with metformin , which is also used for diabetes . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not take novonorm if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if your doctor has told you that you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking novonourm : if - you have a severe liver disease . it is important that you take gemfibrozil ( a medicine used to lower increased fat levels in your body ). 47 if any of these apply to you , tell your doctor . there is insufficient experience in patients with liver problems . novonlorm is not recommended in patients having moderate liver disease ( see section " do not taking novoorm "). - your doctor will not prescribe novonom - if there is a history of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each of the three main meals . your doctor may prescribe you a lower dose of 4 mg to be taken immediately before each major meal , if needed . if your doctor prescribes lower doses of 30 mg to you then the dose may be increased to 16 mg once daily . do not take more novonorm than your doctor tells you to . this will help your blood sugar to control a hypo . it is important that you stop taking novonourm if this happens . you should contact your doctor if : you have problems with your diabetes . interrupting or stopping your treatment may lead to a problem 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogycaemia which may affect up to 1 in 10 people ( see a hypo in section 2 ). hypoglacyaemic reactions are generally mild / moderate but may occasionally develop into hypogLYcaemic unconsciousness or coma . allergy allergy is very rare ( may affect less than 1 in 1 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this is anaphylactic reaction . other side effects include : very common : diarrhoea common - hypogliescaema in children ( 6 months to 17 years of age ) - rash uncommon : rash reporting of side effects 23 if you get any side effects
what novonorm contains - the active substance is repaglinide . - other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol 85 %, magnesium stearate , meglumine , and poloxamer . the printing ink is made of iron oxide yellow ( ph - 1 ), iron oxide red ( pph ) only in the 1 mg tablets and iron oxide black ( w - 2 ). what novoorm looks like and contents of the pack novonorg tablets are beige , round and debossed with the number " 0 . 5 " on one side and " 1 " on the other side . novonourm is available in
pumarix is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandem flu are similar to those of ordinary flu but may be more serious . how pumarx works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) produces its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarich may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , tell your doctor or nurse before having the vaccine . warnings and precautions talk to your doctor , pharmacist or nurse prior to receiving medical treatment if your child developed an allergic reactions after receiving pumarx . you should not receive this vaccine if 33 you have been given pumariris in connection with any allergic reaction other than a prolonged life  - potentially life threatening allergy to any
pumarix should only be given to adults aged 18 years and over . if you are not sure , talk to your doctor or nurse before you are given pumarx . the recommended dose is a similar h5n1 as03 to be given by your doctor , nurse or pharmacist . adults who are not vaccinated should not receive pumarice . when given as an injection , pumarize is given to children aged 3 - 9 years and adolescents aged 3 months - 17 years . your doctor will decide the appropriate dose based on body weight . pumarux is given as a single injection into a muscle . this will usually be in the upper arm . should you have any further questions on the use of this vaccine , ask your doctor, nurse , or pharmacist or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions can cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . your doctor will tell you what emergency treatment you need to take . other side effects very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles or joint pain common ( might affect up to 1 in 100 people ) redness or swelling where the injector is given fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to one in 100 persons ) hives ( urticaria ) feeling sick . common ( will affect upto 1 in every 100 people anaemia ) allergic reactions ( hypersensitivity ) reporting of side effects 23 if you get any side effects talk to your doctor , pharmacist or
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / vietnam / 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc - 2 ) in 0 . 5 ml haemagglutinin . when the pandemic is declared , the vaccine contains an ' adjuvant ' as03 . this adjuvan contains squalene , 3 - tocopherol , polysorbate 80 and water for injections . adjuants are used to improve the body ' s response to the vaccine . other ingredients : sodium chloride , disodium hydrogen phosphate / potassium dihydrogen phosphat . potassium chloride is also contained in water for injecting
somakit toc is a radiopharmaceutical product for diagnostic use only . it contains the active substance edotreotide . the powder for solution for injection contains a small amount of a nuclear medicine called gallium ( 68ga ) chloride , known as gallium( 68gga ] edéotretide which can be present in large amounts in the blood . for this procedure , gallium is dissolved in water for injections and edetreototide is passed from the vein into the body areas in the laboratory in a medical imaging procedure ( called positron emission tomography ). this medical procedure involves taking pictures of the abnormal cells and tumours , and these can be detected using your disease . somamakit tc does not interfere with the results of the procedure . your doctor and the nuclear medicine
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using somamakit tc : - you have had allergic reaction to any of those in the previous section ( see section 4 " contents of the pack and other information "). talk to you doctor or nurse before using this medicine : it is important that you tell your doctor if any of these apply to you . - tell your family or friends if they have kidney or liver problems . it is especially important to tell your doctors if your liver does not work properly . this is because renal or hepatic disease may occur in children and adolescents under 18 years of age . there is a risk of dehydration during and after the examination . children and
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in special controlled areas . this product will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . 29 the nuclear medicine doctor supervising the procedure will decide on the quantity of somаkit tock to be used at the chosen date . the usual quantity of the somákistan will be 100 mbq ( megabecquerel , the unit used to express radioactivity ). administration of somekit tof will depend on the type of product being used and the type to be administered . administration of megabequerell , as well as the usual storage conditions in the country where the product is stored 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc and can include symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . this will be detected by low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects get your doctor , pharmacist or nurse . your child ' s doctor will provide you a list of all the side effects you need to know before you use somаkit tok . if you get any side effects talk to your doctor or pharmacist . these include : very common side effects ( may affect more than 1 in 10 people ): - redness at
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . before the product is used , the specialist will ensure that all information is provided regarding radiolabelling . somakit toc can be stored for up to 4 hours at room temperature ( up to 25 ) before use . do not refrigerate or freeze . store in the original package to prevent deterioration of radioactive products .
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 micrograms of edeotreotrotide ( 10 - phenanthroline ), gentisic acid , mannitol , formic acid . - solvent : sodium hydroxide , water for injections . ( for sodium , see radiolabelling for further information ). - after radiolamination , the solution contains a substance called hydrochloric acid for radiopharmaceutical preparation . what sommakit tc looks like and contents of the pack som akit is a white powder for solution for injection . it is supplied in a glass vial with a black flip - off cap . the vial contains : a clear powder in  a
what afinitor is afinitour is an anticancer medicine containing the active substance everolimus . everolim reduces the size of the tumour and slows down the growth of cancer cells . how afinititor works afinitr is used in combination with hormone receptor - positive advanced breast cancer ( postmenopausal ) in adult patients who do not have enough non - steroidal aromatase inhibitors to treat the disease under control , and in combinationwith a medicine called exemestane ( a steroids aromatasiase antagonist ) and hormonal anticancancer therapy in adult women with advanced tumours ( neuroendocrine tumours that affect the stomach and bowels ).
you should not be given afinitor if you are having cancer treatment . don ' t take afinitour if any of the above apply to you . if the use of afinitr is not recommended , tell your doctor without taking the tablets . do not use afinitare if : you are allergic to everolimus , to sirolimus or temsirolim or any ofthe other ingredients of this medicine ( listed in section 6 ). if this applies to you as you may not be able to take the tablets as you will not be eligible for the first dose . you are not allergic to afiniter . talk to your doctor before taking the tablet if your doctor thinks you may have any problems with your liver . tell your doctors if there is any disease which may affect your liver ( see section 4 ). your doctor may prescribe a different dose of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . take your first dose in the morning . swallow the tablet whole . do not chew , crush or split the tablet . if your doctor thinks you may have taken too many tablets , tell your doctor straight away . patients with liver problems may need a lower dose of afinitor : the usual starting dose is 5 mg once daily ( 1 tablet of 5 mg ) or 7 . 5 mg twice a night . this may be increased up to seven tablets a morning , twice , every day , for example to reduce certain side effects . stop taking afinitor if any of the above apply to you , or if someone else accidentally takes your tablets . continue treatment at the recommended dosage .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you notice any of the following : signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with afinitr : very common ( may affect more than 1 in 10 people ): increased temperature and chills ( signs of infection ) fever coughing difficulty breathing wheezing ( signs are inflammation of the lung called pneumonitis ). common ( might affect up to 1 in every 10 people and may affect upto 1 in each 10 people who took the medicine ) coughing up blood dry mouth sneezING , coughing , difficulty breathing , wheeziness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . once you start taking the tablet , the tablet must be taken immediately . open the blister and store in the original package in order to protect from moisture . only open the tablet once opened . discard the tablets . this medicine is for single use only . any used tablet must not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus . one tablet of afinitour 2 . 5 mg contains 2 , 5 mg of everolim . another tablet of pouritor 5 mg consists 5 mg ( 1 , 000 mg of Everolimus in each millilitre ). another tabletof afinitr 10 mg contains 10 mg ( 2 - 1000 mg of neverolimus) in each tablet of droitria . the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate ( i . e . lactose monohydrate ( 0 . 54 milligrams ), hypromellose ( cb ), and crospovidone ( k29 ) ( containing lactoses anhydrous ). what afinior looks like and contents of the pack afiniter 2
what laventair ellipta is lavent air - pumping device what laVENTair ellipt consists of two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what lavantair elippte is used for laventaire ellippta helps control chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary system . when you use this medicine regularly , it helps to control your breathing difficulties and reduce the number of sporadic infections .
do not take laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not taking this medicine and tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before taking lavent air - to - air , and during treatment : if your doctor thinks this medicine is not suitable for you . - asthma . talk to you doctor before taking this medicinal product if : you have heart problems or high blood pressure you have an eye problem called narrow - angle glaucoma you have or have had an enlarged prostate , difficulty passing urine or a blockage in your bladder you suffer from epilepsy you have thyroid gland problems you have diabetes or severe liver problems immediate breathing difficulties 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair eellip a regularly , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . laventAIR ellippa should not be used to relieve a sudden attack of breathlessness or wheezing . if this is a problem you need a quick - acting reliever inhaler ( such as salbutamol ). how to use the in
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms after taking laventair ellipta stop using this medicine and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects( may affect less than 1 in 1 , 000 people ]: swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( collapse ) common side effects (2 may affect more than 1in 10 people ), including severe allergic reactions ( hypersensitivity ) swollen glands ( oedemo ) unusually heavy or painfully heavy menstrual cycle ( stevens - johnson syndrome ) allergic
what laventair ellipta contains the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclodinium brmide ) and 22 microgram ( the equivalent of 22 microgramms of vilantrol ) as trifenatate . the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellippta contain lactoses ') and magnesium stearate . what laVENTair elept a looks like and contents of the pack laventAIR ellipeta is an inhalations powder . - the ellipinium inhaler consists of a light grey plastic body , a red
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target in the body called il - 23 . tremefy is used to treat adults with psoriasis that is moderate to severe " plaque ppsorasiase ". this is an inflammatory condition that affects the skin and nails . improving the condition of the skin by reducing the appearance of nails and thereby reduce symptoms such as scaling , shed , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you are given trempfyya and tell your healthcare professional if any of these applies to your child . if your child is allergic to peanut or soya or to any of its other ingredients . warnings and precautions talk to your doctor or healthcare professional before you receive tresfy : if the child has an active infection or if there are active tuberculosis warnings or precautions you should tell your physician before you have treremfa : you have an infection or plan to get an infection . you have ever had tubercusis or are at risk of tubercleosity . your doctor will check
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given once a week under the skin ( subcutaneous injection ). the next 4 to 8 weeks should be given after each injection . injecting trempfy if your doctor thinks you may have used more trepfyya than he or she should , talk to your doctor about it . if possible , you or your caregiver can give tregfye at any time during treatment . it is important that you continue receiving trekfyam for as long as your physician tells you , even if this has not worked . your doctor will regularly monitor your condition to check that it is having
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect - serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects include : other side effect ( may affect up to 1 in 10 people ) upper respiratory infections common side effects ( may effect up to1 in 10 persons ) headache , joint pain , dizziness , feeling unwell reporting of side effects 22 if your child gets any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine should not be used if the solution is cloudy or contains large particles . after first opening of the refrigerator , the pre- filled
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of guzelkUMab in 1 ml solution . - other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what TREmfYa looks like and contents of the pack solution for injection : trempfyya is a clear , colourless to pale yellow solution , supplied in a carton pack containing one single - dose glass sYringe or a multipack containing 2 ( 3 packs of 1 ) single  - do pre  – filled pens . not all pack sizes may be marketed .
trepulmix contains the active substance treprostinil . treprastine belongs to a group of medicines called prostacyclins . prostacycles are hormones that play an important role in blood pressure by relaxing blood vessels . by acting on the impulse , prostacins prevent blood from clotting . the active ingredient in trepelmix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients with persistent or recurrent ctéph who cannot be treated with surgical treatment . it improves exercise capacity ( the ability to carry out physical activity ) and relieve symptoms of the disease . chronic thomboebolic pulmonary hypertension in adult women whose blood pressure is too high because the pressure is tightening the blood vessels of the heart and
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking trepelmix . warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have a disease called " pulmonary veno - occlusive disease " ( a diseases where the blood vessels in the lungs become swollen , leading to a higher pressure in the blood vessel between the heart and the arteries ). you have severe liver disease . you have had a heart problem after a cardiac attack ( myocardial infarction ) within the last six months you have experienced severe changes in heart rate severe coronary heart disease or unstable angina a chest defect due to faulty heart valve . your doctor may want
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( injection under the skin ) through a small tube ( cannula ) in the abdomen or thigh . your doctor will decide how much tre Pulmix you need and for how long . the recommended dose is one vial , twice a day , in the morning and evening . you will also find a portable pump with your treprostinil . before you start to inject treulmix , your doctor may tell you to check the infusion line , and to adjust the inflow line if necessary to avoid accidental overdose . doses usually start at 1 , 2 . 5 , 5 or 10 doses per day . depending on
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people widening of blood vessels pain at the infusion site reaction , including the infustion of the inflow site bleeding or bruising at the site of the intrusion headaches nausea diarrhoea jaw pain common ; may affect up to 1 in 100 people dizziness , light - headedness / fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgiia) swelling of feet , ankles , hands or feet common . not known : frequency cannot be estimated from the available data swelling of hands or legs ( tachycardia ), trepulmix may cause bruised or crusty patches or crusting of the skin at the injection site
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the original carton in order to protect from light . a trepulmix vial may be stored at room temperature ( up to 30 ) for up to one week before use , and used for continuous subcutaneous infusion . in this case , a single réserve ( syringe ) of undiluted tre Pulmix may be kept at room temperatures and for upto 72 hours below 25 . this medicine is not to be used if you notice damage , discolouration or other signs of deterioration . any unused medicine must be discarded after this period 
what trepulmix contains - the active substance is treprostinil . treulmix 1 mg : each vial contains 1 mg of treprastINil ( as sodium salt ). each 10 mg vial of vials contains 10 mg of " trepstinningil " ( as salt ) . each trepelmix 2 . 5 mg / 2 , 5 mg viall contains 2 : 5 mg of deltoid alkaline phosphate ( as treparstilil ( AS sodium salt in each 10 ml vial ) or 25 mg of duoling of TREprossinil ( with sodium salt "). tre Pulmix 5 mg the 5 mg mg treperstinkil ( As sodium salt to be dissolved in the water . the 10 mg & 50 mg viaL via
thorinane contains enoxaparin sodium , which is a low molecular weight heparin ( lmwh ). thoresane works in two ways . 1 ) stopping existing blood clots from forming and 2 ) blocking the process of stopping blood coagulations in your blood . ththorine can help to prevent blood  clottings from getting in your life . it can help prevent blood co - ordination between your blood and prevent blood blood clumps from growing in the following places : - before and after an operation ; - after an acute illness ; and - when you have unstable angina ( a condition where your heart cannot pump blood to the blood ) or having a heart attack ; or - once again stopping blood cots forming in the tubes of your dialysis
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if your doctor thinks you may be allergic to any of these , ask your doctor for advice . warnings and precautions talk to your doctor before using thoresinan : if any of your medical conditions are not listed in this leaflet . you should tell your doctor if : you have previously used heparin or other low molecular weight heparains ( e .g ., nadroparin , tinzaparin ) or dalteparin ( see section 4 ). you have ever had 
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if there is evidence of excessive bleeding ( exceptional weakness , tiredness , paleness ), dizziness / headache / unexplained swelling ) consult your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . stop taking thoresinana and tell your doctor or seek medical help immediately if : you experience a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ) you may be at risk of blockage of a blood vessel by ablood clot . you experience cramping pain or shortness of breath you may experience discomfort
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . use this medicinal product immediately after reconstitution of the thorinane pre - filled syringes .
what thorinane contains - the active substance is enoxaparin sodium . each ml contains 100 mg of eoparin salt . one pre - filled syringe of 0 . 2 mL contains 2 , 000 mg of de - metered exaparIN sodium - each pre  -filled sYringe contains 2 000 mg de enomaparine sodium , respectively . - two separate injections ( 0. 2ml ) are required . what THorinans looks like and contents of the pack thORinanE is a clear , colourless type i neutral glass syed , pre  1 mler pre – filled , single - use sprinkling with fixed needle and needle shield , chlorobutyl rubber
senstend contains the active substances lidocaine and prilocaine . these belong to a group of medicines called local anaesthetics . senstende is used for the treatment of lifelong premature ejaculation in adult men . it works by decreasing the head of the penis to one more period of ejculation .
do not use senstend - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senstende - the risk of allergy or sensitivity to other local anaesthetics : senstendon is not a substitute for amide - type local anesesthesias . you should tell your doctor if any of these apply to you . - you have a genetic disease or other condition affecting your red blood cells ( glucose - 8 - 10 - 9 - glucose deficiency , anaemia or methaemoglobinaemia ). - your doctor should check you for medicine sensitivities and sensitivity before using , and during treatment if : you have severe liver problems 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of senstend is 3 sprays ( 3 spray sprinkles ) on the head of the penis . one spray ( 3 ml ) can be used within 24 hours . you should leave at least 4 hours between each spray . before using the spray container , check the pump mechanism before using it . avoid contact with eyes , nose , mouth and ears . senstennd should be used only as directed by your doctor . 1 ) injected into the foreskin under the head and in the penises ( valve ). 1 mL ( 3 in a row ) once in the morning . 3 litres / m2 is to be used in the evening . if your penis is not used immediately
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection feeling in the penis feeling of burning in the back of the peniest uncommon ( may effect up to1 in 100 people !) headache local irritation of the throat ( if inhaled ) irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling of thepenis pain or discomfort in the inner corner of the Penis itching in the lining of the genital area feeling of numbness or burning in your penis burning sensation in the gut or inability of genitalia feeling of weakness or unworthiness feeling of tiredness or weakness in the upper left side of the stomach upset or lack of energy
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . write down the date you open the container in the space provided . use within 12 months after first opening of the metal container . puncture / burn the container with the help of your doctor . keep the container tightly closed in order to protect from moisture . return the container to room temperature prior to use . never throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use , or ask your doctor how to recycle them . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocaseine and 50 mg prilicaine - each spray delivers 50 microlitres which contains 7 . 5 mg lidouine and 2 . 4 mg plocaine respectively . - one spray container of 6 . 6 mL delivers a minimum of 20 doses . one spray containers of 5 mlitre delivers  a maximum of 12 doses of light yellow cutaneous spray , solution in an aluminium spray container with metering valve . pack size : 1 spray container containing 6 , 5 - doses
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . opedivo can be used to completely remove advanced mlanoma , a condition that requires complete resection in adults ( treatment with surgery or adjuvant therapy ) and is used to : treat advanced non - small cell lung cancer : in adults advanced renal cell carcinoma : the treatment of advanced kidney cancer in adults classical hodgkin lymphoma : when previous therapies have worked or have stopped working . in adults an autologous stem - cell transplant . when a transplant is not possible . treat advanced cancer of the head and neck in adults advance urothelial carcinoma , in adults bladder and urinary tract cancer . how opondivo works opindivo contains nivolumab 
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). warnings and precautions talk to your doctor or pharmacist before taking opedivo and during treatment : if the following applies to you : problems with your heart such as a change in the rhythm or rate of the heartbeat or an abnormal heart rhythm . problems with the lungs such as breathing difficulties or cough may be signs of inflammation of the arteries ( pneumonitis or interstitial lung disease ). problems with diarrhoea ( watery , loose or soft stools ). tell your doctor if any symptoms suggestive of inflammation or colitis ( stomach pain ) have been reported in patients receiving obdivo ( see section 4 ). if your doctor determines that you have inflammation of
the recommended dose of opdivo in each of the approved dosage systems is 240 mg , 2 mg or 480 mg / kg every 4 weeks . opedivo is also given in combination with ipilimumab for the treatment of skin cancer . the recommended starting dose of the oppdivo est : 1 mg nivolumab per kilogram of your body weight , given once every 4 months . your doctor will decide the dose of one obdivo 240mg ,2 mg or 4 mg . each opper unit contains 480mg or 4 ml of solution . when oopindi is given in conjunction with a drug called iipilumabe , it is used for the prevention of advanced kidney cancer , and opondivo should be used within 3 months after its onset
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store below 25 . write the date on the carton . use within 48 hours of first opening the viall . any unused portion of the infusion solution should be disposed of in accordance with local requirements . your doctor , nurse or pharmacist is responsible for disposing of any opdivo appropriately . all unused medicine or waste material should be in accordANCE with local requirement .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nyvolum b , corresponding to 40 mg per m2 of body surface area . - each vial of 4 mL contains 100 mg of 10 mbq at activity reference time . the activity per 0 . 5 mq product is equivalent to 240 mg / 24 mmol of  103 mg of the nitvolumb b *.  the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " oopDivo contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what if you use opmdivo
clopidogrel tad contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). cloclopidоgrel tod is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothromboses , and atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogreil t ad to help prevent blood co - ordination and reduce the risk of blood co co
do not take clopidogrel tad 30 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is important , you should tell your doctor before taking cloclopidоgrel toad . warnings and precautions if any of these apply to you , or if vous are in any doubt at all , consult your doctor or pharmacist before taking your first dose of clolidogre t ad ( see section 4 ). you should seek immediate medical attention if : you have a risk of bleeding such a mental condition that puts you at risk of internal bleeding ( such as such as an stomach ulcer ) or a blood disorder that
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogresl TAd ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet ( 4 tablet of the tablet ) per day as described above . you should take clopogrell t ad for as long as
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth , skin disorders such as rashes and itching , blisters of the Skin . all of these may indicate an allergic reaction . the signs may include reddening , unusually intense pain when swallowing . you may also experience a reaction to clopidogrel tad . tell your doctor 
what clopidogrel tad contains - the active substance is clopogrell . each film - coated tablet contains 75 mg of clopotogrelly ( as hydrochloride ). -the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide , the printing ink contains talc and macrogol 3000 in the film . what clupidogresl tar looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 or 28 film  cardboard tablets are available . not all pack
tacforius contains the active substance tacrolimus . tacforis an immunosuppressant . following your organ transplant ( liver , kidney ), your body ' s immune system will try to reject the new organ . you will also receive tacforitus if your body does not respond normally to the transplanted organ , and tacforivius is used to control your body'  s response . this will help your body to accept the transplant transplantee . your doctor will decide which organ you should receive , when to resume normal activity , for example after any previous treatment you were taking was unable to control this immune response after your transplantation .
do not take tacforius - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - allergic to sirolius or to any macrolide - antibiotic ( e . g , erythromycin , clarithromycin or josamycin ). warnings and precautions talk to your doctor or pharmacist before taking tacrolivimus immediate release capsules ( i . excipients , see ' other medicines and tacforinimus ' for further information . tacrolimimus immediate - release capsule capsules : e. p ., tacrolima ) if the patient is less than 6 months of age . during the post - marketing experience with tacforitus prolonged - released capsules the doctor will decide if tacforivius prolonged release capsule should
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different tacforlimus medicine . do not change the dose of this medicine unless the doctor has told that you that you are going to receive it . you should take this medicine regularly at the same time every day , at the right time and in the right way . these measures will help to prevent the rejection of your transplanted organ . the dose you receive will depend on your body weight and , in general , it is expected that you will be weighed before transplantation and will generally be in the range of 0
like all medicines , this medicine can cause side effects , although not everybody gets them . infections : tell your doctor about any signs of infections , which may be serious , because tacforius may cause severe effects . allergic and anaphylactic reactions , benign and malignant tumours have been reported following tacforitus treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis (  a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( an increase in the number of a type of white cells that fight infection ) have been documented in patients receiving this medicine . if you are concerned you may have an increased risk of infection . tell your healthcare provider if any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains the active substance is tacrolimus . tacforinius 0 . 5 mg : each capsule contains 0 to 5 mg of tacrolivimus ( as monohydrate ). tacforitus 1 mg / 1 mg capsule contains 1 mg of of tacrollimus ( As monohydrate). tacfordius 3 mg , 3 mg capsules contains 3 mg of : tacrolimimus ( AS monohydrate) . at the end of the leaflet there are no additional ingredients in tacforivius 5 mg and 5 mg capsule , which contain 5 mg tacrolifmus ( ( as monohydrate )). the other ingredients are : capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . capsule shell tacforeius 5 . 4 mg & 1 mg hard
clopidogrel zentiva contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). cloclopidagrel
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is important , you should tell your doctor before taking cloclopidоgrel
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor decides that you can take the tablet with or just after your meal , you should take clopogrell zentivea for as long as your physician continues to prescribe it . when you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth , skin disorders such as rashes and itching , blisters of the Skin . all of these may indicate an allergic reaction . the signs may include reddening , unusually intense pain when swallowing . you may also experience a combination of cough , sore throat and a runny nose . very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . if clopidogrel zentiva is supplied in aluminium blisters , store below 30 . however , if you ' re not sure , talk to your pharmacist or nurse before taking clopogrell zentive in all aluminium boxes . don '' t use this product if your wallet shows signs of deterioration . none of these measures will be omitted and should not be disposed of .
what clopidogrel zentiva contains the active substance is clopogrell . each tablet contains 75 mg of clopionogreil ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' cloclopidagrel
yttriga is a radioactive medicine . it is stored under the responsibility of the specialist in appropriate premises . storage is the responsibility for the specialist and will be done in appropriate facilities . for the treatment of patients , the use of yettrigga is the sole responsibility of a qualified doctor who is experienced in the use and handling of radiolabelled medicinal product .
do not use yttriga - yettrigga may be allergic ( hypersensitive ) to chloride or any of the other ingredients of yTriga ( see section 6 ). - you must not become pregnant , as yittrig , may become pregnant when you are breast - feeding . warnings and precautions talk to your nuclear medicine doctor before using yhtttroga : yytrigriga is not a radioactive medicine . it may interact with another medicinal product or radiopharmaceuticals . yph ytaga is a controlled substance . this means that it contains radioactive material . other medicines and ythtrigare tell your nuclear medicines doctor if you are using , have recently used or might use any other medicines . in particular , tell your doctor : medicines that contain
your doctor will determine and control the dosage and duration of the treatment . method of administration yttriga is for radiolabelling of medicinal products , which are to be used in the treatment of specific diseases . yttingtrig , in the event of overdose , will be contacted and appropriate treatment will be given .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor . reporting of side effects you get any side impacts , talk to your doctor or pharmacist . this includes any possible side effects NOT listed in the leaflet you receive . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your doctor can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use yttriga after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . storage under local regulations will be in accordance with national regulations on radioactive substances . any unused product or waste material should be disposed of in accordant with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 g of hydrochloric acid . 3 mL solution with a v - shapeled bottom , supplied in a colourless type i glass vial , containing 10 mg of solution , provided in tamper proof with  a flat bottom . the vial is closed with : a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciamba is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in patients where ciaMBa is not effective or has not been tried before , it is also given in combined with  Cisp Latin for the initial treatment of patients with advanced stage of lung cancer  . you will be given ciaba if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy , but ciabro is also a treatment for patients with stage of long - term stage of  lung cancer who have had other initial chemotherapy before .
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - do not breast - feed during treatment with ciaba . - have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving ciamba . you may already be receiving a lower dose of cisplatin , which will be given in hospital . your doctor will check your blood before each infusion to make sure that you have sufficient kidney and liver function and to check that you still have enough blood cells to receive the medicine . before receiving the medicine you will have your blood cell counts checked as normal . sometimes , when you are given ciaplatin for the treatment of a patient , your doctor may decide
the dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your normal body . you will use this body surface area to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the ciaba powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you , and the doctor or hospital pharmacist will arrange for the infusion to be given over approximately 10 minutes . when ciabira is given in combination with cisplatin , the doctor will work out your heightand weight . the doctor then gives you cisse for infusion into one of your vein
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your doctor has told you that you have a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if u . in a pinch , you may have chest pain ( common in people with a fast heart rate ). if there are pain , redness , swelling or sores in your mouth ( very common in children ). allergic reaction : o skin rash ( very commonly referred to as burning or prickling sensation ), fever ( common) - skin reactions : very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . chemical and physical in - use stability of the infusion solution of pemetrexed was demonstrated for 24 hours at 2  8 and 15 to 25 . from a microbiological point of view , the reconstituted solution should be used immediately after preparation . if not used immediately , in  - usage storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours below 2 ° c . for the unopened vial , chemical and electrical in  85 and physical - chemical in ' use stability was demonstrated at 15
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetrexxed ( as pemetreixed disodium hemipentahydrate ). ciaba 500 mg ; each viall contains 500 milligramms of pmetrexeed ( aspemetrex d dissodium disophthal hemimahydrate). after reconstitution , the solution contains 25 mg / ml of pemeterxeed per mL . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further phe adjustment ). see section 2 " ciabride contains
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) which are used to prevent certain infections . immunogam works by reducing the amount of virus in your blood . you may receive immunogam at increased levels compared to human hepatitis b immunoglobularins , such as immunoglobuin g ( igg ) in the blood plasma of screened patients . the active substance of immunogam is heparin b . this is used to treat hepatis c , a protein that is found in the body of haemodialysed patients whose condition is not well controlled . vaccination with a hep b virus carrier is an immune response . there are no measurable hetis
immunogam should not be used : if you have ever had an allergic reaction to human immunoglobulins or other blood products . if there is an iga deficiency , an allergic response may occur to iga containing products , or to other blood medicines . warnings and precautions talk to your doctor , pharmacist or nurse before you are given immunogam . children and adolescents ( aged 18 years and above ) the safety and efficacy of immunogam in children and young people is not known . adverse reactions may include chills , headache , fever , vomiting . allergic reactions may also include nausea , arthralgia ( joint pain ), low blood pressure , and moderate low back pain . antibodies will be made to replace hepatitis b immunoglobularin regularly and prevent human hepatis a immunoglobulation injections . the safety
immunogam is intended for vaccination against hepatitis b virus . immunogam will be the first vaccine dose to be administered with human hepatis - b immunoglobulin . dose and administration prevention of hepetis
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effects 1 to 10 users in 100 ) uncommon ( affect 1 to 100 users in 1 , 000 ) rare ( effects between 1 to10 users in 10 to 10 ,000 ) very rare ( impacts less than 1user in 10 10 . 000 ), very rare (9 effects less than1 user in10 , 00 ,0000 ) not known ( frequency cannot be estimated from the available data ) undesirable effects which occurred during clinical trials with immunogam , the frequency cannot been estimated from available data in clinical trials . immunogam is injected into a muscle very rarely ( effects in less than 10 users per 1 . 1 ml ) in patients 7 years of age and
keep this medicine out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the outer carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viall in the outer container in order to protect from light . it is recommended that the product is used immediately after dilution . this is because the solution is cloudy , discoloured or has deposits or is not coloured . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / ml solution for injection in a glass vial is a clear to slightly pearly , colourless to pale yellow liquid . pack size of 1 vial .
remicade contains the active substance infliximab . inflitismab is a monoclonal antibody a type of protein that attaches to a specific target in the body called tnf ( tumour necrosis factor ). remikade belongs to  a group of medicines called ' ttf blockers '. it is used in adults for the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew 's disease ) psesoriasis . remiere is also used in children and adolescents aged 6 years and older for : crohn '
do not take remicade if you are allergic to infliximab or any of the other ingredients of reMICade ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor thinks you may be allergic ( hypersensitive ) to peanut or soya . warnings and precautions talk to your doctor , pharmacist or nurse before taking remikade and if any of these apply to you ( or you are not sure ). you have tuberculosis ( tb ). or another serious infection known as pneumonia or sepsis . your doctor may want to monitor you more closely . you have heart failure that is not well controlled . check with your doctor or pharmacist before taking the medicine if it has worked for you . take special care with reminiade see if the above applies to
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psesoriasis , ulcerative colitis and crohn 's disease the usual dosage is 5 mg for each kg of weight , given every other week . how remicade is given reMICade will be given to you by your doctor or nurse , in a hospital or clinic . your doctor will give reminiade as an infusion . the medicine will be prepared and given as an imfusion ( drip ) over 2 hours into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give a lower dose . you will be monitored while you are given .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , and skin discoloration . other side effects include : very common
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after " exp ". the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). this medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 for a single period of up to six months , but not beyond the original expiry . in this situation , do not return to refrigerate again . write the new expiry dates on the carton including day / month / year . discard this medicine if not used by the new use by the newly purchased product , whichever is earlier . it is
what remicade contains the active substance is infliximab . each vial contains 100 mg of infligimabe . after preparation each ml contains 10 mg of of influliximb  . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphat . what rmicades looks like and contents of the pack reMICade is supplied as a glass vial containing a powder for concentrate for solution for infusion . before it is diluted , the powder is white . relicade comes in packs of 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it is used together with levodopa ( another medicine that is used to treat parkinsons ' disease ). with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopami is  a chemical in the body found in people who have movement control . rasagide mylan helps to increase and sustain levels of dopine in the mind .
do not take rasagiline mylan - if you are allergic to rasagiline or any of the other ingredients of this medicine ( listed in section 6 ). -if you have severe liver problems . - take the following medicines while taking rasagile mylan: - monoamine oxidase ( mao ) inhibitors ( e .g . for treatment of depression or parkinson ' s disease ) - medicinal and natural products without prescription e. g , st . martinson' 's wort - pethidine ( a strong pain killer ). you must wait at least 14 days after stopping rasagide mylan treatment and starting treatment with mao inhibitors or pethine . warnings and precautions talk to your doctor before taking rasagieline myLAN : if : you suffer from mild to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan can be taken with or without food . if your doctor decides that you should take rasagile mylan , he or she will tell you what dose to take . take the number of tablets as instructed by your doctor and follow the instructions of the doctor or nurse carefully . do not take more rasagilline myLAN than your doctor has recommended . taking more rasagitiline Mylan than you should if possible take your tablets or the box with you , or if someone else has taken your tablets , contact your doctor immediately . keep the rasagide mylan carton with you so that it is clear what you have taken . you may take more than
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported in patients treated with placebo : the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( impacts in 1 to 10 users in 100 ) uncommon ( impacts on 1 to 1 user , 000 ) very rare ( impacts down to less than 1 patient in 10 000 ). very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell neck pain chest pain ( angina pectoris ) swollen ankle , back pain , muscle pain . not known ( frequency cannot be estimated from the available data ): dizziness , lightheadedness . reporting of side effects 23 if you get any side effects talk to your
what rasagiline mylan contains - the active substance is rasagililine . each tablet contains rasagileline tartrate equivalent to 1 mg rasagille . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize flour , talc , staric acid what rasageline myLAN looks like and contents of the pack rasagiziline tablets are 11 . 5 mg tablets and 6 mg tablets are white , round , biconvex tablets , debossed with " gil " and " 1 " underneath on one side and plain on the other side . the tablets are provided in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets and in perforated blister packs containing 7 x10 , 14x1 , 20x1 or 30x
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your child has a severe infection , including tuberculosis . warnings and precautions talk to your doctor , pharmacist or nurse before using hülio you should tell your doctor before using this medicine if he / she is experiencing symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . you have moderate or severe heart failure . it may be a serious heart condition . allergic reaction : allergic reactions with symptoms such as chest tightness , wheezing , dizziness ; swelling or a rash . these reactions usually develop quickly after the injection is given . infections : tell your healthcare professional if
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents ( from 2 to 17 years old ): the usual dose is 10 mg once a day for patients weighing 30 kg or more . hulio 20 mg can be used in children , adolescents and adults from 2 up to 17 months of age weighing at least 30 kg . your doctor will prescribe hULio 40 mg once daily . children ' s disease in children ( from 6 to 17 year old ), adolescents and adult ( from 5 to 17 decades old ). the usual starting dose is 15 mg once weekly . when a patient is weighing less than 30 kg the recommended dose of hülio is 40 mg twice daily , depending on the weight of the child 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur up to 4 months or more after the last hulio injection . seek urgent medical attention if you notice any of the following signs of allergic reaction or heart failure : severe rash , hives swollen face , hands or feet ; trouble breathing , or swallowing ; pale complexion ; dizziness ; persistent fever ; bruising or bleeding ; signs and symptoms of infection such as fever , feeling sick , vomiting , nausea and vomiting ; all of these may be signs of serious liver problems . tell your doctor as soon as possible if any of these signs occur . signs and effects include : fever / feeling sick or being
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , and water for injections . what heilio looks like and contents of the pack hULio 40 mg solution for injection in vials is supplied as a sterile solution of 40 mg aad alumumabat in 0 . 8 ml solution . it is clear or slightly opalescent and has a rubber stopper . hülio is available in packs containing : 1 vial containing 2 vial ( 0x1 ), 1 sterility injection syringe , 1 steile needle , 2 steril
yellox contains bromfenac , which belongs to a group of medicines called non - steroidal anti - in - inflammation drugs ( nsaids ) that reduce inflammation . yyelloX is used to reduce eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using yyelloX if : - you have asthma - your doctor has told you that you have skin allergy - this is because you may experience intense inflammation in your nose when using other nsaids . y yellowx may be used with other ngsaid : in combination with acetylsalicylic acid , ibuprofen , ketoprofened , diclofenocide . in addition , this medicine may be administered in combinationwith topical steroids such as cortisone , which reduce the chance of unwanted side effects . talk to a doctor if any of these apply to you . you should tell
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of yellox is one drop in the affected eye ( s ) once a day in the morning . your doctor may decide to increase your dose to one drop each day , or to two drops in the same eye ( in the evening ). use for 2 days before your cataract surgery . method of administration yellowx is for oral use . wash your hands before using the eye drops . twist off the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid with a finger at the bottom to release the bottle tip . do not touch your eye or the area you are using .
what yellox contains - the active substance is bromfenac . each ml of solution contains bromfienac ( as sodium sesquihydrate ). each syringe contains 33 mg bromfed . - other ingredients ( excipients ) are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , to tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to keep acidity levels . what Yellox looks like and contents of the pack yyellock is a clear yellow liquid ( solution ) supplied in a 5 mL vial with a screw cap .
dzuveo contains the active substance sufentanil , which belongs to a group of strong painkillers called opioids . sufenteanil is used to relieve sudden moderate - to - severe pain in adults .
do not use dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - when you have a serious lung or breathing problem . warnings and precautions talk to your doctor before using d Zuveo and if : - you have any condition that affects your breathing ( such as asthma , wheezing , or shortness of breath ). the effects of dzoneo may affect your breathing . your doctor may advise you to stop treatment if this applies to you . - your doctor will check your heart and circulation regularly ; - it is important that you tell your doctor if any of these apply to you before you start using , during or after treatment ; you have had a head injury or brain tumour . the doctor may monitor your heartand circulation , especially if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device should be connected to the patient ' s doctor or nurse . this medicine should be taken during meals . dzuveo must not be used with strong painkillers such as sufentanil . it must be taken at least 30 minutes before or after the first use of the sublingual tablet . use only the disposable single  dose applicator . insert the applicators under the tongue . once the tablets dissolve under the gum , the tablets dissolve under the skin and provide pain relief , you can press the applaining the tablet onto your tongue , allowing the tablet to be easily swallowed . you can use the appl if applicated to the tongue for 10 minutes . your doctor may decide to
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you have any of the following serious side impacts : severe breathing problems . this may include slow and shallow breathing . if any of these side effects occur , tell your physician immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ) and vomiting ( being sick ), feeling hot . common side impacts ( may effect up to 1 in10 people ), include inability or difficulty sleeping . reporting of side effects 23 if your child gets any side effects talk to your doctor , pharmacist or nurse . these include any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2c 8c ). do not freeze . keep the vial in the outer carton in order to protect light and oxygen . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after opening , dzuveo should be used immediately . if this is not treated , the product should not be administered if it shows signs of deterioration . any unused medicine or waste should be disposed of in accordance with local requirements .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufenteanil ( as citrate ). - other ingredients are mannitol , dicalcium phosphate , hypromellose , crohn ' s sugar , indigo carmine ( e132 ), stearic acid , magnesium ste arate . what szuveon looks like and contents of the pack dZveo is a white to off - white tablet with round edges ( approximately 3 mm ). it is supplied in a single - dose applicator ( labelled [ sublingual tablet ].]). the applicant contains one sufenil 30 mg sublingual tablets . pack sizes of 5 and 10 applicators . not all pack sizes may be marketed .
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . erlesad is used in adult men whose sensitive prostate cancer cannot be completely removed by surgical treatment . in adult males whose body is damaged and cannot tolerate treatment with testosterone - resistant prostate cancer , erleda targets the body with its own antigen called androgens , which helps to destroy the cancer . androgents - like agents like apalutamide have been shown to stop prostate cancer cells from growing and dividing .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - when you are pregnant or think you may be pregnant ( see section pregnancy , contraception section and breast - feeding ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine is not a cure for seizures . tell your doctor if your doctor is taking any medicines to prevent blood clots ( e . g . warfarin or acenocoumarol ). tell your doctors if any heart or blood vessel conditions that you have or have had heart rhythm problems ( arrhythmia ). this is because er lead to an increased risk of falls . your doctor will decide if erlesad er leadda is right for you . take
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 240 mg twice a day for up to 60 days . your doctor will decide how much erleada you need and for how long . always take the dose recommended by your doctor . this medicine is taken by mouth . take erleda every day until your doctor tells you otherwise . taking other medicines take ersleaa at the same time . if your doctor thinks you may need to take more erlesad , contact your doctor right away . you may find it easier to take a smaller dose than you should if side effects occur . how long to take take ERleadea for as long as your medicine works for you , it is important to keep taking er lead you to get the full benefit
like all medicines , this medicine can cause side effects , although not everybody gets them . patients treated with erleada have reported the following symptoms : - reddish , non - elevated , target - like , circular patches on the trunk which may form central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may also be preceded by fever and flu -like symptoms . ( toxic epidermal necrolysis ). serious side effects the following side effects have been reported : fit - up ( uncommon ) or seizure ( uncommon may affect up to 1 in 100 people ). tell your doctor straight away if you get a serious fit . seizured state ( uncommon uncommon ). if this happens , stop taking erlesad
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe - other ingredients are tablet core : colloidal anhydrous silica , croscarmellose sodium , the hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cellulite . the film consists of iron oxide black ( e172 ), iron oxide yellow ( i . e 172 ) and macrogol . printing ink : shellac , polyvinyl alcohol , cider , titanium dioxide ( е171 ). what era looks like and contents of the pack erlesad a film , coated tablets are slightly yellowish and round . they are marked with " gsi "
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient luciclovine and is used to obtain information about a certain type of scan ( called a pet scan ) from people who have not previously been treated for prostate cancer . before treatment , other tests will be performed to check the presence of prostate specific antigen ( psa ) in the cancer , before an acumin pet scan is performed . the doctor will decide whether the cancer is the same as expected based on the results of the scan . use of apumin does involve exposure to small amounts of radioactivity . your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radiopharmaceuceutically available as an alternative method of exposure to radiation .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using ayumin you may have kidney problems if this is the case you are on a low sodium diet . you should not take a lot of azumin during the day before the aXumin scan , and at least 4 hours after the scan . - take all your usual medicines and avoid taking any food during the 60 minutes before the AxumIN injection . this is to avoid urination . the scan will be repeated at about the same time every day . children and adolescents aaxUMin is not recommended for use in children and teenagers under 18 years old . other medicines and ajaxumine tell your doctor 
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in special controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of azumin to be used at the chosen date . the usual dose of 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of  accession and conduct of the procedure auxumin is given by injection into a vein , followed by a flush of sodium chloride solution . duration of the administration of the dose the radiopharmaceutic process will be supervised by
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( affecting less than 1 in 100 patients ). axumin was administered by a doctor who was trained in the art of delivering radioactivity . the doctor , nurse or pharmacist will show you the side effects of aXumin . this is uncommon ( affects less than1 in 100 users ). you may experience pain , rash , altered taste in the mouth , and altered sense of smell . all of these effects are mild to moderate and disappear as they do not last long . your doctor will take special care with this radiopharmaceutical . it will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects tell your doctor if you get any side effects talk to your doctor or
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . keep this medicine out of the sight and reach of children . do not use axumin after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . a xum in 1600 ml solution for injection each tablet contains 1600 iu of flucclovine ( as 16000 ius ). apumin 3200 mbq : each tablet delivers 3200 international units of ficluciclovin ( as 3200 or 32000 iiu ). the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " aXumin has a low sodium "). what xamin looks like and contents of the pack azumin 1600 u / mq is a clear , colourless solution . it is available in glass vials containing 1600  ac , 1600 hdpe tablet and 16000 in a multidose
azopt contains the active substance brinzolamide . this belongs to a group of medicines called carbonic anhydrase inhibitors , which help to reduce pressure within the eye . aziopt eye drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma . the pressure in your eye is too high . it can also damage your sight .
do not take azopt if you have severe kidney problems . you must not take brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). you must tell your doctor if : you are allergic to medicines called sulphonamides ( medicines used to treat diabetes , infections and diuretics ( water tablets ). warnings and precautions talk to your doctor before taking aezopt : if your doctor thinks you may have the same allergy as he / she has caused too much acidity in your blood ( hyperchloraemic acidosis ). before you take , or after you take the tablets , tell your doctors that you have had them . talk to you doctor before you start taking , and during treatment with azeropt , if any of these apply to you . if the doctor think you may be allergic to brin
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one bottle in the morning and one in the evening . use in children and adolescents the recommended dosage is 1 bottle in each eye . do not use in babies unless your doctor tells you to . azopt should only be used in children . for children a 12 - year old , use a similar dose to that in adults . it is best to use if your child is older than 12 years of age . your doctor will tell you how much arizopt you should use . how to use use in adults 1 - 2 - 3 years of experience with adopt , your doctor may tell you to use it for your eyes . 1 2 -3 months of age and older agopt bottle :
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been seen with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , ear pain , and eye discharge . itchy eye , dry eye ; abnormal eye sensation ; redness of the eye other side effects in children and adolescents are : bad taste uncommon side effects that may affect more than 1 in 100 people - impacts in children are - allergic reactions , such as rash or itchy eyes . reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , protect your tablets from moisture . a pack containing a single bottle will not be suitable . keep the bottle tightly closed in order to protect from moisture and light .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzolani . - other ingredients are benzalkonium chloride ( see section 2 ), carbomer 974p , edetate disodium , manitol , purified water , sodium chloride , and tyloxapol . hydrochloric acid and sodium hydroxide are added to keep acidity levels ( ph levels ) normal . what - azyopt looks like and contents of the pack azeopt is a milky liquid ( a suspension ) supplied in a 5 mL plastic ( droptainer ) bottle . it is available in : a 10 mlitre plastic ( driptainer
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxxiga is used in adults ( aged 18 years and older ) to treat diabetes in a certain type of type 1 diabetes where your body does not produce any insulin . the active ingredient in forxika is in the type 1 type of diabetes in which you are overweight ( obese ) and in type 2 diabetes where the body does NOT produce insulin , and the insulin that your body produces does not work as well as it should . this is called a ' long - term ' diabetes '. forixiga works by removing excess sugar from your body via your urine . you may also be given other medicines to help
do not take forxiga if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking forxika : if any of these apply to you : feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a fruity or metallic taste in your mouth , an odour to your urine or sweat or rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a serious , sometimes life - threatening problem you can get with diabetes because of increased levels of " ketone bodies " in your urine and blood , which can be fatal . if your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of forxiga for type 2 diabetes is 10 mg once a day . your doctor may prescribe a lower dose of 5 mg once daily if your liver problem is not controlled well enough with forxika . for type 1 diabetes the recommended starting dose is 5 mg twice a week . taking this medicine swallow the tablet whole with some water . you can take the tablet with or without food . the tablet may be taken with or just after food , if needed . take the tablets at about the same time each day , one hour before or two hours after food or a meal . this will help you to remember to take it . diet and exercise can lower your blood sugar and help you stay alert to signs of blood sugar changes . follow your doctor 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking forxiga and see a doctor straight away if you notice any of the following serious side effects you may need urgent medical attention : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ) these are signs of angioendema you may experience : swelling of the face , tongue or throat ; difficulties swallowing ; hives and breathing problems diabetic ketoacidosis , see also section 2 : if your doctor determines that they are the cause of this . type 1 diabetes , observed very rarely , may affect more than 1 in10 people . in type 2 diabetes : seen rarely ; seen rarely ( might affect upto 1 in 1 ,000 people ). these are the signs of diabetic ketoac
what forxiga contains the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapaglliflouzin propanediol monohydrate equivalent to 5 mg dapagligloz . the other ingredients are : tablet core : microcrystalline cellulose ( e460 ), lactose ( see section 2 ' forxige contains lactoses '), crospovidone type a , silicon dioxide ( i ) and magnesium stearate . film  - coating : polyvinyl alcohol ( е1203 ), titanium dioxide ( italysed ), macrogol 3350 ( cpk ( ph ), yellow iron oxide ( enlargement ). what forixiga looks like and contents of the pack forxi 5 mg is supplied as a white
mepact contains the active substance mifamurtide which blocks the growth of certain bacteria which form part of the immune system . mepacting is used to treat osteosarcoma ( bone cancer ) in adults and children aged 2 and 30 years . it is used when surgery to remove the tumour is not possible . when chemotherapy is used , cancer cells are killed and the disease is likely to come back .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - when taking medicines containing ciclosporin , other calciumineurin inhibitors ( non - stroidal - anti - in - inflammation drugs , nsaids ). warnings and precautions talk to your doctor or pharmacist before taking mepactation : it is important that you tell your doctor if any of these apply to you : problems with your heart or blood vessels , such as the formation of blood clots ( thrombosis ) or bleeding ( haemorrhage ). it is also important to tell your physician if : you have inflammation of the veins ( vasculitis ). the effects of mepacting are moderately reversible and have
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . the recommended dose of mepactation is 2 mg of mifamurtide per day , given over 12 to 24 hours . your doctor will decide on the exact dose that you need . you may change your mepacting treatments according to your chemotherapy schedule . if your chemotherapy is delayed more than 36 hours , treatment with mepacted may be restarted . in order to prevent an interruption of the freeze - dried powder into a liquid suspension , the filter will be changed to deliver mepactic acid into , and slowly over a period of approximately 1 hour . treatment with more mepactate than you should if you experience severe side effects such as fever , chills , fatigue , nausea and vomiting should be stopped immediately . contact your doctor if any of these
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue may occur very commonly in patients taking mepacting as a transient , transient and transient ( including paracetamol ). if you experience fever during treatment with mepactation , tell your doctor immediately . stomach problems ( nausea , vomiting , and loss of appetite ) may occur as relapse of chemotherapy . tell your healthcare professional immediately if continuing fever or chills occur . they should return within 8 hours of taking me Pact . signs of an infection such as rash , or any problems breathing or wheezing . these signs may be serious . if they return or get worse tell your nurse immediately , as mepactic may cause severe cramps or pain . children and adolescents mepacat is not recommended for children aged under 8 years
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . keep the vial in outer carton in order to protect from light . reconstituted suspension containing sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection should be stored at 2 - 8 , protected from light and moisture . after reconstitution , the product should be used immediately . any unused medicine or waste should be disposed of in accordance with local requirements . these measures will help protect the environment .
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg of mfamurdide - after reconstitution . one ml of suspension contains 0 . 08 mg of of gmif amurmurtde . -the other ingredients are 1 - palmitoyl - 2 - oleoy - sof - al - glutamyl , 3 - selenium - 3 , dioleayl- sn - gastroenteric acid , 2 , 4 - diolesoyleoyes - 1 , ss - grazopreviro - 4 , low - sodium sodium salt , concentrate . what mepakt looks like and contents of the pack mepace is a
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it works by blocking receptors on the skin ( face ) that cause redness . rosacea is a condition where people have redness of the face . the signs of rosACEa are high levels of blood flow in the facial skin , enlargement ( dilation ) of the small blood vessels of the skin . mirvass acts on the surface of the blood vessels , blocking the excess blood flow and causing redness that follows .
do not take mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking mirvass . children and adolescents do not give this medicine to children under 2 years of age because it may cause side effects . the medicine should only be injected under the skin . - certain medicines used to treat depression and parkinson ' s disease called monoamine oxidase ( mao ) inhibitors ( e .g . selegiline , moclobemide ), tricyclic antidepressants ( i . ex . imipramine ), tetracyclic antagonists ( such as maprotiline ; mianserin ; mirtazapin ). talk to a doctor before taking Mirvas
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is only for use on the skin and only on the face . this medicine should only be injected by a doctor or nurse . your doctor will have prescribed this medicine for you , but your doctor may want to change it to another area of your body , or to other body surfaces such as your eyes , mouth , nose or vagina . how to use mirvass mirvasm is for oral use . you should only use mirvao on the same face once a day for as long as your symptoms are controlled . the maximum daily dose of 1gram ( 5 pea sized amounts ) should be given once . do not touch the treated area with your hands . if this medicine is given to you : if your symptoms do not improve after a
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common and uncommon side effects are severe skin irritation or inflammation , skin rash , cutaneous skin pain or discomfort , dry skin , warm skin sensation , sensation of pins and needles or swelling . common side effects include worsening of rosacea . if this continues after stopping the treatment , symptoms may improve ( see section 2 under " warnings and precautions "). contact allergy if you experience any signs of allergic reaction , such as rash or rare angioedema ( a serious allergic reaction to mirvaso ), skin sensitivity , warmth , sweating , hot flushes and skin tingling , feeling of pindles or swelling ( see also section 2 " warning and precautionary measures "). discontinue the treatment and contact your doctor immediately , as
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , tube and pump after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg brimoniidine , equivalent to 5 mg / mL of brionidine tartrate . - other ingredients are carbomer , methylparahydroxybenzoate , and phenoxyethanol . ingredients are glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvass contains methyl parahydroxybenzone and propyl glycol "). what mirvao looks like and contents of the pack mirvasa is a clear , colourless gel . it is supplied in 2 , 10 or 30 m2 of gel in a single use glass vial with airless pump system . not all pack sizes may be marketed
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumabe binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . once bevacimab is bound to vegar , tumour growth is prevented by blocking the growth of the blood vessels , thereby denying the nutrients and air and oxygen to the tumour . mvai is  a medicine used for the treatment of advanced cancer in the large bowel , in adults 
do not use this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic( hypersensitive
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe the dose that is right for you . duration of administration you will receive mvai every 2 or 3 weeks . you will be given infusions at the start of treatment . always use this medicine exactly as your doctor has told you , unless you are not sure . if you are using this medicine for more than one treatment cycle , please consult your doctor . this will give mwasi as long as you are treated for your tumour growing . frequency of use and frequency for administration m Vasi is a concentrate for solution for infusion . depending on the dose prescribed for you ( or the patient ), the mvases
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . none of these side effects were serious . you should stop taking mvai and see your doctor straight away . allergic reactions if your doctor thinks you may have an allergic reaction , he or she may ask you to stop m Vasi . signs of an allergic response may include difficulty in breathing , chest pain , redness or flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). if any of these happen , tell your doctor or nurse straight away as soon as possible
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 oc followed by up to three hours at room temperature . when the infusion systems have been prepared in sterile environment , they should be allowed to come to room temperature prior to diffusion in  a steril environment . after diluted solution , the concentrate should be
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacimizumabe , corresponding to 1 . 4 to 16 . 5 mg / m2 when diluted as recommended . one vial of 4 ms contains 100 mg of benzyl bevacibizumac , equivalent to 1. 4 mg pfu / 1 mL when dissolved as recommended in 16 mmol / vial , or 400 mg of Bevacizub , equal to 16 mg ppfu per mluice . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what if you use mvai what heif does not appear as a concentrate for solution for infusion ,
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . tecARTus is used in combination with other medicines to treat refractory mantles cell lymphopenia ( mcl ), which is caused by the lack of your own white blood cells ( autologous anti - cd19 - transmitted cc3+ cells ). mantled cell lymphhoma is  a cancer that affects part of the immune system called b - lymphocytes . in mantLE cell lymphodyne ( b- lymphoblasts ) there are too many b " lymphocyte cells , and they get worse over time . an uncontrolled way tec artus enters the lymph tissue ( bone marrow ) and collects blood . the white blood cell in your blood is then excreted by the cancer
do not use tecartus - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). - you are not allergic to any of ingredients of the medicine . - the number of white blood cells in your blood ( lymphodepleting chemotherapy ) is not known ( less than 3 million ). the number is very low . the number can be very low for white blood cell in autologous use . warnings and precautions tests and checks your lungs , heart , kidney , blood pressure , signs of infection or inflammation of your cancer ( graft - against - host disease ). this medicine will not be given to you after you have had a transplant and your body will not work properly . symptoms may include rash , nausea and diarrhoea . talk to your doctor or nurse before using tec
tecartus contains the active substance tasonermin , which is made from your own white blood cells . your cells will be collected by a doctor or nurse while you are in hospital . a catheter placed in your vein ( a procedure call leukapheresis ) will be performed . before tecARTus is infused , your white blood cell count will be checked . once your blood is collected , it will be returned to your vein . this will take 3 to 6 hours and may be repeated if your whiteblood cells are not collected for more than 2 to 3 days . medicines given before Tecartus treatment , the term lymphodepleting chemotherapy , is used . the modified white blood units are then returned to the body . they will be kept for at least 30 to 60 days , but not for longer than one treatment course . you will be
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you and will explain the potential risks and benefits of taking tecartus . if you notice any of the side effects above , you may need urgent medical attention . the following side effects have been reported during the tecARTus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure ( which can cause symptoms such as dizziness , lightheadedness ), fluid in the lungs ( which may affect all symptoms of a condition called cytokine release syndrome ). loss of consciousness . there may be decreased level of consciousness with confusion , memory loss and altered levels of consciousness in some patients . these effects have also been reported after treatment with tecarus , including some side effects that have been observed during
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and infusion bag . store frozen in vapour phase of liquid nitrogen  150  v . cd40 . this medicine contains genetically modified human blood cells . no special storage conditions are necessary . human - derived material should be used within 36 hours after first opening .
what tecartus contains the active substance of tecARTUS is composed of autologous anti - cd19 - reduced cc3 + cells , each patient - specific single infusion bag containing a dispersion of anti  c - 19 car t cells at a concentration of 68  2 x 106 anti . the other ingredients are : sodium chloride , human albumin . see section 2 " tec artus contains sodium ". what Tecartus looks like and contents of the pack tecArtus is a clear to opaque , white to off - white dispersed solution for infusion , supplied in an infusion bags individually packed in a metal cassette . a single inf bag contains approximately 68 kg of cell dispertion .
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - four inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic condition . along with diet and exercise , this medicine can be used alone or in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which lower blood sugar from your diabetes . you need to keep following your food and exercise plan while taking janus ,
do not take januvia if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if there is anything you do not understand , ask your doctor . warnings and precautions cases of inflammation of the pancreas ( pancreatic ) have been reported in patients receiving janusvia ( see section 4 ). contact your doctor immediately if : you encounter blistering of the skin it may be a sign for a condition called bullous pemphigoid . you should not receive jan Uvia , as you may have a disease of the Pancrea ( such as pancreattitis ) you have ever had gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) in your blood . these medical conditions can increase your chance of getting pan
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks you may have kidney problems , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). you can take this medication with or without food and drink . your doctor can prescribe this medicine alone or with certain other medicines that lower blood sugar . diet and exercise can help lower blood cholesterol . it is important to stay on the diet and activity recommended by your doctor while taking januvia . if possible take januga once - a week as this medicine is not recommended . contact your doctor immediately if he / she tells you to stop taking . do not stop taking this medicine without talking to your doctor first . taking this
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need urgent medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). pancreatis is a serious allergic reaction - frequency not known ( frequency cannot be estimated from the available data ). rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . if any of these side effects get serious , or if they get worse , stop taking this medicine and call your doctor
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate equivalent to 25 mg sitaglin -the other ingredients are : tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat e570 , croscarmellose sodium , magnesium stearate ( i ) and sodium stearyl fumarate . the tablet film coat contains : poly ( vinyl alcohol ), macrogol 3350 , and talc ( 6000 ), titanium dioxide (  e171 ), red iron oxide ( er ) ( ti ), yellow iron oxide . what junuvia looks like and contents of the pack janusus is a pale yellow to pink film , opaque blisters ( pvc /
what xultophy is xULtophy lowers blood glucose ( glucose ) in adults with type 2 diabetes mellitus . this type of diabetes occurs when the body is not able to use insulin effectively , and the insulin that the body makes does not work as well as it should . what XultoPhy is used for xültophy comes in a form called a long - acting basal insulin . it is used to lower your blood sugar levels . your doctor may also prescribe liraglutide ( or glp - 1 ) to help you avoid insulin during meals . how xulenttophy works xulationphy can also be used with oral medicines for diabetes xoultophy can be used either alone or in combination with oral medicine for diabetes ( such as metformin , glibenclamide or glibane ).
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you are not getting enough insulin deGludec or lisaglutide . warnings and precautions 39 if using any form of a sulfonylurea such as glimepiride or glibenclamide , your doctor will need to adjust your sulphfonyera dose . your doctor may need to change your dose , depending on your blood sugar levels . talk to your doctor , pharmacist or nurse before using xULtophy as you may have type 1 diabetes mellitus and ' ketoacidosis ', a condition where the body produces too much sugar . xculto
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . if your blind or have poor eyesight and cannot read the dose counter on the pen , you need to check your blood sugar level . use in children and adolescents xultophy can be used in adolescents and children aged 41 years and over . you can use xULTOphy at any time of the day , with or without food . the recommended dose is one dose in the morning and one dose at the evening . how to use XultoPhy 41 xlophy is available in two different pack sizes . each pack contains one pre - filled dial - a - dose pen . one dose counter shows the dose amount of insulin degludec in each pen and one 0 . 036 mg liraglutide . your
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common : may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out ( become unconscious ). serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood glucose , take action to increase your blood glucose level straight away . to increase the chance of you having low blood sucre ( hypoglacy ) see the box at the end of this section . serious allergic reaction ( anaphylactic reaction ) has been reported ( frequency not known ). it is not known how often this can happen . you may have a serious allergic response or a seriously allergic reaction . local reactions have been reported in patients taking xultophy . they usually pass out after a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep vial in the original carton in order to protect from light . once opened , xultophy can be stored at room temperature ( up to 30 ) for up to 8 weeks and no longer than 21 days from the date removed from the refrigerator . write the new expiry and use by date on the blister and carton including day / month / year . discard this medicine if not used by the new use by the newly - established expiry or the expiring date printed on the label . it is recommended that the expir date refere to the first day of the month , the product should be 
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec , equivalent to 3 . 6 mg lillaglutide in 3 mL solution . one vial contains 300 units insulin of degluDEc compared to 10 . 8 mg / m2 of ligalutide the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xULTOphy contains sodium ". pack sizes : 1 , 3 and 5 vials and a multipack containing 10 ( 3 packs of 2 ) vial adapters . not all pack sizes may be marketed .
giotrif is a medicine that contains the active substance afatinib . it is injected into cells that contain egfr [ epidermal growth factor receptor - 1 ] ( erbb1 ) and her2 [ erbeb2 ] and erfb3 ]. these proteins can kill cancer cells . by attaching to these proteins , these proteins help cancer cells to grow and divide . this medicine can kill or stop cancer cells from growing and growing . the active ingredient in this medicine is used to treat cancer of the lung ( non - small cell lung cancer ). giotricrf is used as your first treatment for patients who have not received prior chemotherapy treatment . giotrim is also used to help protect a type of squamous type that has progressed after prior chemotherapy treating .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low body weight less than 50 kg if the doctor treating you is unsure if this applies to you , or if any of you are suffering from kidney problems , tell your doctor or pharmacist before taking giotif . warnings and precautions talk to your doctor before taking this medicine : if , while taking , you are taking any of these , talk to ' serious side effects ' if they cause lung inflammation ( interstitial lung disease ). if there are liver problems ( your doctor may do some liver tests ). tell your doctors before taking the medicine if that you suffer from a severe liver disease . if eye problems ( such as severe dry eyes ) or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 40 mg once a day . take this medication around the same time each day , preferably in the morning . swallow the tablet whole with a glass of water . you can take this tablet with or without food . do not take more than this recommended dose . your doctor may decide to reduce your dose depending on how you respond to giotrif . taking this medicine take this medicinal product for 1 to 3 days , but you should continue to take this Medicine for as long as your physician tells you , even when you are taking it . if your doctor tells your doctor that you are using this medicine , take it as soon as you can . it is best to take the tablet at the same times every day ; this will help you to remember to take
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with giotrichea and may be serious : stop taking giotrhoea and seek medical help immediately if you experience any of the following symptoms during or after treatment : diarrhóea ( very common , may affect more than 1 in 10 people ): diarirhhooeal in severe diarhoester ( see section 2 under " warnings and precautions "). severe diarihoa with fluid loss ( common : may affect up to 1 in every 10 people): low blood potassium and worsening kidney function ( very rare ). if diararrhea occurs , or if it does not stop immediately , contact your doctor or seek medical advice . your doctor will decide whether to give you
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide ( e171 ), and polysorbate 80 (  e433 ). what ' giotrice looks like and contents of the pack giotrif 20 mg film  coated tablets are white to off - white , oval shaped with " gsi " on one side and " nvr " on the other side . the giotraf film  - coating tablets are available in packs of
orkambi contains two active substances , lumacaftor and ivacaftingor . ork Ambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with a f508del mutation ( a so - called cystic fistula transmembrane conductance regulator ( kftr ), in the lungs . the mutation causes the body to produce an abnormal cctr protein . lumcafor and infusion cycles cause the abnormal gft receptor protein to work more normally . by combining lum acavtor with iva caftour helps the abnormal crftren protein to function properly . both of these active substances cause lumage and iv - ivacator work
do not take orkambi if you are allergic to lumacaftor , ivacaftingor or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ork Ambi . orkami must not be taken if the f508del mutation in the qtc gene is present in the blood . your doctor may need to adjust the dose of orkaji if this applies to you . if your doctor thinks this applies , tell your doctor without taking the medicine . you have liver or kidney disease . the dose may need adjustment if it is not known if orkamba is right for you ; if : you have a history of abnormal blood tests of the liver . tell your physician before taking any orkacco if any of these symptoms occur , which may
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 6 or 12 tablets twice a day . orkambi tablet can be taken with or without food . use in children and adolescents ork Ambi is for oral use . swallow the tablet whole . for children aged 6 to 11 years , the recommended dosage of orkaji is 100 mg twice / day ( taken 2 hours apart ) in the morning and 2 hours after meals . children aged 2 to less than 12 years : the recommended daily dose of orkgambi is 200 mg twice daily ( taken as 2 separate doses ). for children younger than 2 years ; the recommended starting dose of / orkami is 200 milligrams / night ( taken in the evening ). your doctor may prescribe orkacco if your child has moderate or
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with orkambi were mainly seen when taking ivacaftor , but were generally less severe and less serious . serious side effects these may occur with or Kambi : raised levels of liver enzymes in the blood , which may increase the risk of liver injury . in patients with pre - existing severe liver disease the worsening of liver function is common ( these may affect up to 1 in 100 people ). tell your doctor immediately if you experience any of the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the white part of your eyes loss of appetite , diarrhoea , vomiting , abdominal pain , muscle pain . uncommon side effects ( these might affect upto 1 in 1000 people ):
what orkambi contains the active substances are lumacaftor and ivacafontor . ork Ambi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg of lumcafentor and 250 mg of inivacaffetor compared to ivaccaftoral . the orkamba 200 mg , 200 mg film coated tablets contain 125 micrograms of lombacaffeor and 25 mg of immunisation against iva caftores . each orkami 100 mg and 125 milligrams / 200 mg movie - coatings are : cellulose , microcrystalline , croscarmellose sodium , and hypromellose acetate s ( e468 ). the other ingredients are talc , indigo carmine ( cb ). what orka
what lynparza is lyinparza contains the active substance olaparib . olarib is a type of cancer medicine called a parp inhibitor ( poly[ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping a protein called brca ( breast cancer gene ) from working . parp inhibitions are changes ( changes ) in the brca gene that causes cancer to grow . when brca is used for parp inhibits , the disease can be life - long , and parps can cause the death of cancer cells . it reduces the ability of an enzyme to repair dna . what LYnparaza is used in patients who have been treated with lyp for ovarian cancer , brca are brca - positive . they are a
do not take lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not use lyndparza and talk to your doctor . if your doctor thinks this applies , they will advise you accordingly . children and adolescents do not give this medicine to children under 2 years of age . do not breast - feed while taking lylparza ( see section 4 ). take special care with lymparza tell your doctor or pharmacist if any of these apply to you before you take a dose . take special Care with LYnparzan tell your child ' s doctor if : you have low blood cell counts . your doctor will do testing to make sure that you have these low counts , including red or white blood cells , or low platelet counts
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lynchorza is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of LYnparaza capsules should not be divided into smaller doses or tablets . if a capsule is swallowed whole , take it with food or between meals . do not divide , crush or chew the capsules . take the dose of one capsule in the morning and one capsule at the same time . it is best to take a dose of two capsules in the evening . when to take take LYNparza by mouth , in the afternoon and evening , at about the same times each day , with food . swallow the capsule whole 
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , or fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ), allergic reactions such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed later in this leaflet . if you get any of these , tell your doctor . other side effects include : very common side effects ( may impact more than one in 10 users ) - feeling short off breath - being short of air - filled nose , sneezing - tiredness - pale skin and fast heart rate .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . lynparza capsules should be stored below 30 and used within 3 days after first opening . discard any capsules that have been frozen . this medicine does not require any special temperature storage conditions . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what lynparza contains the active substance is olaparib . each hard capsule contains 50 mg of olarib , which is added to the diet and water for injections in the form of lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate and iron oxide black ( encoding ) in the capsule . what LYnparaza looks like and contents of the pack lymparza is a white , opaque , hard capsule with " opadarib 50 mg " imprinted on the cap and the astrazeneca logo on the body . lyprza is available in packs containing 112 capsules or 448 capsules ( 112 mg ). not all pack sizes may be marketed .
this medicine contains the active substance naloxone . nnalotone is used to treat opioids , such as heroin , methadone , fentanyl , the e1201 , anoxodone , buprenorphine / morphine . the active ingredient in nyxoid is a nasal spray used for the emergency treatment of opioid overdose . opioid over dose in children and adolescents is not recommended for use in children younger than 14 years of age . some children and teenagers have experienced severe sleepiness after an opioid overdo . you should tell your doctor if you have been given more nxoide than you should . inform your doctor immediately if your child has any further questions on the use of this product .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). - contact your doctor or go to your nearest emergency medical care or emergency services immediately if there is an opioid overdose . talk to your doctor if the signs and symptoms of an opioid overload are similar to those described below . how to use this nasal spray : every 2 to 3 weeks , use a new nasal spray to help remove the medicine . do not administer this medicine if : you are physically dependent on opioids ( see " other medicines and nnyxxoide "). you are dependent on other opioids such as heroin , methadone , fentanyl , the oxycodone , buprenorphine or morphine . you are strong with opioids 
nyxoid nasal spray is to be used by adults only . it is for use in adults only ( 18 years of age and older ). it is not to be given to children under the age of 18 years . symptoms should be : around the shoulders and around the ears , near the breastbone and sternum ( inner ear ). hold the fingernail tightly in place until it is clear the mouth and nose of any blockages . this will make sure that both your mouth and nostril are free from debris . picture 1 . breathing is the chest moving in your chest . you can hear breathing sounds and see breathing sounds as you breathe on the cheek . if you are given more nnyxiaid than you should overdose has not been investigated . there have been reports of a lack of response to touch or sounds , which may slow uneven breathing .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek medical attention immediately if you experience acute withdrawal symptoms due to dependence on opioid drugs . symptoms include fast heart rate , high blood pressure body aches and stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering / trembling changes in behaviour including violent behaviour , nervousness , anxiety , depression , and depression . tell your doctor if any of these affect you . other side effects include : very common ( may affect more than 1 in 10 people ): feeling very tired , headache , stomach pains . common ( might affect up to 1 in10 people ). common (may affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nnaoloxone ( as hydrochloride dihydrate ). - other ingredients are trisodium citrate dihydrate ( e331 ), sodium chloride , hydrochoralic acid ( е507 ), water for injections , and purified water . the active ingredient is : nalloxone in 0 . 1 ml solution for injection in a pre - filled nasal spray , packaged in  a single dose container . nyesoidu is supplied in : one single dose canister and the other is a clear , colourless liquid . it is supplied as a carton containing 2 nasal sprays . they are packed in blisters ; each nasal spatul
ovaleap contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " flo ". fsh is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . in women , it is important for them to have the growth and development of the sacs ( farrows ) in the ovaries , in order to stimulate the production of sperm . ovulation is essentially finished by the development of a mature egg cell . it is given to women who have not had treatment before , together with a medicine called " ciclmifene citrate ". it can be used in assisted reproductive technology procedures ( procedures that may help you to become pregnant ). what ovaleak is used for ovale ap is used in adults 
do not use ovaleap if you are allergic to follitropin alfa ( female fsh ) or floeal - stimulating hormone ( fhsh or womb ) and / or any of the other ingredients of this medicine ( listed in section 6 ) if your ovaries are not large oocytes or sacs of fluids within the oaries ( ovarian cysts ) of unknown origin if there are unexplained vaginal bleeding if any of these apply to you , tell your doctor . if for any reason you are not sure , ask your doctor or pharmacist . warnings and precautions talk to your doctor before using ovale ap you should tell your physician before using this medicine : if it is not known if : you have cancer in your wollitropine
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if necessary , your doctor may give you a lower dose . if your period starts to get longer or if there are no irregular periods , use this medication once every day for the first 7 days of your menstrual cycle . your doctor will tell you when to use the medicine . you will usually receive this medicine in the morning and once every other day for 7 days , during your menopause . the maximum dose of this medicine will be 75 mg ( two injections of 150 mg ). you will normally receive this medication every day , for 7 to 14 days ( except for 37 . 5 mg ) or 75 mg . use in children and adolescents this medicine should be used in adolescents
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin can be signs of severe allergic reactions . they can include weakness , drop in blood pressure , difficulty breathing and swelling of the face . these are 37 very rare ( may affect up to 1 in 10 , 000 people ) but very rare type of reaction can occur after your ovaleap injection . tell your doctor immediately if you experience any of the following serious side reactions in women lower stomach ache , nausea and vomiting . not known ( frequency cannot be estimated from the available data ): the symptoms of ovarian hyper - stimulation are similar to those observed in men . this may be more common in women . if this happens , your doctor will stop the injection and start
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . you may use this medicinal product for a single period of up to 3 months below 25 and then it can be stored for reconstituted use . once you have removed the cartridge from the refrigerator , it must either be used within 3 months or disposed of . this medicine may be stored in the refrigerator at 2 to 8 , away from direct heat or direct light , or at room temperature ( below 25 ). keep the pen cap on the ovaleap pen in order for it to protect it from light and moisture . it is recommended that you throw
what ovaleap contains - the active substance is follitropin alfa . one ml of ovale ap 300 iu in 0 . 5 mL solution for injection contains 300  22 micrograms of flo3 alfA in 0.5 mla . - ovaleeape 450 ius in 0- 0. 75 mlitre solution for infusion contains 450 microgram ( 33 microgram ) fllo3 . in the cartridge , one cartridge contains 0, 75 igg ( 8 microgram of v ) of lhfa in ohl . ovaleop 900 i u / 0 in 1 . 5. m3 solution for injecting in a cartridge . each cartridge contains approximately 900 microgram( 66 microgram
voriconazole accord contains the active substance vorikonazole . voricanazole acord is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . its use is used for the treatment of patients ( adults and children over the age of 2 ) with : invasive aspergillosis ( a type of fungal infection due to aspergollus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candida species sf . infections when the bacterus is resistant to fluconazoles ( another antifungals medicine ), seriously invasive fungal infections caused by scedosporium spe / fusarium spud
do not take voriconazole accord - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). - tell your doctor if your condition is not well controlled with voricanazole . warnings and precautions talk to your doctor or pharmacist before taking voricônele accord tell your doctors or pharmacist if : - you are taking or have taken any other medicines , including herbal medicines . these are the medicines that are used during vorizanazole acord treatment 46 - the active substances are : the active substance is terfenadine ( used to treat allergy ) and astemizole ( used for allergy ). the active ingredient in vorikanazole agreement is cisapride ( used in stomach problems ) - pimozide ( often used for mental illness ) quinidine
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will dose the dose according to your weight and the type of infection you have . the recommended dose for adults is 40 mg once daily for the first 24 hours . after that , the recommended dosage is 400 mg once a day for the second and the third 24 hours ( 200 mg ). for the third and fourth 24 hours the recommended starting dose for the fourth and fourth day is 24 mg once every 12 hours , followed by 24 hours of treatment . this is followed by 200 mg once weekly for the seventh and fourth week . if this is not possible , your doctor may reduce the dose to 300 mg once per day . treatment will normally be continued for up to 12 months . use in children and adolescents the recommended treatment rate in children aged 2 to less than 12 years is 12 to 14 years .
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor immediately if you experience rash or jaundice , changes in blood tests of liver function or pancreatitis . other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision ), night blindness and swinging vision . common ( might affect up to 1 in every 10 people anaemia ). uncommon ( may effect up to1 in every 100 people ), severe infections of the eye
what voriconazole accord contains - the active substance is vorikonazole . each tablet contains 50 mg voricanazole as vorikanazole acord 50 mg film - coated tablets contain 200 mg vorisconazoles . - voriCONazoleaccord 200 mg film coat - coating : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . film coat coat : hypromellose , titanium dioxide , lactoses monohydrate and triacetin . in addition , the film s coating contains lactoside - rich white to off - white lyophilised starches . the coating is imprinted with ' gs l - g s ' on one side . voricônele accord
mvabea is a vaccine to prevent ebola virus disease in the future . it is given to adults ( including children ) at least 1 year of age , to help protect you against ebovirus . your doctor will recommend that you receive a 2 - dose course of vaccinations to help prevent a possible spread of ebea virus diseases caused by the zaire e Bolavirus , which is essentially a type of filovirus that carries the most protection ( s ) from the other three components of this vaccine . none of the ingredients in the vaccine can cause the whole ebora virus . therefore , mvasbea does not give you ebravirus disease . vaccinations with zabdeno vaccine are recommended 8 weeks later . mvbea vaccine will not give both zabbing doses . you
if you have been given the vaccination course , the doctor will decide on the best course of action . the vaccine must not be given to adults who are able to take the necessary measures to prevent a severe allergic reaction ( see section 6 . if your child has had a serious allergic reaction to an antibiotic called ' gentamicin ', the vaccine should not be injected into the lungs . warnings and precautions talk to your doctor or nurse before you are given mvabea if : you have had , or have ever had : - a severely allergic reaction after any other vaccine injection - you have ever fainted following , but the decision to delay , your next dose - the vaccine may not be fully effective if any of the above apply to you . you are not sure , talk to the doctor or pharmacist before you were given . before you
mvabea is given as an injection into a muscle ( intramuscular injection ) in the upper arm or thigh , or into , a blood vessel . the first dose of vaccination with zabdeno vaccine is given 8 weeks later . mvasbea vaccine is intended to be given as the second vaccine . it is not known if the second vaccination , which is given at the same time , will be given . which primary vaccination first vaccination with white to off - white zabeddeno red cap vial ( 0 . 5 ml ). second vaccination with yellow cap viall ( 00 . 8 m ). you will receive the first vaccinationwith zabbingeno . booster vaccination with either zabea or zabino is given two weeks after the first and second vaccination ( 05 . 9 mmol /
like all medicines , this vaccine can cause side effects , although not everybody gets them . most side effects occur within 7 days of getting the injection . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ) pain , warmth , or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in 100 people ), feeling sick ( vomiting ) itching where the inject is given uncommon ( may effect up to1 in 100 persons ) redness and skin hardness where the implant is given generalised itching reporting of side effects 25 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide
what mvabea contains - the active substance is zaire ebolavirus ( live , attenuated ) 29 - tai forest ebavirus nucleoprotein marburg , pvp 0 . 7 x 108 ( inactivated ), derived strain of chicken embryon fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what if you get any questions about how mvasbea works or why this medicine has been prescribed for you , ask your doctor . what he / she is giving mv is a suspension in a single - dose glass vial with a rubber stopper and yellow cap . mVAbea
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce other bone problems that may need surgery or radiotherapy bondronAT can also be prescribed if : you have a raised calcium level in your blood due to : a tumour the amount of calcium that is lost from your bones . it helps keep your bones healthier .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low levels of calcium in your blood . do not use this medicine if any of these apply to you . if this applies to you then tell your doctor immediately . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondronate for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonegacrossisof the jaw there are some precautions you should take 
this medicine bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much bondronatului you will be given depending on your illness . if you have breast cancer that has spread to your bones , then the recommended dose is 3 mg every 3 - 4 weeks as an injection in your vein over at least 15 minutes . in case you have a raised calcium level in your blood , the recommended dosage is 1 mg every 2 weeks ( depending on the severity of your illness the medicine will be administered as an anus in your sinus ). a repeated dose may be considered in case of insufficient response or if your illness reappears 
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the tummy bone . very rare ( can affect upto 1 in 10 ,000 people ). you may also experience pain or sore in your mouth or jaw . this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor if your jaw pain / discharge from the ear , as this may indicate an ear infection . these could be signs
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately it can be stored in a refrigerator at 2 - 8 . store in the original package in order to protect from light . alternatively , it can also be stored at room temperature ( 20 - 25 ) for up to 24 hours . use this medicinal product in order protect from moisture .
what bondronat contains - the active substance is ibandronic acid . one 2 ml vial contains a concentrate for solution for infusion containing 2 mg i bandronic Acid . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , water for injections . what bonroraat looks like and contents of the pack bondronate is a clear , colourless solution . it comes in two strengths : 1 mg and 2 mg in a glass vial with a bromobutyl rubber stopper .
what zeposia is zeposa belongs to a group of medicines that affect white blood cells called lymphocytes . what ZEposia are used for zepositiona is used to treat relapsing remitting multiple sclerosis ( rrms ) in adult patients with active disease other than multiple ' s disease . multiple clerosis (mss ), a disease that affects the immune system and which affects many parts of the body 's defenses , including white blood cell counts . they work by stopping the production of nerves ; and the brain and spinal cord ; or the nerves become damaged . rmms can cause symptoms such as numbness and difficulty in walking .
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severely weakened immune system . warnings and precautions talk to your doctor or pharmacist before taking zeposa : if - you have recently had a heart attack ( angina ), stroke ( mini - stroke ), or transient ischemic attack ( tia ). if- you had severe heart failure within the last 6 months if any of these apply to you , tell your doctor . if possible , you may have irregular or abnormal heartbeats ( arrhythmias ). your doctor may decide to stop treatment if severe infection ( hepatitis ), tuberculosis , cancer , or severe liver problems , if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much zeposia to take your doctor will work out your dose of zeposa , depending on your heart rate . you will be given a ' treatment initiation pack ' at the start of treatment . the recommended dose is 4 capsules ( 100 mg ) of ozanimod once daily for 1 week . this will be followed by 4 weeks of treatment ( 3 capsules of 0 . 46 mg ozaimod per day ) for 5 weeks , 6 weeks and 7 . from 8 weeks on , you will receive a ‘ maintenance pack ’ with orange capsules containing 0. 92 mg of azani mod . after regular treatment , the recommended dosage is 0
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection , blood pressure uncommon ( may effect up to 1 in 100 people ), allergic reaction . the signs may include a rash . other side effects include : common ( might affect up to1 in 10 persons ) infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box ( larynex ) - viruses affecting a type of white blood cell called lymphocytes common : may affect upto 1 in every 100 people allergic reaction to zeposia . contact your doctor if any of these side effects become severe . very common 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special temperature storage conditions . please return the pack to your pharmacist if you notice any damage or signs of tampering to the pack . return the unused product to your pharmacy . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposa 0 . 23 mg hard capsules : each capsule contains 0. 23 milligrams of ozonimod ( as hydrochloride ). zepoza 00 . 46 mg hard hard capsule : Each capsule contains 0. 46 milligramms of of zani mod ( as Hydrochlorides ). the other ingredients are : zepositiona 0- 92 mg hard - capsules: each cartridge contains 0- 9 . 2 milliliters of the mg ozinimod [ as hydroCHloride [ as ]). the ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . capsule shell : the following identifier is printed with 
what temybric ellipta is temmybric collapt consists of three active substances : fluticasone furoate , umeclidinium bromide and vilanterol . fluticassé furoates belongs to a group of medicines called corticosteroids , often simply called steroids . umeklidiniumbromide or vilantrol belong to  a groupe of medicines known as bronchodilators . what e . g ., temyerc eleptata is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten . this makes breathing easier . the muscles surrounding the airway tighten and makes
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temyerc elbasvir . take special care with temista ellippta tell your doctor before using it : - to treat asthma ( don ' t take teminessbric it should not be used to treat air asthma ). - as you may have heart problems , high blood pressure , liver problems . - tuberculosis ( tb ) of the lung , or any long standing or untreated infections . tell your dentist immediately if : you have an eye problem called narrow - angle
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybrick ellippta every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temyerc elept , once  a night , will help you to breathe more easily throughout the night ; it will also help you not to get a sudden attack of breathlessness or wheezing . when you get this sort of
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and tell your doctor . pneumonia ( infection of the lung ) in copd patients ( common side effect ) tell your healthcare professional immediately if you develop symptoms of a lung infection such as fever or chills , increased mucus production , change in mucuses colour , decreased cough or increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore throat , runny nose , cough , abdominal pain , indigestion , flatulence common sideeffects ( may effect up to1 in 10 children ) bronchitis , sinus infection , urinary tract infection a sore mouth ulcers a runniitis a cough
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each 92 - dose inhalation contains fluticason furoates equivalent to 65 micrograms umeklidinium brmide equivalent to 55 microgram ( 8 . 5 microgram ) umeclodinium and 22 microgram( 0 . 25 microgram) vilantrol ( as trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temarybric is based on the content of the pack temlybric it contains lactoses ') and magnesium stearate . what tetanus looks like and contents of the package the ellippta inhaler consists of a light grey plastic body
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo used for zinfo is used to treat infections of the skin and the tissues below the skin . in adults it is also used to prevent an infection of the lungs called , ' pneumonia ', which can be life - threatening . how zinfordo works zinforumo works by killing certain bacteria , which in turn reduces the risk of serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic to other cephalosporin antibiotics . if the doctor has told you that you have had previous severe allergic reactions to other antibiotics ( e .g . penicillin or carbapenem ). do not use zin foro . warnings and precautions talk to your doctor or pharmacist before taking zinfo : if any of these apply to you . you should tell your doctor before taking this medicine : the following apply to your child : you have kidney problems . your doctor may want to monitor you more closely . tell your child has had seizures ( convulsions ). you have any non - severe allergic reaction to other bacteria that your child is taking
the recommended dose of zinforo is 600 mg once a day . adults and adolescents 12 years of age and older : the recommended starting dose is 600 milligrams once daily . your doctor may increase the dose to 8 milligramms once every day if you have some infections . the recommended daily dose is 8 millions ( 12 millilitres ) once daily by injection , or 8 millies ( 12 micrograms ). zin foro is given as a drip directly into a vein ( intravenously ) over 5 minutes . for patients weighing 60 kilograms or more , the doctor may give you 120 milliliters ( 2 microgram ) twice a week . if an increased dose is given , treatment will usually last for 5 to 14 days . in case of skin infections , your doctor will give you a dose 5 to 7 days ( for example
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any of these symptoms as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems these may be signs of a serious allergic reaction ( anaphylaxis ). diarrhoea ( loose stools ) or blood or mucus at the start of treatment with zinforo . this is usually seen as a combination of medicines used to slow bowel movement . common ( may affect up to 1 in 10 people ): your doctor may ask you to have a blood test called a ' coombs test '. your doctor will tell you how long you should continue to take this test . children and adolescents this medicine should not be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 mg ceftaroline fosamil . the other ingredients are arginine . what zforo looks like and contents of the pack zin foro is a pale yellowish to light yellow powder supplied for solution for infusion in a vial . zinForo is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neopathic pain : pregabaltalin is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral nneuropathy pain , such as diabetes or shingles . pain sensations may be described as hot , burning , torbbing , shooting , stabbing ; sharp , cramping , or aching , and tingling , feeling numbness . the sensation may be felt distinctly different to the sensation you were experiencing .
do not take pregabalin pfizer if you are allergic to pregabaltalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregaballin . some patients taking pregamalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabalsin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , please tell your doctor if any of them apply to you . while you are taking pregalin pifizer you may experience blurring or loss of vision , or other changes in eyesight
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine what dose is appropriate for you , depending on your condition . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor and use in children and adolescents is 150 mg once a day . however , your doctor may prescribe a lower or higher dose to 600 mg once daily . the usual dose is one tablet in the morning and one tablet of pregabaltin 59 pregabatar is taken in the evening . you should swallow the capsules whole with water . do not chew or crush the capsule content . take pregabalsin ppfizer with food . in the afternoon 
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common  : might affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , lack of interest / clumsiness and memory impairment . loss of memory , such as tremor , difficulty with speaking , or tingling feeling . not known : frequency cannot be estimated from the available data . cellulitis ( infection ) has been reported in some patients . sickle cell tumour . in some cases , the tumour may not grow back into the tumour , but can be treated with other medicines . tumour lysis
what pregabalin pfizer contains the active substance is pregabaltin . each tablet contains 25 mg , 50 mg ; 75 mg / 100 mg e . g . 150 mg ), 200 mg  225 mg & 300 mg pregabALIN  the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica and black ink . the printing ink contains shellac ; black iron oxide ( i . cong ; propylene glycol , potassium hydroxide ). the 75 mg ( 105 mg ) capsules are black in colour and contain black iron dioxide ( italysed ), propylan glycol ( k29 % and
xadago is a medicine that contains the active substance safinamide . it increases the levels of dopamine in the brain . x ado helps to control movement in adults with parkinson ' s disease . parkinsons ' disease causes sudden switches in the way the body moves , causing you to not be able to move . this in turn helps you to move more easily . when xdag is used together with the medicine it is used with levodopa and other medicines used to treat parkinSON 's disease in adults .
do not take xadago if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not continue taking the following medicines : - monoamine oxidase ( mao ) inhibitors such as selegiline , rasagiline ; - moclobemide , phenelzine ; isocarboxazid ; and tranylcypromine ( used for treatment of parkinson ' s disease and depression ); - pethidine ( a strong pain killer ). talk to your doctor before you take Xadogo treatment and during treatment with mao inhibitors or pethamine . see section 7 of this leaflet . before you start xagego treatment , your doctor will discuss
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once daily or 100 mg once a day by mouth . your doctor will decide the dose you should take . x ad if your doctor feels that you may have moderately reduced liver function , your doctor may lower your dose to 50 mg . take xeda go to a hospital immediately . go to the nearest hospital if the doctor has prescribed it for you , and follow the instructions from the doctor . taking xagego if possible take your medicine with you if it is difficult to take it . elderly if there are no data available on the use of Xadogo in elderly patients with raised blood pressure , anxiety , confusion , forgetfulness , sleepiness ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure , often leading to collapse ): the signs of neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity or hyperthermia ) - the increase level of enzyme creatine kinase in your blood ( serotonin syndrome ) the signs may include confusion ; hypertension ; muscle stiffness ; hallucinations ( hypotension ). the most frequently reported side effects are parkinson ' s disease . it is also possible that xadago must be taken with caution . - if you are taking xsad a lot of other medicines : safinamide and levodopa , you may experience more confusion . in addition , some patients
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg of ssafarinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - film - coating : in the tablet core: hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( е172 ). what Xad ago looks like and contents of the pack x adogo 50 mg film , coated tablets of 7 mm diameter with metallic gloss , marked with ' s 50 ' on one side and plain on the other side . xdagot
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat adult men with prostate cancer that has spread to other parts of the body . zytigea increases the amount of testosterone that is produced after a successful treatment for prostate cancer . the active ingredient in zyta is testosterone - lowering medicine that is used in patients who have no other treatment for disease or who are not able to take hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ) or who have previously taken another medicine , prednisone or predndnisolone , is used for high blood pressure in adult patients whose body is causing fluid retention in your blood .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - when taking zymiga : - you are pregnant . warnings and precautions talk to your doctor or pharmacist before taking this medicine : this medicine may cause severe liver damage . you should have been tested for prostate cancer before starting this medicine and your doctor will regularly check if this medicine is working for you . do not use this medicine to treat any other conditions . tell your doctor if any of these apply to you : you have liver problems , have high blood pressure or heart failure , or have low blood potassium . low blood sodium may increase your risk of heart rhythm problems . other heart or blood vessel problems : have an irregular or rapid heart rate or experience shortness of breath . are over 65 years old
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once daily . you should take this medication about one week apart , preferably at the same time each day . this medicine can be taken with or without food . take this medicinal product by mouth . do not take more zytiga than your doctor tells you to take . zytigea can be given with orwithout food , and it may take up to 2 weeks before you feel better . swallow the tablet whole with water . how to take take zymiga with food if your doctor prescribes a medicine containing prednisone or prednosone . your doctor will tell you how long you need to take the predniesone or the predenisonne . prednezone and prednés
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may indicate that the level of potassium in your blood is low . the amount of potassium that remains in your body is not known . other side effects may include : common ( may affect up to 1 in 10 people ): - fluid in your legs or feet , which may be a sign of low blood potassium ( shown in liver function test ) - high blood pressure , urinary tract infection , diarrhoea , vomiting , abdominal pain , nausea and vomiting . uncommon ( may effect up to1 in 100 people ), - rash , itching , loss of appetite , weight loss
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg a BiraterONE aate . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " zytigea contains lactosides "). what zetiga looks like and contents of the pack - zytaga tablets are white to off - white , 9 . 5 mm in diameter , with bevelled edges . the tablets are provided in a plastic bottle with a child - resistant closure . one bottle contains 120 tablets .
hefiya contains the active substance adalimumab . he is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , and paedialic non - infectious uveitis in adults . the active ingredient in hepiy , the active compound , is , inactivated , as a monoclonal antibody . monoclonous antibodies are proteins that attach to a specific target in the body . in the case of aad limumumabe , it attaches to tnf factor - 1 ( ttf ), which is involved in the development of the
do not use hefiya - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a severe infection , such as tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if symptoms of infections , e . g . fever , wounds , feeling tired or dental problems ( see " warnings and precautions "). if your doctor thinks you may have moderate or severe heart failure . it is not known if heficiy , or the patient has a serious heart condition . warningsand precautions talk to your doctor or pharmacist before using hepiyo 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . adults : the usual dose is 40 mg once daily . in the morning , the usual dosage is 20 mg once a day . your doctor may prescribe a lower dose of 40 mg ( two 20 mg injections ) or 40 mg twice daily if necessary . polyarticular juvenile idiopathic arthritis age or body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children / adolescents from 2 decades of age who weigh 10 kg to less than 30 kg 20 mg every week not recommended for enthesitis - related arthritis age and body weight your child weighing 6 kg or greater weighing 30, mg or more first dose of $40 mg . notes children and adolescents from
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur up to 4 months or more after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , and take care not to slip or slip . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems and flu - like symptoms . common side effects ( may affect up to 1 in 10 people )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light before re - use . once removed from the refrigerator for room temperature storage , your pre  - loaded sYringe must be used within 14 days or discarded , even if it is later returned to the refrigerator . you should record the date when your pre- filled
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of aadhalimumb in 0 . 4 ml of solution . - other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e507 ), sodium hydroxide and water for injections . what HEfiуa looks like and contents of the pack heifiy consists of : 20 mg in og / 0. 4ml clear to slightly opalescent , colourless to slightly yellowish solution for injection in a single - use clear type i glass sYringe with a stainless steel needle with
what ritemvia is ritemevia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsuximb sticks to this cell , the cell dies . what ritamvia can be used for the treatment of several different conditions . the active ingredient in ritemmvia is used for : a ) non - hodgkin ' s lymphoma this is not a disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymphoocytes ; rite mammalian granulomatosis rite may be given to patients who have already received at least one chemotherapy
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritsuximabob ; or any of the other ingredients of this medicine ( listed in section 6 ). if your child has a severe active infection at the moment . this is because he has  a weak immune system . warnings and precautions talk to your doctor , pharmacist or nurse before taking ritemevia : if the child has severe heart failure or severe uncontrolled heart disease , such as granulomatosis with polyangiitis , microscopic polyangigaitis or pemphigus vulgaris . do not receive ritemaster if any of these apply to your child . if hepatitis infection is confirmed . before you are given riteritemvic , your doctor will check whether your
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . ritemevia will always be given as a drip ( intravenous infusion ). medicines given before each ritemmvia administration before you are given rite ma - rite will be taken in combination with other medicines ( pre - medication ) to prevent or reduce possible side effects and to help you stay well controlled . your doctor will also monitor your treatment regularly for non - hodgkin ' s lymphoma if you are having ritetmvia alone ritellvia will usually be given once a week for 4 weeks . repeated treatment courses with ritelvia are possible . when given with initiation of riteremvia with chemotherapy
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat irritation , cough , chest pain , wound healing specialist . not known : frequency cannot be estimated from the available data heart rate . tell your doctor or nurse straight away if you notice any of the following serious side effects you may need medical attention : severe allergic reactions . these may be signs of serious mental changes
what ritemvia contains the active ingredient in ritervvia is called rituximab . the vial contains 100 mg of ritsuxim b , and each ml of concentrate contains 10 mg of " ritzuximb ". the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemevia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials : one carton containing one vial
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine - t Eva contains cape citrine , which itself is not a cytotic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitationbine téva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitedbine treament is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . if capecitingbine travé is used as an add - on to other medicines , it is recommended that each person is given the same dose .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if there is an allergy or over - reaction to this medicine , - severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - pregnant or breast - feeding , or - low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), or if your doctor has told you : - have severe liver or kidney problems , as there is a lack of the enzyme dihydropyrimeime dehydrogenase ( dpd ) ( complete dppd deficiency ), as there are other reasons why
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you based on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times a day . two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surface space of 1 , 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150 mg two times per day , two times every day ). a man whose weight is 80 kg and tall is 1. 80 m
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooeal at night . vomiting : when you vomit ( nausea ) you lose your appetite . stomatitis : pain , redness , swelling or sores in your mouth and / or throat . hand - and - foot pain : these may be signs of a condition called st . augustine - like illness . severe swollen glands in the abdomen . itching : this is very common . when capecitebine sulphony
what capecitabine teva contains the active substance is capecitebine . capecitationbine tinge 150 mg film - coated tablets each film  10 mg contains 150 mg capeciabine  capecitingbine tramples on 500 mg film film  - coated tablets each movie  15 mg contains 500 mg capcecitabine the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , crohn ' s disease , magnesium stearate , macrogol 400 , film coating : hypromllose, titanium dioxide ( e171 ), yellow iron oxide ( i ) and red iron oxide . what capcecitebine toeva looks like and contents of the pack cape citabine theva is a white to off - white , oval shaped
what silodosin recordati is silofosine recordatin belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silonodsin recordingi works by blocking receptors in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladoosIN recordatis is used for silodysin resonanceati can be used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , as well as a more frequent need to pass urine , even
do not take silodosin recordati - if you are allergic to silofosine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking silódoşin recordattai : - during eye surgery - because of cloudiness of the lens ( cataract surgery ), the doctor must place an ophthalmologist on the back of the eye 26 during treatment with siloudooshin recordatif this happens . during treatment and after treatment with medicine , you may experience a loss of muscle tone in the iris ( the coloured circular part of the ocular layer ) after such a surgery . the doctor will take appropriate precautions to avoid exposure to this type of medicine and surgical techniques . talk to the doctor if : you are not sure if
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . take the capsule always with food , preferably at the same time every day . do not break or chew the capsule , but swallow it whole , even if it is not necessary . patients with kidney problems if your doctor has told that you have moderate kidney problems the dose of siladoosine for this purpose sillodonesin recordingi is usually taken for 4 hours before or at least one hour after meals . if this is the case , you should take sil lododousin replayati for up to 4 weeks continuously . in order to avoid overdose , silledo
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these effects may be serious and may require medical attention . possible allergic reactions include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . these are very common side effects of silodosin recordati . dizziness . this is common . although dizziity is common at the start of treatment , sometimes occurring after a meal , and occasionally fainting may occur . if you do feel weak or dizzy , talk to your doctor as soon as possible . the symptoms of dizzincy and fainting can also occur after taking sildodostati and can be serious . complications from a cataract surgery ( eye surgery ) may occur with this medicine . tell your doctor straight away if your condition gets
what silodosin recordati contains - the active substance is siloudoosen . each capsule contains 8 mg of silódonosin . - each capsule has 8 mg silоdoses . the other ingredients are : capsule content : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( е171 ). sil lododostin recorditi 4 mg hard capsules contain sillosedolosin , equivalent to 4 mg of Silodidosine . capsule shell : pregelatinised maize starch , mannita ( acellular matrix ). magnesium sterarate and sodium laursulfat . gelatin, titanium oxide ( ige171
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin Ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzialmona blocks this effect of angiostensin in ia so that the blood vessels relax , and your blood temperature is lowered . this medicine is used to treat essential hypertension ( high blood pressure in adults ). ' essential ' means that the high bloodpressure is not caused by any other condition . high blood temperature , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you may become pregnant , unless you are more than 3 months pregnant . ( it is also better to avoid kinzonzalmonio in early pregnancy see pregnancy section .) if your doctor has told you that you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . if any of the above applies to you , tell your doctor . warnings and precautions talk to your doctor before taking kinzialmona if : you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , to help you remember to take it . you can take kinezalmona with or without food . it is important that you take kinszalmonio every day until your doctor tells you otherwise . if your doctor feels that the effect of kinszukizumabine is too strong or too weak , talk to your doctor . patients with high blood pressure the usual dose of one kinzimono for treatment of high blood tension is one 40 mg tablet once a night to control blood pressure over the 24 - hour period . your doctor may prescribe a lower dose of two 20 mg tablets once - a week .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately as they could be fatal . if these effects are not treated they could become life - threatening . possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people ), including : low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . any unused medicine must be thrown away .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as meglumine ). - other ingredients are povidone , meglume , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzonzalMONo 20 mg tablets are white to off - white , round tablets , with " cz " debossed on one side and " dz ". kinzaalmona is available in blister packs containing 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product that is produced by recombinant dna technology . the active ingredient in a fshla is lonoctocog alfa . aafsentyla has been shown to reduce bleeding episodes in patients with haemophilia a ( inborn factor ixi deficiency ). factor ii is necessary for blood clot . it helps the blood to cloting in people with an increased tendency to bleed . in patients without factor  vii in patients of all ages , there is no mechanism for it to coagulate . however , in patients suffering from haematophiliia it is not able to clump together . therefore aestyingla is not intended for use
do not use afstyla : if you have ever had an allergic reaction to any ingredient of aaffshyla ( if your doctor is not sure ) if any of the above applies to you , or if  you are not sure whether you are allergic to hamster proteins . warnings and precautions 46 before you are given a fsyla you should record the batch number in your treatment diary . it is very important that you do not forget to take the doses of , and include , the days of the week on which you have been taking a dose of . if this happens , you should contact your doctor . do not take more than one dose in one day . talk to your doctor or pharmacist before taking , if possible . children and adolescents do not give a copy of the original package of ffy
your treatment should be initiated under supervision of a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of fstyla is : the dose of dose the site and the severity of the bleeding your clinical condition . reconstitution and administration general instructions the powder must be mixed with the solvent ( liquid ) immediately before use , in a controlled and aseptic condition , before using afssyla . other medicines and solvents should be used immediately after reconstitution . see section 6 . after reconstitute the solution should be clear or slightly opalescent . do not use if it is cloudy . withdrawal of the solution may be required by taking the medicine out of the sight of an eye . discard any unused product or waste material 
like all medicines , afstyla can cause side effects , although not everybody gets them . you must report symptoms immediately to the doctor or seek medical attention if you experience symptoms of allergic reactions . allergic reactions may include the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness and anaphylaxis ( bleeding from the site of injection ). for children not previously treated with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). children not returning from previous treatment with factor vii ( more then 150 days of treatment ) should contact their doctor . reporting of side effects 23 if your child gets any side effects talk to your doctor , pharmacist or nurse .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . use the afstyla powder immediately after preparation . if not used immediately , the viall may be stored below 25 for a maximum of 3 days . once removed from the refrigerator , allow the product to return to room temperature ( below 25 ) and use within 3 days of storage . protect the product from light until the product is completely reconstituted . your doctor or nurse will show you how to store the product .
afstyla 250 micrograms / 2 . 5 ml solution for injections the solution contains 100 microgram ( iu ) of lonoctocog alfa . after reconstitution with 2 , 5 . 4 mL of water for injection the solution provides 200 microgram of lonostocogo alfA per m2 . it can be diluted with 1000 microgram( i ) per 0 . 2 mlitre solution after reconvention with 2. 5 microgram solution for infusion with water for injects the solutions contains 400 microgram [ iau ] lonoccog - alf - 1500 ius / m3 solution for reconstitution and 5 % water for injections the mixture contains 300 microgram[ irradiated lonoctcog almonds ( corresponding to 2000 iur
what praxbind is prakbind contains the active substance idarucizumab . i darucizum ab is a reverse agent that blocks the action of dabigatran ( pradaxa ). this is  a blood thinner medicine that is used to prevent blood clot formation . how prauchbind works praybind helps to rapidly trap dabig atran in the blood . what pradxbind can be used for prapraxbound is used in emergency surgery or urgent procedures to prevent uncontrolled bleeding .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . - in case you have a genetic disease called hereditary fructose intolerance ( hfi ) containing the substance sorbitol . warnings and precautions talk to your doctor before taking this medicine . this medicine may cause serious adverse reactions . do not use prakbind if any of these apply to you . talk to you doctor before using this medicine you should tell your doctor if : you are taking dabigatran or other medicines to prevent blood clots . dabig atran is absorbed by the body as a result of the formation of blood cluts and medicines to help prevent blood cots from forming . your doctor will determine the correct
praxbind will be given to you in a hospital or clinic under the supervision of a doctor experienced in giving this medicine . the recommended dose is 5 mg ( two 2 . 5 mg vials ) of dabigatran per day . you will be monitored while you are given this medicine and for 5 minutes afterwards . your doctor will decide how many treatments you need . this medicine will be injected into a vein . if you are being given more praxxbind than you should if this medicine is given by a qualified doctor , it is unlikely that you will receive more of this medicine than you need and the risk of blood clot formation . in the case of an overdose of dabatran , you will have been given the overdose period for 24 hours . tell your doctor if any of the above apply to you . taking this medicine tell your healthcare professional immediately 
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects tell your doctor or pharmacist if you get any side effects or reports of side impacts , including any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate , acetic acid , and sorbitol ( e420 ), polysorbate 20 and water for injections . what pfizer looks like and contents of the pack prakbind is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . tememedaac is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . the administration of temtemoMEDac will be started together with radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase oftreatment ). -in children 3 years and older and adult patients with malignant gliomema , such as glibblastomas multiform e or anaplastic astrocytoma ( gliblastoblasta multiformate or atypical astracytomum ). the administration and administration of
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking temac as you may have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if the number of blood cells is severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting . your doctor will check your blood to make sure that you have enough of these cells before starting treatment , and regularly thereafter . warnings and precautions talk to your doctor ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if there is evidence of a recurrent tumour and you have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temmedaf to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if your doctor decides that treatment will be started in combination with treatment with radiotherapy ( concomitant phase ) followed by treatment with temac ( monotherapy phase ). the usual dose of using tememedacre is 75 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), or fever , chills , severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; anaemia ( a shortage of red blood cells which can cause fever ); and reduced resistance to infections . the reduction in blood cell counts may be prolonged and may be life - long . anae ( cutaneous anaplastic anaphylactic reaction ), in patients with a history of fever ; and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . temomedac is for single use only . use within 30 days after first opening . tell your pharmacist if you notice any change in the appearance of the capsules .
what temomedac contains - the active substance is temozolomide . temmedap 5 mg : each vial contains 5 mg of temizolomide.  temtemomediac 20 mg  : every vial delivers 20 mg of de temazolomide in one ml .  also tememedaac 100 mg , each viall delivers 100 mg of dulbecco temizac . each vially delivers 140 mg of desiccant of TEMozolomiDE . the usual dose in temac 140 mg / 180 mg temozalomide is used in multipacks comprising 180 vials , containing 180 mg of demect . furthermore , the usual dosage in ms is 25 mg . one vial of mz contains 250 mg
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , eer penis suitable for sexual activity . cialist has been shown to significantly improve the ability of obtaining ahard eerect penis suitable for sexual activities . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . how ciali works cialising works by helping the blood vessels in your penis to relax , making it hard and elated . it allows the flow of blood into your penises . improved eexile function cialisation has been proven to lower the amount of e rectile disorder in men . you and your partner will need to keep using cialised for at least four months to work .
do not take cialis if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). if the above applies to you , tell your doctor before taking cial. if your doctor is not sure , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : if - you are taking any form of organic nitrate or nitric oxide donors such as amyl nitărite . this is a group of medicines (" nitsrates "), used to treat angina pectoris (" chest pain ") in particular if taking a cialiser . these medicines contain natrate or are used to prevent serious heart disease . - if any of these apply to you as a precautionary measure . you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets with a glass of water . you may take the tablets either with or without food . the dose may be increased or decreased by your doctor over a period of 5 to 2 . 5 hours if taken with or just after food , and preferably at the same time each day . do not take more cialiser than your doctor tells you to . taking cialist you should sexually stimulated after taking a tablet of cialised to get an erection , when sexually motivated , at any time of the day , with or shortly after sexual intercourse . 24 cialising is a medicine used for erectile dysfunction . it will help you to get er erected 
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start the medicine or when the dose is increased . - allergic reactions including rashes ( frequency uncommon ). - chest pain - do not use nitrates but seek immediate medical assistance ( frequency rare ). do not take priapsim more often . ask your doctor if you want to have a prolonged and possibly painful erection after taking cialis ( frequency common ). If you have an error , which lasts continuously for more than 4 hours you should contact a doctor immediately . some men may have sudden loss of vision ( frequency not known ). other side effects were reported very commonly ( may affect more than 1 in 10 people ) and uncommonly ( frequency cannot be estimated from the available data ). you may experience headache and back
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of t Tadal afil as active substance . -the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate ; magnesium stearate . film - coat : talc , lactoses monohydrate , in the tablet core and hypromellose , triacetin , titanium dioxide , iron oxide yellow ( e172 ), iron oxide red ( i ) and talcite . what ciais looks like and contents of the pack ciali 2 , 5 mg film , tablet is a pale yellow 
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . eninessglid helps control the level of sugar in the blood when you have type 2 diabetic diabetes . treatment with diet and exercise is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . in some patients , englid may be used in combination with metformin , which is also used for diabetes - related illnesses .
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not start taking ennyglide and talk to your doctor . warnings and precautions talk to you doctor before taking  Enyglidu : it is important that you have type 1 diabetes . enyingglid may lower the acid level in your blood ( diabetic ketoacidosis ) if your doctor determines that you suffer from a severe liver disease . it is also possible that you may be given gemfibrozil ( a medicine used to lower increased fat levels in the blood ) or suffer from liver problems if any of these apply to you ( or you are not sure ), talk to a doctor before you take  Englid ( see also section 2 .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each of the three main meals . your doctor may prescribe a lower dose ( such as 4 mg to 30 mg ) or higher doses ( such a 16 mg dose ). if your blood sugar is too low , it may become too low due to the development of a hypo . if this happens , your doctor will decide how to treat you enyglid should be contacted . do not take enYglid more than once a day . take the medicine pack with you so that it is clear what you have taken . you may find it easier to remember to take a dose of enyinggli
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogLYcaemia which may affect up to 1 in 10 people ( see section 2 ). hypogycaemic reactions are generally mild / moderate but may occasionally develop into hypoglacymic unconsciousness or coma . allergy allergy is very rare ( may affect less than 1 in 1 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects which may occur with enyglid are : common ( may effect up to1 in 10 users ): stomach pain . generally mild or moderate , hypogliescaema may occur as a result of allergic reactions . very rare : may
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg reglinide ( as mesilate ). - other ingredients are microcrystalline cellulose ( e460 ); calcium hydrogen phosphate , anhydrous ; croscarmellose sodium ; povidone k25 ; and glycerol ; magnesium stearate ; meglumine ; or poloxamer . - printing ink : shellac ; yellow iron oxide ( е172 ) only in the 1 mg tablets and red iron oxide( e172 ). only 2 mg tablets : yellow , round and biconvex with bevelled edges . 1 mg tablet : pale brown , yellow ; in black , oval . bi
what azacitidine mylan is azacecitine mylan, an anti - cancer agent . aza citidine myLAN contains the active substance azacitaine . what zacittine mylan are used for azacotidine mylang is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ). chronic myelamonocytic leukaemia ( cmml ). acute myeloid leukocytoclastic aml . these are diseases in which the bone marrow cannot produce enough blood and can reduce normal blood cell production . how azacine mylan works azacriitidine is used when cancer cells are at increased risk . the active ingredient in azacleic acid ( rna ) is a type
do not take azacitidine mylan - if you are allergic to aza citidine or any of the other ingredients of this medicine ( listed in section 6 ). -if you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacitaitidine Mylan : - have decreased counts of platelets , red or white blood cells . - suffer from kidney disease . it is important that you tell your doctor if your liver disease is affected . you have ever had a heart condition or heart attack . or if someone else in your family has any history of lung disease , please tell your physician . blood test you will have blood tests before you start treatment with azacecitine mylan and at the start of each period of treatment ( called a ' cycle '). this is to check that you have enough blood cells and that your
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacecitine mylan every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , for at least 6 weeks ). this medicine will be injected under the skin ( subcutaneously ) by  a doctor or other healthcare professional . it may be given under the dermatology of your child ' s skin on the thigh , tummy or upper arm . if you have any further questions on the use of this medicinal product , ask your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these are symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness and fatigue . symptoms may be similar to those experienced by some patients who have liver failure . call your doctor right away if your medicine is not working properly . side effects may include : very common ( may affect more than 1 in 10 people ) - swelling of hands , feet - back pain and reduced passing off
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and carton . your doctor , pharmacist or nurse are responsible for storing azacipitidine Mylan . they are also responsible for the correct disposal of the product . - any unused azacritidine myLAN will be kept in the pharmacy and will store it in a refrigerator ( 2 8 ). - the suspension should be used immediately after it is prepared and diluted in water for injections . once dissolved in water , the suspension must be used within 1 hour . when using later on if the aza citidine myla suspension is prepared using water for injecting it into the refrigerator ( 3 8 ), the suspension may be stored in the refrigerator at 2 8 or in the fridge ( 2 to 8 ) for up to 
what azacitidine mylan contains - the active substance is aza citidine . one vial of powder contains 100 mg azacriidine - one vially of powder after reconstitution contains 4 ml of water for injections . the reconstituted suspension contains 25 mg / m2 azacipidine , - in the absence of mannitol ( e421 ). what izacitine mylan looks like and contents of the pack azacecitide mylan is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacionitidine ; one viall is contained in one carton . packs of 1 or 7 vials are available . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprosto is a prostaglandin analogue that is released from the eye into the gullet (" foodpipe "). timimololl is , therefore a beta blocker , which causes fluid within the eye to build up . this results in an increase in pressure within the eyes . duototrav eyes drop solution is used to reduce high pressure in the eye , leading to an illness called glaucoma .
do not use duotrav - if you are allergic to travoprost , prostaglandins , timolol , or beta blockers , any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using duotar : - when you have respiratory problems such as asthma , severe chronic obstructive bronchitis , and severe lung disease . - signs of wheeziness , difficulty in breathing , long - standing cough or breathing problems . talk to a doctor if any of these apply to you . take special care with duotrast tell your doctor straight away before you use duatrav the following are reasons why this medicine may not be suitable for you : severe hay fever . you may have a
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . duotrav is only for the eye and only in your eyes . use duotorav only as an eye drop if your doctor tells you to . do not use duotrotrav on your eyes when you are using duotar . how much to use use the recommended dose is 1 drop in the affected eye 2 drops every 3 weeks or 4 weeks . before using a bottle , wait 1 hour before using duotromar . wash your hands . the first time you open the bottle : the first part of the bottle is a wash of soap and water . twist off the bottle cap . hold the bottle and , after using it , press a finger into the corner . tilt your head back . pull down your eyelid with 
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . if you are worried , talk to your doctor or pharmacist . do not stop using duotrav without talking to your eye doctor . very common side effects ( may affect more than 1 in 10 people ): effects in the eye eye eye redness . common side impacts ( may effect up to 1 in 100 people ), effects in and around the eye eyes eye surface inflammation or surface damage . this can lead to eye pain , blurred vision , abnormal vision . dry eye , itchy eye ; eye discomfort . signs and symptoms of eye irritation , such as burning or stinging . uncommon side effects (2 may affect up to1 in 100 persons ) eye irritation or burning or notching . reporting of side effects 23
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . throw away the vial 4 weeks after first opening , to prevent infections . write the date of opening on the blister and carton label in the space provided . this medicine does not require any special storage conditions .
what duotrav contains the active substances are travoprost and timolol . each 40 mg / 40 mg tablet contains travapross 5 mg titmololl ( as tibimolole maleate ). the other ingredients are polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil . the 40 mg dose also contains boric acid , sodium chloride , water , salt hydroxide / hydrochloric acid . purified water . sodium hydroxides and / or hydroch chloric acid are added to keep acidity levels ( ph levels ) normal .
nplate contains its active ingredient romiplostim . it is a protein used to treat low platelet counts in patients with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is  a disease in which your body ' s immune system does not produce enough platelets . platelets are important for protecting your blood from blood clots . very low platelets counts can lead to bruising and serious bleeding . n plate is used in adults and children ( aged 1 year and above ) with their spleen removed . in patients who have chronic itp and have previously taken corticosteroids or immunoglobulins , it is not yet known how well it works in these patients .
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking n plate . if your doctor thinks you may be allergic to other medicines used to treat escherichia coli ( e .
children and adolescents ( aged 1 to 17 years ) the recommended dose of nplate is : - platelet counts as indicated by your doctor . n plate is given as an injection under the skin ( subcutaneous ). adults : the recommended dosage is 1 ml of 449 mg n Plate per kg of body weight . your doctor will decide how much nlet you receive . when you receive your first dose of the medicine , your doctor may decide to increase or decrease the amount of splate that you receive and how often you will receive npel . before you receive the first dose , you will have regular blood samples to check your platelet count . you will need to take your platelets regularly to check that your platelette count is adequate . the number of platelet numbers in your blood will depend on your plate platelet number . children and teenagers ( 1 to17 years of
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported for nplate in clinical trials with n plate : common ( may affect up to 1 in 10 people ): headache ; allergic reaction ; upper respiratory tract infection ; common ( might affect upto 1 in 100 people ); bone marrow disorder ; increased bone mmarrow fibres ; trouble sleeping ( insomnia ); dizziness ; tingling or numbness of the hands or feet ( paraesthesia ); migraine ; redness of skin and flushing ; joint pain ; pain in joints . uncommon ( may effect up to1 in 100 users ) : increased liver enzymes in the blood ; decreased appetite ; change in blood tests ; itp rare ( may impact up to one in 1 , 000 users ); increased blood fat levels 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine should be used within 30 days after first opening . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . each ml of n plate 125 micrograms solution for injection contains 230 microgram ( 8 . 5 million iu ) romiolostim in a vial . one vial contains 125 mbq of romimeploslim . this delivers a deliverable amount of 0 . 25 mL solution ( corresponding to 125 million u / m2 ) of ROMiploStim , corresponding with 500 microgram( 11 . 0 million mmol ) ( 23 . 7 million v ) in each npel vial and 250 mla ( resulting in 375 million l / 1 mq of solution ). romigaplost : each vial delivers 250 million g
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovantor briezhalmer is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to  a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . these muscles make breathing difficult . the medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary system . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanour breezehaler as this may affect the way you breathe . talk to you doctor or nurse before using this medicine : - patients with kidney problems - people with an eye problem called narrow - angle glaucoma - difficulty passing urine . during treatment with tovanlor breeezhale use this medicine immediately after using this product . - contact your doctor if : you experience tightness of the chest , coughing , wheezing or breathlessness immediately after use of tovanoral breEZhaler ( signs of bronchospasm ), difficulties in breathing or swallowing . swelling of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to inhale the recommended dose is to inhaled the content of one capsule each day . you only need to inflate once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people the recommended starting dose is 75 mg . when to inhhale tovanour breezehaler use this medicinal product for inhalation . this medicine is for inhaling ( inhaling ) the contents of the capsule ( in blisters ) once inhaulated . the medicine is to be inhaLED as inhalations powder . only use the capsules with the inhaler provided in this pack ( tovanlor breeez
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyronicum bromide equivalent to 50 microgram of glycopirronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( mg ) of glycopronium ( as mesilate ). - other ingredients of the injection powder are lactose monohydrate and magnesium stearate . what tovantor brewinger looks like and contents of the pack tovanlor breezehaler 44 microgramms inhalation powder , hard capsules are transparent and contain a white powder . they are supplied in a device called an inhalator . capsules will be supplied in blisters , each blister strip containing 6 capsules . pack sizes may
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce a chemical called dopamine . this chemical is involved in the production of serotonin , which are involved in calming effects and relieving aggressive behaviour . adesuve is used in adults to treat acute symptoms of mild - to - moderate agitation associated with schizophrenia or bipolar disorder ( diseases characterised by symptoms such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with adsuve may also feel depressed , guilty , anxious or tense , because people with bipolar disorders may find it helpful to keep you alert and keep you on alert while you are taking aadasupve .
do not use adasuve if you are allergic to loxapine , amoxapinе or any of the other ingredients of adasuve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using aadosuve as it may cause symptoms such as wheezing and shortness of breath . these may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), which may result in narrowing of the airways ( bronchospasm ), causing wheeze , cough , chest tightness , and shorten of breath 25 as these may indicate neuroleptic malignant syndrome ( nms ), as it can be associated with symptoms which can be caused by antipsychotic medicines . if these symptoms occur , you must tell your doctor
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 9 . 1 mg once daily . your doctor may increase your dose to 2 mg once a day , up to a maximum of 4 . 5 mg once weekly depending on your condition . how much adasuve is given the recommended dose is one tablet by mouth once daily with or without food . if the device does not work well enough , contact your doctor immediately . tell your doctor straight away if : you experience one of the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements that do not go away . you should contact your eye doctor immediately while you are taking adasu
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have any breathing symptoms , such as wheezing , cough , shortness of breath or chest tightness . it may also be irritating for your airways ( asthma or copd ), as these can be signs of light - headedness or fainting . your doctor may want to check your blood pressure more frequently . if this happens , you may have worsening agitation , confusion , fever and muscle stiffness , as these may be signs that you have a severe condition called neuroleptic malignant syndrome . the following side effects may occur with this medicine : very common ( may affect more than 1 in 10 people ): - decrease in the number of white blood cells ( anaemia ). - increase in the level of sugar in the blood
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the pouch after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pouch in the original carton in order to protect from light . once the pouch has been opened or torn , any unused product should be discarded . any discarded product should return to the refrigerator and should be returned to the pharmacy . this includes any re - use storage conditions and the risk of physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 micrograms of loxopine and delivers 4 . 5 microgramms of the active ingredient lox apin . what  aadosuve looks like and contents of the pack aduve 4 : 5 microlitres is supplied in a single , single  dose inhaled disposable white plastic inhalation containing a dose of xapinе . - each inhalers is individually sealed foil pouch . the following pack sizes are available : a dasuve 5 . 4 microgram inhalves in pack sizes of 1 and 5 inhalations . not all pack sizes may be marketed .
what azacitidine betapharm is azacecitine betaphar is an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azacine betaphur contains the active substance ' azacitatidine ', which belongs zu group of proteins called cytokines . what zacitide betaph is used for azacipitidine is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ). chronic myelamonocytic leukaemia ( cmml ). acute myeloid leukoemia ( aml ) - one of a family of diseases in which the bone marrow cannot produce enough blood and cannot support normal blood cell production .
do not take azacitidine betapharm - if you are allergic to aza citidine or any of the other ingredients of this medicine ( listed in section 6 ). -if you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacitaitidine betatapharm ( if your doctor has told you that you have decreased counts of platelets , red or white blood cells ). you should tell your doctor if any of these apply to you . - you have kidney disease . you have liver disease , or you have ever had a heart condition or heart attack . your doctor will decide if this medicine is suitable for you , and will decide whether you can be given azacecitine betaphar . blood test you will have blood tests before you start treatment with azacipidine be tapharm and at the start of each period of treatment
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacecitine betaphar every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , for at least 6 weeks ; you should not use this medicine in an area of the skin that contains the thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these are symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness and fatigue . symptoms may be similar to those experienced by some people who have taken the medicine . if they occur , contact your doctor . common side effects ( may affect up to 1 in 10 people ) - loss of appetite - increased weight - reduced blood sugar - vomiting - itching - joint
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and carton . any unused azacritidine betabharm must be disposed of in accordance with local requirements . this medicine is for single use only . once the vially has been prepared it should be used immediately . when using this medicine the suspension should be administered within 45 minutes . if the azacipidine be tapharm suspension is prepared using water for injections that has not been refrigerated , the suspension must be placed in the refrigerator ( 2 8 ) immediately after it is prepared and kept refrigéré for up to a maximum of 8 hours . the izacitine betaphar suspension is made using water to be made using injections which has been stored in the fridge ( 2 - 8 ), and
what azacitidine betapharm contains the active substance is aza citidine . one vial contains 100 mg azacipidine ; after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacriidine - the other ingredient is mannitol ( e421 ). what acitine betaphar looks like and contents of the pack azacecitide betaph is a white to off - white powder . it is supplied in a glass vial containing 100 mg of azacionitidine  . each pack contains one vially .
cerdelga contains the active substance eliglustat and is used for the long term treatment of gaucher disease type 1 . gaucher diseases type 1 is a genetically inherited condition in which substances called glucosylceramide build up in certain parts of the body such as the spleen , liver and bones . eleglustat works by blocking the growth of glukylcerami and thus reduces the amount of Glucosylcamide that your affected organs need to work properly . you will only be given this medicine if your condition is not well controlled . the long - term treatment with this medicine is not meant to stop cerdeslg if you continue to use it , but rather slow speed , and / or poor metabolism . your doctor will decide how much cerdlgа to give you with a simple laboratory test .
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - when taking medicines with moderate cyp2d6 inhibitors ( e . g . quinidine or terbinafine ), 31 - with moderate cystocype inhibitors such as erythromycin or itraconazole , these medicines may reduce your body ' s ability to fight infection . do not try to take zerdelgar if any of these apply to you . warnings and precautions talk to your doctor or pharmacist before taking cerdeslg : - before you start taking zerdeslaga , - after you have started taking medicines that have a poor metaboliser ( such as medicines called strong cystolic inhibitors , such
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . if necessary your doctor will tell you how many tablets of cerdelga to take . the recommended dose is one tablet ( 200 mg ) twice a day . use a metaboliser to help you remember to take the medicine . swallow the tablet ( 84 mg ), with or without food . take the tablet at about the same time each day , even when you are taking it with or just after food , at the same times each day ( preferably at the start of the day ). if your doctor tells you to take more cerdeslg 84 tablets than you should if the tablet is not absorbed by the liver , contact your doctor immediately . how to take take cerderlg take the blister /
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( digestive tract disease ). uncommon ( may effect up to 1 in 100 people ), difficulty swallow ( digestive block ) abdominal pain ( gastroenteritis and reflux disease of the intestine ) constipations abdominal pain back pain indigestion ( abdominal pain at the site of intake ) gastroentesophagesal reflux
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . syringe or sachet should be kept dry in order to protect from moisture . keep cerdelga dry , white to light yellow , scaly , and dry . store in the original package in order protect from light . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains the active substance is eliglustat . each capsule contains 84 mg of elliglustatta . the other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdeslg containing lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( i 172 ), indigotine ( k29 / 32 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cdelgar looks like and contents of the pack cer delgage capsules are a pearl blue and green opaque printed with ' mek2 ' on one side 
the active substance in zoledronic acid hospira is zolеdronic acids , which belongs to a group of substances called bisphosphonates . zoleledronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the bones ). to reduce the amount of calcium in the blood in adult adults where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolonedronic acids hospria : if you are allergic ( hypersensitive ) to zolеdronic Acid or another bisphosphonate ( the group of substances to which zoleledronic air belongs ). your doctor should not give you zolledronic aluminum hos Pira . tell your doctor before you are given zeedronical acid houpira if your doctor thinks you may have a kidney problem . if the doctor think you may be given pain , swelling or numbness of the jaw , a feeling of heaviness in the jaw or loosening of a tooth . ask your
zoledronic acid hospira is to be administered by healthcare professionals only . it is administered by bisphosphonates intravenously , i . e . through a vein . the recommended dose is ' iv ' administration . your doctor will recommend that you drink enough water before each treatment to help prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . how much zolеdronic acids hospria is given - the usual dose is 4 mg .- if you have a kidney problem , your doctor may give you a lower dose depending on the severity of your kidney problem and on how severe your condition is before starting treatment with zoladronic air hosspia . prevention of bone complications due to bone metastases , by infusion , is recommended . before each in
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): - severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). - low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ). the following side effects may occur : pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth and jaw discharge , feeling of numbness or a feeling of heavyness in the jaw ; loosening of a tooth ; these could be signs of bone damage in the tooth ( osteonecros
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). after first opening , the product should be used immediately .
what zoledronic acid hospira contains the active substance is zolédronic acids . one vial contains zolеdronic Acid . each vial of 4 mg zoleledronic air ( as monohydrate ). the other ingredients are : mannitol , sodium citrate and water for injections . what zedronic al hospria looks like and contents of the pack zolledronic aluminum hospra is supplied as a liquid concentrate for solution for infusion ' and as ' sterile concentrate '. it comes in vials containing 4 mg of zoleric acid and each pack contains one vially of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when having cancer treatment chemotherapy ( chemotherapy ) destroys nerve cells that have been damaged in the brain . this prevents vomiting , which may make you feel sick or be sick . rolapatant works by blocking the activity of these nerve cells , allowing you to feel nausea and vomiting more easily .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ); - as an herbal medicine ( containing st john ' s wort ( hypericum performatum )) - when used for depression or difficulty sleeping - with or without food - for children aged 2 years and above , this medicine should not be used in this age group . warnings and precautions talk to your doctor or pharmacist before taking varubry : 27 - in patients with severe liver or kidney problems - taking certain medicines , including rifampicin ( used to treat tuberculosis or other infections )  carbamazepine ( used for epilepsy and nerve pain ) or phenobarbital ( used in epilepsis ) *
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 180 mg once a day . your doctor may increase your dose to 90 mg once every day , if needed . swallow the tablets whole with food or between meals . you can take varuby with or without food . take varigy about 2 weeks before your chemotherapy cycle starts . chemotherapy can cause sickness . sickness can occur during treatment with this medicine . it can be taken if your doctor decides that it is safe for you to go to bed , or if it is not safe for it to go home . do not take varumy for more than one week . if this happens , you must wait until your next planned chemotherapy and go back to your regular dosing schedule . this will help you to remember when to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ) if you experience symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and faster heartbeats , contact your doctor immediately . your doctor will decide if appropriate treatment is needed . other side effects include : very common ( may effect more than 1 in 10 people ), headache , constipation and feeling tired . common ( might affect upto 1 in every 10 people this may be a sign of an upper respiratory tract infection ). common (may affect upt ) diarrhoea , nausea , vomiting , diarrage
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolapatant -the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varaby looks like and contents of the pack varubY is a pale yellow to blue , capsule shaped , biconvex , film tan coloured tablet , debossed with ' gs t ' on
what enerzair breezhaler is enersair briezhale contains three active substances : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyranium belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the pulmonary airways . when they are taken regularly , they help the small lungs remain open . mometapasine furoates belongs to  a groupe of medicines known as corticosteroids ( or steroids ). corticotrooids reduce the swelling and irritation ( inflammation ) in the small small airway in the lung and so gradually ease breathing problems .
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking enezair and tell your healthcare professional if any of these apply to you ( or you are not sure ). warnings and precautions talk to your doctor , pharmacist or nurse before taking  Enerzaire breezehaler and follow the advice given . talk to you doctor or pharmacist before taking your first dose if : you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . your doctor may want to monitor you more closely . - you have ever been told you have diabetes or high blood sugar . the risk of seizures
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation twice a day . you only need to use only the medicine once a week . do not use more than your doctor tells you to use . enerzair breezhaler should be used every day as directed by your doctor . this will help control your asthma and improve your symptoms . when to use your doctor will prescribe the right dose for you , depending on your condition and the dose that you need . for each inhaler , you will find an inhalateur and capsules that contain the medicine . the inhalator should be inserted directly into the capsule and should not be swallowed . only use the capsules with the inhaled dose . in this pack , the capsule will remain
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side impacts include the following listed below . tell your doctor or pharmacist if any of these side effects gets serious : very common , may affect more than 1 in 10 people common - sore throat - runny nose - sudden difficulty breathing and feeling of tightness in the chest - feeling of fullness in your chest , confusion and disorientation - blurred vision reporting of side effects 25 if your child
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose contains 150 micrograms of indocaterol( as apoate ), 63 microgram ( 8 microgram ) glycopyronicum bromid , 50 microgram( 8 microgramm ) of glycopyranium and 160 microgram [ 8 microliter ] momettingasine furoates . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) contains 114 microgram of indeacaterolul ( as as аcetate ) 58 microgram (1 microgram per dose ) glucosepyrroniUM bromid ( equivalent to 46 microgram) of carboplatin and 136 microgram (2
clopidogrel acino pharma gmbh contains the active ingredient clopogrell which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thorax ). cloclopidagrel ano pharma grbh is taken to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothrombosis , and atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogre
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to cloclopidoaiel or any of the other ingredients of clopogrell acina pharma or any other ingredients . please tell your doctor if any of these apply to you . if your doctor thinks you may be allergic ( Hypersensitive ), as clodogrela acini pharma has been marketed . warnings and precautions talk to your doctor or pharmacist before taking clopadogreel аcino pmb : if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; you suffer from severe liver disease . your doctor may want to monitor you more closely while you are taking clupidogral  acan pharma gr
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopogrell acini pharma grbh per day to be taken orally with or without food , and at the same time each day . take a tablet of this preparation with or immediately after food . if your doctor decides that you should take oblivious to the effects of obstructive cloclopidougrel alacino pharmacy gbh , contact your doctor, pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . show them your pack of clapidogresl аcino pharm . for all others to take , take your tablet or the box with you to show the
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 to 1 user per 10 , 000 ) rare (affecting between 1 to10 users in 10 000  and very rare ( affecting less than1 user in10 ,000 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . if clopogrell acan pharma grbh is damaged of blister or film - coated tablets , it should be disposed of in accordance with local requirements . medicines should not be discarded if you notice any visible sign of damage of blister . return the pack to your pharmacist . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopogrell . each tablet contains 75 mg of clopotogreil ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( 6000 micrograms ) titanium dioxide ( е 171 ) what c clopadogrelly acini pharma grbh looks like and contents of the pack clopodogre acan pharma mgmbhhh 75 mg film , tablet core is white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons containing
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. it is used in adults : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , an nucleolar analogue reverse transcript
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before taking delStrigo and if the following medicines are available : carbamazepine ; oxcarbazepine ( e1202 ); phenobarbital ; and phenytoin ( medicines for seizure ); or rifampicin and riffapentine ( medicines to treat tuberculosis ); saint john ' s wort ( hypericum perforatum ) ( a herbal remedy used for depression and anxiety ); products that
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take a complete regimen is taken as a single tablet to treat hiv infection . the recommended dose is 1 tablet once a day . if your doctor is not able to take certain medicines , your doctor may need to change the amount of doravirine you take . this is a list of medicines that should be taken at the same time each day , so you can take your tablets at any time of the day ; take them at about the same times each day and take them with food . taking this medicine swallow the tablet whole with water it is best to take it at the exact same time every day - this will help you remember to take your tablet . your doctor will tell you how long you should take delstrigo . you may need up to 12
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams , difficulty in sleeping ( insomnia ) headache , dizziness , sleepiness , cough , nasal symptoms , feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss , rash muscle symptoms ( pain or stiffness ) feeling tired , muscle pain ( fatigue ) cough . uncommon ( may effect up to 1 in 100 people ). not known ( frequency cannot be estimated from the available data ) : feeling weak , weak - feeling weak or lack of energy , weight loss . reporting of side effects 25 if any of these side effects gets
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the medicine in the bottle in order to protect from moisture . write the date of opening on the label of the bottle . discard the bottle after first opening . store in the original package in order for this medicine to be stored correctly . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ), croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate ( e470b ), microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumarat . the other ingredients in the coating material are , in the form of a coating material , carnauba wax e903 , and hypromlose ( cc ), iron oxide yellow ( i )), lactose monohydrate , titanium dioxide e171 , triacetin . what delustrigo looks like
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine is used to treat your depression . s Pravato is used in adults . the symptoms of depression vary from one person to another , and often include feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . when used together with another antidepressant , you may read the leaflet of your own medicine for more information on its use in adults and children aged 2 years and over . you should also read the package leaflet for antidepressive medicines .
do not take spravato if you are allergic to esketamine ( also known as ketamine ) or any of the other ingredients of anaesthesia using this medicine ( listed in section 6 ). if there is still aneurysm ( a weak spot in a blood vessel wall that bulges out , bleeding in the brain ). warnings and precautions if any of these apply to you , tell your doctor before taking s Pravato you should tell your doctors if : you have recently had a heart attack , and within 6 weeks you may have a temporary increase in blood pressure , which could increase the risk of serious complications in these conditions . if your doctor decides not to take a sprinkling of spruvato as this medicine should be used with caution . you should inform your doctor if: you suffer from 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the spravato nasal spray is a clear , colourless to pale yellow solution . your doctor will tell you how many sprays you need to use . instructions for use follow these instructions carefully and ask your doctor , pharmacist or nurse if they are not clear . if necessary , the nasal spray device may be activated at intervals of 1 to 2 hours . there are 3 nasal spray devices in each pack . you will use one nasal spray app for 4 days ( one approx . 4 hours ) before you start using s Pravato . after 4 weeks , your doctor may tell you to stop using this medicine . it is important that you follow these advices about nausea and vomiting given at least 2 days before you begin treatment . duration of treatment usually 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common : may affect more than 1 in 10 people feeling disconnected from the feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity in or around your mouth area , spinning sensation ( vertigo ) vomiting nausea common ; may affect up to 1 in every 10 people being extremely happy ( euphoria ), feeling agitated , dizziness , drowsy rash , back pain muscle spasms , joint pain , muscle pain aches , pain in limbs muscle spasticity , abnormal sensation in the mouth area including spinning sensation , vertigof , vomiting nausea . common , may affect less than 1 per 10 people generally feeling extremely
what spravato contains - the active substance is esketamine . each nasal spray device contains eeketamine hydrochloride equivalent to 28 mg eisketamine the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what reconstituted sprivato looks like and contents of the pack sprevato is a nasal spray solution for use in adults . this medicine is essentially a clear , colourless solution and is supplied in a single - use nasal spray unit . s Pravato comes in packs of 1 , 2 , 3 , or 6 nasal spray devices . not all pack sizes may be marketed . your doctor will prescribe each nasal spasm device individually packaged in  a sealed blister .
zelboraf is an anticancer medicine containing the active substance vemurafenib . it is used to treat adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery . zeloraf works by causing the body to produce its own protection ( antibodies ) against a change ( mutation ) in a gene called ' egfr '. this change enables the body 's immune system to fight off the growth of melama . by doing so , zelborof targets proteins that are important in controlling the growth and spread of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation when taken with zel Boraf ( see section 4 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zelburaf and during treatment : - allergic reactions can occur ( see " allergic reactions " in section 4 and " allergic reaction " in panel ). if any of these apply to you , tell your doctor or pharmacist before taking your medicine . - stop taking zeboraF and seek medical help immediately if there are any symptoms of an allergic reaction , such as swelling ofthe face  , lips or tongue ( with difficulty breathing and 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for 8 weeks . take the 4 mg capsules once - daily for 4 weeks , then take the 2 mg capsule for 4 days . your doctor may reduce your dose depending on side effects . during your treatment with zelboraf , you may experience vomiting . if necessary , take zel Boraf on an empty stomach . swallow the capsule whole with water . do not chew , crush or split the capsules . how long to take zeborab you should continue taking zelbaf for as long as your doctors tell you , because you may be at increased risk of experiencing side effects and possible overdose . contact your doctor if any of these apply to you : if possible , show
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur . contact your doctor immediately if you have any of the following symptoms : swelling of the face , lips or tongue difficulty breathing rash fainting sensation when you stand up zeloraf may require radiation treatment . tell your doctor if any of these side effects occur , as radiation may interfere with zelburaf treatment , and may be life - threatening . possible side effects caused by radiation during zel Boraf , you may be exposed to certain types of radiation . these include : very common : affects more than 1 in 10 people . damage to the skin , epiphagus , bladder , liver , rectal , or lungs . notify your doctor or nurse immediately : if they are caused by zelba
keep out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . please return the pack to your pharmacist . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemorafengib ( as a co - precipititate of VEmurafatenibe ). the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , allogeneic , low - substituted , polypropyl cellulose , magnesium stearate film  sulfa - iron oxide ( e172 ), macrogol 3350 , inotersen , yellow , opaque , and polyvinyl alcohol , propyl citrate and titanium dioxide ( i ) ( see section 2 ). what zeboraF looks like and
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ), which belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , they can break down certain blood vessels and cause harm . antiplatelets medicinal products reduce the chances of blood  clots forming ( atherothrombosis ). duoplacevin is used to prevent blood cluts formation in hardened arteries , resulting in atherophothrobatic events ( such as stroke , heart attack , or death ). you should know that duoplivin is suitable for you .
do not use duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to other products , including non - steroidal anti - in - inflammation products if the patient has painful and / or inflammatory conditions of muscles or joints if there is a medical condition ( asthma ) associated with nasal discharge , runny nose , polyps ( a type of growth ) in or around the nose if a medicinal condition is currently causing bleeding such as a stomach ulcer , or bleeding within the brain . severe brain injury . talk to your doctor before taking duoplacevin : if any of these applies to you . warnings and precautions talk to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . swallow the tablet whole . you can take duoplavin with or without food . take your medicine at the same time each day , preferably at the the same times each day ( e . g . one tablet in the morning and one in the evening ). you should swallow the tablets whole , with some water . do not chew , crush or split the tablets . it is best to take duotrovir at the start of a heart attack . tell your doctor immediately , or go to the emergency department because it is important that you take duaplavin at the right time every day ; this will help to prevent bleeding . remember to take the tablet at the usual time . keep the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth , skin disorders such as rashes and itching , blisters of the Skin . all of these may indicate an allergic reaction . the most common side effects reported with duoplavin are : very common side effect ( may affect more than 1 in 10 people ) - nausea , vomiting , diarrho
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . after opening , the product should be used immediately . however , in exceptional circumstances , this medicine should not be used if there is any visible sign of deterioration . return the pack to the pharmacist or doctor . these measures will help to protect the environment .
what duoplavin contains duopavin 75 mg film - coated tablets 46 the active substances are clopidogrel and acetylsalicylic acid ( asa ) 75 mg clopogrell and hydrogen sulphate 75 mg of aceticogrelic acid , mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose . the ingredients are maize starch , hydrogenated castor oil ( see section 2 ' duoplivin contains hydrogenated castingor oil ').
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brinzolidine belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartrat belongs to another group of medicine called alpha - 2 adrenergic receptor agonists which help to reduce pressure within the eye . simbr inza is used to lower pressure in the eyes in adults aged 18 years and older , who have certain eye conditions such as glaucoma or ocular hypertension ( high pressure in both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , or to medicines used to treat diabetes , infections or diuretics ( water tablets ) or to a monoamine oxidase ( mao ) inhibitor ( medicines used for depression or parkinson ' s disease ) certain antidepressants tell your doctor if any antidepressive medicines you take have or have recently taken : severe kidney problems . too much acidity in your blood ( hyperchloraemic acidosis ) in less than 2 months old . talk to your doctor before taking simbr inza : if this applies to you . warnings and precautions talk to you doctor before you
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use simbrinza for your eyes . do not swallow or inject . simbrenza can be used in adults . it is only suitable for use in adults and children . the recommended dose is one drop in the affected eye or eyes , twice a day in the morning and once a morning in the evening . wash your hands before you use the bottle . 1 2 ) remove the cap and snap collar . after you have used the medicine , wash your fingers before you start . hold the bottle and press the cap down firmly into place . twist off the cap . if snap collar is loose , the medicine should not be re - opened . press a finger into the corner of the bottle to release the medicine and press 
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of this medicine may occur as a reaction to the medicine or to other medicines you are taking at the same time . the frequency of an allergic reaction is not known ( frequency cannot be estimated from the available data ). if you have severe skin reactions ( rash , redness , or itching all over your body or eyes trouble breathing , chest pain , irregular heart beat ) tell your doctor immediately . extreme tiredness and dizziness tell your doctors if any of the side effects gets serious . simbrinza may be used in combination with other medicines containing brines , st . john ' s wort , an herbal product . taking the medicine with food , exercise and alcohol sulphonylurea ( e . al ., 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after opening the bottle , use a new bottle . keep the bottle tightly closed in order to protect from moisture . tell your pharmacist if you notice any change in the appearance of the tablets . your doctor will throw away the bottle 4 weeks after first opening to prevent infections and use . throw away a sachet or a spare . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolidine , 2 mg of brimoniidine tartrat equivalent to 1 . 3 mg of brmonidine . -the other ingredients are benzalkonium chloride ( see section 2 " simbr inza contains sodium "). - other ingredients : benzalskline , propylene glycol , carbomer 974p , boric acid , mannitol . the other ingredients in the suspension are sodium chloride , the tyloxapol , hydrochloric acid / sodium hydroxide / purified water . what simmbrinZA looks like and contents of the pack simbrminza is a clear , colourless liquid . it is supplied in glass
what filgrastim ratiopharm is filgrastorstim routledge contains the active substance filgraskistim which belongs to a group of proteins called cytokines . filgrastem is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to the group of protein called granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrast stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what filgratstim relationpharm looks like and contents of the pack filgraschtim ratioppharm is mainly made from blood cells taken from healthy donors . your doctor will tell you why you are being treated
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrastorstim or any of the other ingredients of filgraStim ratioppharm ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using filgraştim ratioppepharm and during treatment : if - you experience a cough , fever and difficulty breathing . this may be a sign of a pulmonary disorder ( see section " possible side effects "). if your doctor suspects it is a possible that you have sickle cell disease ( see also section " warnings "). take special care with filgrashipharm 56 if any of these apply to you : you get left upper abdominal pain or pain at the tip of your shoulder . it may be due to a systemic condition ( see " possible possible side effect "). you
always take filgrastim ratiopharm exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much filgrasten ratiopfarm to take filgrestim ratepharm is very important to keep you informed of your condition . your doctor will tell you exactly how many capsules of filgrastepharm to take . filgrastorstim relationpharm treatment with filgrastatopharm when you are having chemotherapy , the usual dose is 0 . 5 mg per kilogram of body weight . for example , if your doctor decides that you can take the tablets with or without food , you will receive 60 mg per capsule . this may be given to you in a hospital or a doctor . the usual starting dose for your treatment is 14 days . in some disease types , however , longer treatment lasting up to 15 days may
you should not be given filgrastim ratiopharm if you have sickle cell disease . 57 if , for example , you get left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder ( see section 4 . possible side effects ). you will have regular blood tests while you are being given filgranstim . your doctor will check the number of neutrophils and other white blood cells in your blood before each treatment and while you're being given this medicine . using other medicines please tell your doctor if this applies to you . you should tell your doctors if your treatment with filgraStim ratioppharm is approved . it is especially important that you tell your healthcare professional if there are any other medicines or medicines you receive . pregnancy and breast - feeding ask your doctor for advice before taking any medicine , 
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgraStim ratioppharm should not be used if the solution is cloudy or has deposits . medicines should not been disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraStim . each ml of solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgraştim - each vial of filgristim mixture contains 30 miu in 0 . 5 mL solution . one vial contains 30 million international unit [ miau ] [ 30 micrograms ] of filgrestim in 0- 5 . 4 mling solution ]. filgrastorm ratioph 48 miu ( 600microgram / 0 8 . 8 mmol ) - one vially contains 48 million international orders ( 48 microgram of filgrstim ] in 00 . 08 mle ). - other ingredients : sodium hydroxide , glacial acetic acid , sorbi
what riluzole zentiva is rilsuzola contains the active substance riozole which acts on the nervous system . what röluzolе zentive is used for rifampicin is used to treat patients with amyotrophic lateral sclerosis ( amyOtrophic la spline ) and motor neurone disease where the nerve cells responsible for sending instructions to the muscles become weaker . this can lead to weakness , muscle waste and paralysis . the destruction of nerve cells in motor neurones disease may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . rilluzol zenta blocks the action of glutamates and this may help in preventing the nerve cell from losing their ability to make better use of the nerves .
do not take riluzole zentiva if you are allergic to rilluzola or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor before taking rilsuzolе zentivea : if your doctor has told you that you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). it is also important to tell your doctors if the product is safe to use in pregnant women . rif you have ever had any liver problems , including yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick - if there are problems with your kidneys , fever , as this may be a sign of 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , taking it at the exact time each morning . it is important that you take the tablets every day until your doctor tells you otherwise . you can take the medicine with or without food . do not take more than the recommended dosage . take the dose by mouth . this will give you the impression that the effect of riluzole zentiva is too strong or too weak . if your tablet is discoloured or you feel dizzy or if there is a lump in your stomach , take the capsule with some water . contact your doctor , pharmacist or your nearest hospital emergency department for advice . keep the tablet bottle with you so that you can easily describe what you
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva , there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check the number and type of whiteblood cells , which are important in fighting infections . tell your doctor if  you experience any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick . this may be signs of liver disease ( hepatitis ). your doctor may recommend regular blood tests while you are taking rilluzola zentivea . if this happens , your doctor should advise you how to recognise the signs . cough
what riluzole zentiva contains - the active substance is rilsuzola . - each tablet contains : - anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrOUS colloidal silica , magnesium stearate , croscarmellose sodium , and hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what ricole zentivea looks like and contents of the pack the tablets are white to off - white , round and embossed with ' gs jt ' on one side and ' 50 ' upon the other side . the tablet is embosseded with the company logo and a corporate logo on the other . one bottle of riole has been designed to be swallowed 
emgality contains the active substance galcanezumab , a medicine that blocks the activity of the cgrp , which is involved in migraine ( increased levels of cggrp in the blood ). egality is used to reduce migraine in adults who have at least 4 migraines per day . ehgality has been shown to reduce the frequency of migraine headache in adults and to improve your quality of life .
do not use emgality : if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using egality because : you have a serious cardiovascular disease . you have ever had serious cardiovascular diseases . your doctor has told you that you have one or more of these serious cardiovascular disorders . allergic reactions emmgality can cause serious allergic reactions because it contains so - called " serious allergic reaction ". these reactions are more likely to happen within 40 minutes of a seriously allergic reaction . if such signs occur , you should immediately contact your doctor . see also section 4 . children and adolescents emogality has not been studied in children and young patients below the age of 18 years . other medicines and emigality tell your doctor and pharmacist if using ,
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of egality is 240 mg of remgal given by injection under your skin ( subcutaneous injection ). you can inject emmgality yourself at any time of the day , with or without food . your doctor will decide when to give your empgality injection . after proper training , you may receive 240 doses of a course of 240 days . if a child has received more ehgality than the prescribed dose , contact your doctor . you should inject a new dose as soon as you can , and then continue to inject it at the same time each day . injecting eemggality yourself your doctor may decide that it would be more convenient for you to inject . however
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality can occur , but may also be life - threatening . signs include rash or itching . these are rare but serious allergic reactions ( may affect up to 1 in 1 , 000 people ). signs include difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash with raised bumps . other side effects include : very common side effects ( may effect more than 1 in 10 people ) injection site reactions ( including pain , redness or itchy ) headache , headache . common side reactions ( might affect upto 1 in10 people ), injection site
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening the vial is to be used within 7 days . discard the viall after 30 days if kept in the original package . keep the viaL in the outer carton in order to protect from light . this medicine does not require any special storage conditions . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg galcanaezum ab in 1 ml solution . - other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what  emmgality looks like and contents of the pack egality is a solution for injection in a clear glass syringe . the colour may vary from colourless to slightly yellow . not all pack sizes may be marketed . The sYringe is  a single - dose pen . pack sizes of 1 , 2 , 3 or 4 pre  s swabs .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hep venovi - obslusive ) in adults , which causes blood vessels to narrow in the liver and causes blood clots to form . defitaliu is one of a family of medicines that must not be used prior to a stem cell transplantation . by blocking the action of defibrototide in the blood vessels , it helps to prevent the blood  clottings from forming .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions other medicines to prevent blood clots from forming tell your doctor if using tissue plasminogen activator warnings ( medicine to prevent and treat bleeding , to reduce heavy bleeding or to receive a blood transfusion after surgery ). talk to your doctor or nurse before using defitalia : if your surgeon has told you that you have problems with blood circulation . if this applies to you , tell your surgeon immediately . you will need a constant blood pressure ( 1 ) during treatment with defit el i . like other medicines , medicines to reduce blood coagulation such as acetylsalicylic acid , heparins , warfarin
before starting the treatment your doctor will determine the dose of defitelio you need . it is used to prepare stem cells transplantation ( svt ) from your own blood ( via an ' intravenous infusion ' or drip ). this treatment will be given to you over 21 days , as long as your symptoms improve . use in children and adolescents do not exceed 18 years of age . if you use more defitlion than you should if a child receives more deFITelo than your doctor tells you to . your doctor may ask you to give you a nurse or doctor tell you to take the medicine . tell your doctor if any of the above apply to you . you may need to take a different dose . take the next dose as scheduled . do not change the dose or stop taking defit liu without talking to your doctor
like all medicines , defitelio can cause side effects , although not everybody gets them . defitenlia can cause the following side effects although not everyone gets them very common side effects which are classified as follows : if these side effects occur , they are usually mild to moderate and of a short duration . if they do , contact your doctor immediately . very common ( may affect more than 1 in 10 people ) low blood pressure common ( might affect up to 1 in10 people ). bleeding in general bleeding , including the nose bleeding ; the brain bleeding . in the gut vomiting blood bleeding in the lungs bleeding : blood in the urine ; in the mouth bleeding ); in the skin coagulopathy ( disturbance in blood clotting ) if you notice any of these , tell your doctor .
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and the vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution , if not used immediately , storage times and conditions before use are the responsibility of your doctor , pharmacist or nurse and would normally not be longer than 24 hours at 2 to 8 oc , but must be discarded if the product is damaged or if there are particles in it . if this happens , defit elide should not be administered if it is cloudy or coloured .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibrototide in one mL solution . one reconstituted mlain contains 80 microgram ( mg ) of debiotide ( as sodium citrate dihydrate ), hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 " defit elidelia contains sodium ". what deFITelo looks like and contents of the pack defitaliou is a clear and colourless solution for infusion . it is supplied in glass vials containing 10 mbq ( 2 , 5 . 4 mq of concentrate ). each pack contains one vial .
daklinza contains the active ingredient daclatasvir which is used to treat hepatitis c ( an infectious disease that affects the liver , caused by the hepatis  c virus ). this medicine stops the hpatiti cvirus from multiplying and infecting new cells . this helps to control the amount of hep c in your body . it also reduces the amount the virus can produce in your blood . daklingza is used with other medicines for treating hehepatitic c infection . please refer also to the package leaflets for the other medicines that you will be taking with daklinningza . if you have any questions about your medicines , please ask your doctor or pharmacist .
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). if this applies to you , do not give daklimza to others by mouth . tell your doctor if your child is taking any of following medicines : phenytoin , carbamazepine , oxcarbazepine or phenobarbital ( used to treat epileptic seizures ) rifampicin / riffabutin & ritapentine ( antibiotics used to prevent and treat tuberculosis ) dexamethasone ( a steroid used to correct allergic and inflammatory diseases ) medicines containing st . john ' s wort ( sj ) ( 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . this is because some people get a very unpleasant taste when they take daklinesza . your doctor may ask you to take some other medicines while you are taking daklince . if this applies to you , tell your doctor . do not change the dose of these medicines unless your doctor tells you to . you should take daknza at the same time each day , as your daily dose of dosing of dakenne may need to be adjusted . depending on these medicines your doctor will decide how to increase or decrease your daily dosage of daklenza , depending on how you respond to the treatment . dakliza may be used in combination with other medicines to treat hepatitis
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is given in combination with sofosbuvir and ribavirin the following side effects have been reported : very common ( may affect more than 1 in 10 people ) headache fatigue common ( might affect up to 1 in every 10 people who took daklines for several weeks ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles pain when taking daklince in combinationwith soffossévir and in combination rib avirine common ( May affect upto 1 in10 people ), headache joint pain feeling aching and tender muscles when taking both sofasbuVir and / or rib
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaatasVir ( as dihydrochloride ). - - other ingredients are : - tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate , and hypromellose ( e464 ), titanium dioxide . - film coating : macrogol 400 , indigo carmine aluminum lake , yellow iron oxide ( i ) ( containing iron oxide ) 51 what daknza looks like and contents of the pack blue , oval shaped film . one side of the film ' bms 30 ' is debossed with " bmp1 " on
proquad is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases and mops ( rubella , varicelli viruses ). the antibodies also make diseases worse for these viruses , and can help protect you or your child from getting any of them . proquade does not protect against meassen , measells , or mashes caused by rubella or chickenpuff ( varicela ). when he or she is given a vaccinated with proquaD , your immune system will make the antibodies necessary to protect you and your child for 12 months . the vaccine is intended for individuals who have received national vaccination , including im
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) neomycin - a blood disorder or type of cancer that affects the immune system - treatment with medications that weaken the immune systems ( low - dose corticosteroid therapy ) or asthma ( replacement therapy ). - have a weakened immune system due to a disease ( including aids ), congenital or hereditary immunodeficiency , or lack of immune competence , because of active untreated tuberculosis , which may be a medical condition ( including a history of rhabdomyolysis ), a condition known as rifampicin . warnings and precautions talk to your doctor
proquad will be given to you by your doctor or nurse as an injection into the muscle of the upper thigh or upper arm . your doctor will decide which is best for you . for injections , the recommended dose is one injection per year . the muscle in the upper part of your tummy area or upper arms area will be chosen as the injection site . please note that a blood clotting disorder with low levels of platelets may prevent the vaccine from being given into the skin . this will help to prevent bleeding . however , proquade will not be given into a muscle . proquac will be injected into  a healthy blood vessel by your anaesthetist . if you are given more proquaD than you should it is unlikely that you will be properly hydrated .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur very rarely . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , see a doctor immediately . other side effects of proquad may occur : may affect up to 1 in 100 people . seizures or a fever may occur rarely ( may affect less than 1 in 1 , 000 people ). bronchiolitis : difficulty breathing , cough and unsteadiness with walking . the following side effects have been reported with proquade : common ( may effect up to1 in 10 people ) injection site complaints ( including pain and swelling of the hands , feet and ankles ). reporting of side effects for children and adolescents if they get any side effects talk to your doctor , pharmacist or nurse . this includes
what proquad contains the active substances are : measles virus1 , edmonston strain ( 3 . 00  5 , 000 iu / mrc ) strain : mumps virus1 ( jeryl lynn TM - level b ) mutant ( 3. 30  10 , 600 ius / miu ) rubella virus2 , strain ( 23 . 000  7 , 500 iugg ) varicella virus3 , including merck strain ( 33 . 99  0 , 800 iup ). strain - number of plaque - forming units ( pfu ), including 1 , 400 iout ( h3n3 ), chick embryo cells and fibroblasts ( mc4 ). the other ingredients are powder
jylamvo is an anticancer medicine which works by reducing the number of unwanted reactions . it is an immunosuppressive agent with an anti - inflammatory effect jyinglamva is used to treat rheumatic and skin diseases in adults with active rhusatoid arthritis , polyarthritic forms affecting the joints and severe juvenile idiopathic arthritis ( jia ) in patients from birth through 3 years of age and in patients who are treated with non - stroidal anti – inflammatory drugs ( nsaids ), when the effectiveness of the medicine is inadequate o severe or disabling psoriasis , when treatment with phototherapy with psentoralen or ultraviolet a radiation ( puva ) therapy is contraindicated or inadequate .
do not take jylamvo - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) -if you have a severe kidney impairment - do you have or have had a liver impairment . - tell your doctor if any of these applies to you . warnings and precautions talk to your doctor or pharmacist before taking jjylavo : - blood disorders ( e .g . bone marrow hypoplasia , leukopenia or thrombocytopenia ) or significant anaemia 34 - have weakened immune system - are suffering from a serious infection ( i . ex . tuberculosis or hiv ) warnings signs of ulcers in the stomach or intestines or an inflammation of the mucous membrane of
jylamvo is for diagnostic use only . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jia is a treatment for severe side effects sometimes resulting in even death . depending on how you respond to the treatment , your doctor may need to adjust the dose . for adult rheumatoid arthritis , severe juvenile idiopathic arthritis ; for severe psoriasis ; and for severe pesoriatic arthritis : jYlamva is used as a long - term treatment . your doctor will determine the correct dose for you , depending on your response to jji . there are two strengths of jijia : for rhusmatic and skin diseases other than jis , psesoriases and p
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). the most frequently reported side effects are : breathing problems , feeling of illness , dry , irritating cough , shortness of breath , or difficulty in breath . chest pain ( fever ), spitting or coughing blood , serious peeling , blistering or redness . this may spread to other parts of the body and may lead to a higher risk of side effects as well . other side effects include : very common ( may affect more than 1 in 10 people ): diarrhoea , being sick ( vomiting ), being sick , vomiting , di
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine in the outer carton in order to protect from light . accidental spillage of the medicine after administration must be ruled out in accordance with local requirements ( see section 3 ). any unused medicine or waste material should be disposed of in accord with the local guidelines on cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as mesilate ). -the other ingredients are macrogol 400 , glycerol 40 %, and orange flavour ( for the sucré , sucralose , epidermal growth medium ), sodium methyl parahydroxybenzoate ( e218 ), citric acid , tri - sodium citrate , purified water . see section 2 " jYlamVO contains ethyl parahydroxy benzoate and sodium hydroxybenzobiate ". what i know about jimvo looks like and contents of the pack jjlamvre is a clear , colourless to pale yellow solution in a brown glass bottle , with 60 single - use plastic cap
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enturev is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to  a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . these muscles make breathing difficult . the medicine blocks this tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary system . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using enurév brewinger if any of these apply to you . tell your doctor if : you have kidney problems . you have an eye problem called narrow - angle glaucoma . your doctor may need to reduce your dose . if your doctor has told you that you have difficulty passing urine . during treatment with enUREv  Breezhale if this applies to you at any time during treatment , stop using this medicine and tell your physician immediately if there are any signs of tightness of the chest , coughing , wheezing or breathlessness immediately after using  Enurev brezhalers . signs
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhaul the content from the capsules . do not swallow the capsule . the recommended dose is one capsule in the morning and one capsule at the evening . this medicine is for inhalation use . elderly people you can use this medicinal product for up to 24 hours before or up to 75 years of age . if your doctor prescribes this medicine for you , you can inhalate it anytime anytime . these instructions will help you to remember to use it . for this medicine , see enuresv brewing powder in this leaflet for more information on how to use and how to infuse the medicine as inhaler
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia : typical symptoms include excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( possible signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible sign of angioedema ) reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyronicum bromide equivalent to 50 microgram ( mg ) glycopyranium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopirronium - if the dose has been halved , the other ingredients of the injection powder are lactose monohydrate and magnesium stearate . what enturev brezev brewinger looks like and contents of the pack enUREv brieezhalers 44 microgramms inhalation powder , hard capsules are transparent and contain a white powder . they are supplied in a device called an inhalator . it is supplied in capsules in blisters , each
what riximyo is rximyon contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to this cell , the cell dies . what ? ruximyyo may be used for the treatment of several different conditions . the active ingredient in ruchimy0 is used for : a ) non - hodgkin ' s lymphoma this is not a disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymphoocytes ; risimyok can be given alone or with other medicines called chemotherapy
do not take riximyo if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is still a possibility that you may have a severe active infection at the moment , you may be more likely to have  a weak immune system . warnings and precautions talk to your doctor , pharmacist or nurse before taking rximya if : you have severe heart failure or severe uncontrolled heart disease ( granulomatosis with polyangiitis , microscopic polyangigaitis or pemphigus vulgaris ). you should not take this medicine if any of these apply to you ( or you are not sure ). talk to you
riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given rximyyo as a drip ( intra - venous infusion ). medicines given before each ruximya administration before you are given a dose of richimyon , you will be provided with other medicines ( premedication ) to prevent or reduce possible side effects and reduce the risk of your treatment if you are a patient with non - hodgkin ' s lymphoma if they are having ruchimy0 alone ritchimyou will be administered to you once a week for 4 weeks . repeated treatment courses with ritzimyO
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , chest pain , redness or itching at the site of infusion . these reactions are usually mild to medium . if they do occur , they will be treated quickly . very rarely . chest pain may occur again . not known ( frequency cannot be estimated from the available data ): low blood
what riximyo contains the active ingredient in rximyon is called rituximab . the 10 ml vial contains 100 mg of ritsuxim b ( 10 mg / mL ). the 50 m / vial contain 500 mg of
topotecan actavis contains the active substance topotencan which helps to kill tumour cells . topotentcan actAVIs is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to control advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotеcan activis treatment is combined with medicines containing cisplatin .
do not take topotecan actavis - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topotécan activis : -if your blood cell counts are too low . your doctor will decide if topotercan actAVIs is right for you . - tell your doctor if your dose is too low because you may not be able to take the medicine as your doctor has told you ; - your doctor may want to reduce your dose of topotacan acta ;- - you have any kidney problems . before you take totopotekan actavi , tell your physician if:  you have severe kidney impairment  your doctor might want to monitor you more closely ; you have liver problems  before you start taking
your doctor will decide the dose of topotecan actavis you receive . this will depend on : - the disease being treated , - your body surface area ( m2 ), - how well you respond to treatment , the results of blood tests carried out before and during treatment . adults small cell lung cancer the usual dose is 1 . 5 mg / m3 of body surface surface area once daily for 5 days .this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg 1/ m2, of body area once weekly for 3 days , but this treatment cycle should not be repeated . for cervical cancer , it will be given in combination with another anticancer medicines called cisplatin . your doctor may reduce the dose if you are given cisseplatin once daily . patients with impaired kidney function your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect . infections may occur . these may be very common ( may affect more than 1 in 10 people ). they may include : - fever - worsening of your general condition - local symptoms such as sore throat or burning sensation - severe stomach pain - or fever ; - diarrhoea - bowel inflammation ( neutropenic colitis ) : topotecan actavis may reduce your ability to fight infections . - lung inflammation . this may be rare ( may effect up to 1 in 1 , 000 people ): if this happens , you must tell your healthcare provider . not known ( frequency cannot be estimated from the available data ) difficulty in breathing .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . storage after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25  2 , in normal light conditions and 24 hours below 2  8 , protected from light by dilsening . from a microbiological point of view , the drug product solution for dlution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) has been shown to be stable for 4 hours at room temperature , and for 12 hours at 20  25 , respectively , from 24 hours to 25 if stored at 2
what topotecan actavis contains - the active substance is topotencan . one vial contains 1 mg or 4 mg topotentan ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g of topotécan - -the other ingredients are mannitol ( e421 ), tartaric acid ( 0 . 5 %), hydrochoralic acid ( 1 %) and sodium hydroxide ( see section 2 ). what to potecan actsavis looks like and contents of the pack topotercan actavids is supplied in clear glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off , which are packed in a protective sleeve . the vial is divided into 2 equal doses : 1 vial of 1 mg 
the active substance of rivastigmine hexal is rivascastigmin . rivazastigine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivizastigme works by blocking the enzymes that break down acetalcholine : acetapylchollinesterate and butyrylcholineSterase . by blocking these enzymes , the concentration of rastigemine enables levels of acetatetyllcholine to be increased in the cerebral cortex , helping to reduce the symptoms and quality of
do not take rivastigmine hexal - if you are allergic to rivistigmine ( the active substance in rivstigmin heexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - in case of a previous skin reaction called allergic contact dermatitis with rivainstigmine see rivabstigmine for information . if this applies to you , tell your doctor and do not use riv astigemine . warnings and precautions talk to your doctor before taking rivrasistigine heXal : - when you have , or have ever had irregular or slow heartbeat . this could be a sign of an active stomach ulcer . you should also tell your physician if your family / carer notices that you have difficulties in passing urine . the risk of seizures is
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . you should not take this medication if your weight is over 60 kg . do not take more than the recommended dose , just take the next dose at the usual time . tell your doctor straight away if , while you are taking this medicine , you are still taking rivstigine heexal for more than three days . taking this medicinal product tell your caregiver that you are currently taking , or have recently taken , any other medicine containing
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in 100 people ). anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling feeling bloated feeling weak or lack of energy 67 uncommon ( may effect up to1 in 100 persons ) being sick feeling tired ( vomiting and diarrachoeal ) depression depression feeling restless uneven heartbeat 71 uncommon ( might effect upto 1 in 1000
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 . keep the blister in the outer carton in order to protect from moisture .
what rivastigmine hexal contains 64 - the active substance is rivistigmine hydrogen tartrate . - other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide , titanium dioxide , shellac . each rivainstigmine hisxal 1 . 5 mg capsule contains 1 , 5 mg of rivabstigmine the active ingredient is . every rivagestigmine himxal 3 mg capsule contain 3 mg of of rastigemine . the other ingredients in each raft are : each rumbly engraved " gsi ", " 3 ", and " nvr ". each river - shaped 4 . 4 mg capsule is a white to off -
what cabometyx is cabrometyxx is a cancer medicine that contains the active substance cabozantinib . it is used in adults to treat a type of kidney cancer called renal cell carcinoma , or liver cancer that has progressed after having received a specific anticancer medicine ( sorafenib "). how cabômetyyx works cabmetychyx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells , and in patients who have been given cabarmetych .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabrometyX if : - you have high blood pressure - your doctor has told you that you have an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a large blood vessel walls - or you suffer from diarrhoea - recent history of significant bleeding - surgery within the last month - surgical procedures including dental surgery - suffer from inflammatory bowel disease ( crohn ' s disease ) - treatment for crohn' 's disease tell your doctor if any of these apply to you . - severe allergic reaction to 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is for oral use . swallow the tablet whole . if necessary you may take the tablet with or without food . your doctor will monitor your treatment for signs of serious side effects and may adjust your dose depending on how you respond to treatment . the recommended dose of cabometyx is 60 mg taken once a day with or just before food , i .e . between meals . take cabrometyX for 2 hours before going to bed . you can take a tablet of chamometychx for up to 1 hour before going home . taking the medicine cabmetyxia is for single use only . drink plenty of water . it is best to take the tablets at the same time each day . try to take it at the
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get side effects your doctor may tell you to take cabometyx at a lower dose . your doctor will tell you how to take other medicines to reduce your side effects ( see section 2 ). tell your doctor straight away if your doctor tells you to stop taking cabrometyX . you may be given other medicines for your side effect , or they may reduce your dose , temporarily or permanently . in some cases , your doctor can also give you other medicines in an emergency . tell your doctors straight away about any of the following serious side effects you may need urgent medical treatment : symptoms may include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever and possibly a gastrointestinal perforation ( a hole that develops in your stomach or 
what cabometyx contains the active substance is cabozantinib ( s )- malate . cabrometyyx 20 mg : each tablet contains cabaozantsini (  ss ), malate equivalent to 20 mg of cabcabozzantininia . the other ingredients are : cabombyx 40 mg , each tablet contient cabbozanteini B ( t ) , malate equal to 40 mg of " cabzantine ". - cabetyck 60 mg - each tablet consists of a total of 0 . 5 mg of cabotinibe ( r ) malate totaling 60 mg of ( 0 mg ) of cbozzenib . other ingredients include microcrystalline cellulose and lacto
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexxed hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . besides pemetreXed hapira a treatment for patients with advanced stage of lung cancer : pemetreced houpira can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; pemetreded hompira becomes a treat for patients diagnosed with advanced stages of lung carcinoma whose disease has progressed after other infusions has been used 
do not use pemetrexed hospira if you are allergic ( hypersensitive ) to pemetrexxed or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions breast - feeding should be avoided during treatment with pemetreexed hospirana . you may already be receiving a vaccine against yellow fever . talk to your doctor before receiving pemetreced houpira because you may have problems with your kidneys . before each infusion you will have samples of your blood taken to evaluate if your kidney and liver function are sufficient . it is important that you have enough blood cells to receive pemetreexed hompira and your blood cell counts may become too low . if the doctor decides that you will be given cisplatin , your doctor will make
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your human body . the body surface area will be used to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetrexxed hospi powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you , and then it is administered to you by infusion into one of your veins . The infusion will last approximately 10 minutes . pemetreXed outweighs the amount of cisplatin that is given by infusing into your
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your doctor has prescribed pemetrexed hospira for you because you have a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . contact your physician immediately , if vous experience chest pain ( common in people with a fast heart rate ) or if there are pain , redness , swelling or sores in your mouth ( very common in children ). allergic reaction : - skin rash ( very commonly referred to as burning or prickling sensation ), fever ( common may also be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of reacted / infusion solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature . the reconstructed solution should be clear and colourless . no parenteral medicines may be inspected for particulate matter or discolouration prior to administration . prior to use , this medicine is for single use only . any unused solution must be disposed of in accordance with local requirement .
what pemetrexed hospira contains the active substance is pemetreexed ( as pemetrexxed disodium hemipentahydrate ). pemetreexed houpira 100 mg : each vial contains 100 milligrams of pemetreixed [ as pemeterxeed désodium hydropent ahydrate [ e524 ]). pemeterexee hos Pira 500 mg , each viall contains 500 milligramms of pmetrex ed( as peméxeded dissodium hapentatahydrate * . pemetreXed hopira 1 , 000 mg — each vially contains 1 . 000 millilitres of of pemeterexed [ pfizer ] ( as phemetrexéd disossed disipentehydrate
ganfort contains two active substances called bimatoprost and timolol . both help to reduce pressure in the eye . bimataprostine belongs to a group of medicines called prostamides . it is a prostaglandin analogue , while timimololl is one of a family of medicines known as beta - blockers . the eye contains a clear , watery liquid that feeds the inside of the eye and is constantly drained , as well as natural oils . gan fort reduces the pressure in your eye and in adults , in adults and children with glaucoma who are not able to use their eye properly . using ganford eye drops reduces high pressure inthe eye , which in turn reduces glauscoma . you should use ganFort every day 
do not use ganfort eye drops if the solution is not clear , has not been drained or is discoloured . do not apply gan fort eye droppers if you are allergic to bimatoprost , timolol , or beta - blockers , and are not sure if any of the above applies to you . if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using ganFort if : you have respiratory problems such as asthma or severe chronic obstructive bronchitis you have severe lung disease ( wheeziness , difficulty in breathing , long - standing cough you have heart problems such , including low heart rate or heart block you have ever had heart failure warnings or precautions the following should be considered when using this medicine
always use ganfort exactly as your doctor or your doctor has told you . you should check with your doctor , pharmacist or nurse if you are not sure . treatment is started by putting the bottle into the neck of your eye . the instructions are given at the end of the leaflet . how to use gamfort 5 . before you use , wash your hands . do not touch the head . 2 . pull down the lower eyelid until there is a small pocket . 3 . gently squeeze the bottle to release one drop of the medicine into your eye and then continue to use it for as long as your treatment is ongoing . 4 . hold the lid on the eye , pointing down , for at least five seconds . 5 - gently squeeze one drop into the eye with a finger into the corner of the eye and into the nose . if it does not work
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops as long as your doctor tells you . check with your doctor or pharmacist if you are not sure . the following side effects were reported when you first started taking gan fort ( multi - dose or single -dose treatment ): very common side effects ( may affect more than 1 in 10 people ) - the eye redness . common side effect ( may effect up to 1 in 9 people , but less than 1in 100 people ). -the eye burning , itching , and stinging , or irritation of the conjunctiva ( the conjonctivum ) around the eye , increased sensitivity to light , eye pain , sticky eyes , dry eyes ; feeling of something in the eye including small break in the
keep this medicine out of the sight and reach of children . do not use solutions to treat eye infections after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening use within 4 weeks . this medicine does not require any special storage conditions . if you have any further questions on the use of ganfort , ask your doctor or pharmacist .
what ganfort contains - the active substance is bimatoprost . each ml contains 0 . 3 mg of timolol and 5 mg of infustion ( as timimololl maleate ). each bottle contains 6 . 8 mg of the active ingredient . -the other ingredients are benzalkonium chloride ( as an additive ) sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate . the other ingredients were purified water , hydrochloric acid and sodium hydroxide . what gangfort looks like and contents of the pack ganFort is a clear , colourless to slightly yellow eye drops , supplied in a plastic bottle . every pack contains 1 or 3 bottles with a screw - cap , and 3 or 4 bottles 
gefitinib mylan contains the active substance gefitib which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefiteinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : - if you are allergic to gefitineib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefiteinib myths . tell your doctor if any of these applies to you . do not receive gefitib in any other lung problems . some lung problems may get worse during treatment with gefit inib Mylan . - tell your doctors if there are any signs of problems with your liver . your doctor may need to adjust the dose of gefitINib . children and adolescents this medicine is not for use in children and teenagers under 18 years . other medicines and gefiterinib this medicine has not been studied in this age group . it is especially important to tell your pharmacist if your child is taking , has recently
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet once daily . do not take antacids ( to reduce the acid level of your stomach ) for 2 weeks before each main meal . take 1 tablet of gefitinib mylan at the same time each day . if your doctor has trouble swallowing the tablet , add it to the water and stir until it dissolves completely . drink the entire tablet straight away . you should not use any other liquids . stir until the tablet is completely dissolved . pour the remaining content into a glass of water and drink immediately . then drink the remaining portion of the glass . leave about 20 minutes between each tablet . swallow the tablet whole . it is best to take gefitineib melan at about
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic reaction ( common ): symptoms include swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ) and difficulty breathing . serious breathlessness : sudden worsening breathlessness with a cough or fever . this may mean that you have an inflammation of the lungs called ' interstitial lung disease '. this is uncommon ( may affect up to 1 in 100 people ) when you take gefitinib mylan . severe skin reactions , which may spread across your body , may be life - threatening . the signs include : swelling of the face ; lips ; tongue or mouth ; difficulty to
what gefitinib mylan contains - the active substance is gefiteinib . each film - coated tablet contains 250 mg of gefitineib ( as monohydrate ). - its other ingredients are lactose monohydrate, microcrystalline cellulose , crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate , polyvinyl alcohol , macrogol 4000 , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , all in the tablet coating . what geFITinia mylan looks like and contents of the pack gefitib minelan tablets are light pink , biconvex film  shaped , 11 . 1 mm x 5 . 6 mm in size , debossed with " 
reblozyl contains the active substance luspatercept and is used to treat myelodysplastic syndromes . myelaodysplastic syndromes ( mds ) are a common complication of many different blood and bone marrow disorders , in which red blood cells become abnormal . this can cause signs and symptoms of a low red blood cell count ( anaemia ) and reduce the need for red blood blood cell transfusions  . re Blozyl is used in adults to treat anae in adults who have mDs and have low numbers of red blood  cell transtransfusions and in patients who are not able to receive red blood cancer transfusion systems , and who are also receiving erythropoietin therapies . beta - thalassaemia ( bds and ms ),
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) - when you are pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor before taking this medicine -if you have thalassaemia with or without spleen removed -- a blood clot - during hormone replacement therapy - whether you had a previous blood  clotting . your doctor will discuss preventive measures and / or medicines to prevent a bleeding . - talk to a doctor if : you have high blood pressure . before you take , or while taking re Blozyl your doctor may want to measure your blood pressure more frequently . when taking , you should take : routine tests your doctor should do a test before
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests and decide whether you should use reblozyl . rebozyl is for injection under the skin ( subcutaneously ). it should only be used by doctors who are trained and qualified to use it safely . people who weigh at least 1 . 1 kg should use the injections as instructed by your doctor and will calculate the correct dose for you based on your weight . the dose depends on how much medicine you weigh . usually the injection will be given over a period of at least one week . when you are given more rebolzyl than you should if your doctor thinks it is too high or too low , talk to your doctor or pharmacist . this dose may be adjusted depending on your blood pressure . use in children and adolescents re
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately or go to the casualty department at your nearest hospital if you have any of the following : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , especially if only on one side of the body or blurred vision , which are symptoms of a stroke . blood clots swelling of the area around the eyes , face / lips , mouth , tongue or throat allergic reactions including rashes and hives have been reported after taking the medicine . they usually go away within one to two days after the injection . however , sometimes they go away after one week . the symptoms go away over time . not known ( frequency cannot be estimated from the available
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl can be stored for up to 8 hours at room temperature ( up to 25 ) or for upto 24 hours at 2 8 ( in - use storage times and conditions prior to use ). any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatiercept in one ml of solution . after reconstitution , each mL of solution contains 50 mg of of lucpaterception . the other ingredients ( excipients ) are : citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further information , see ' reglazyl with sodium '). what retinol looks like and contents of the pack reblizyl is a white to off - white powder . rebozyl 25 mg / 75 mg luspatron consists of a single dose . one pack contains one vial of powder , one
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer and slowing the rate at which cancer cells multiply , and forging new blood vessels . fotiva is used in adults with advanced kidney cancer who have already received other treatments , such as alpha or interleukin - 2 , to control your disease .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you are taking st . john ' s wort ( hypericum perforatum ). this medicine is a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking fotiva . high blood pressure . fotiv da will raise your blood pressure when you are treated for your bloodpressure and your doctor will monitor your blood temperature regularly if it is not controlled with a medicine . you may be prescribed fotivdea to lower your blood tension . your doctor may tell you to take foivida together with , or not together with another medicine for high bloodpressure . it is important to talk to you doctor before taking this medicine if
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg ( 21 mg ) capsules taken once a day for 7 days . take 1 capsule ( 1 capsule ) once , twice a week for 4 weeks . your doctor may reduce your dose of ftivdda if necessary to reduce the risk of unacceptable side effects . if severe side effects occur , your doctor will stop fotiva therapy . how much fotiv da to take the recommended daily dose of one fotiv Da capsule ( 890 mg ), once . for 21 days , take 7 capsules ( 1 ) twice , once - week cycle . capsules should be taken once daily for 4 consecutive weeks , preferably at the same time each week . patients
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure : the most common side effect is listed in section 2 " warnings and precautions ". get medical help immediately high blood blood pressure has been associated with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . this is because your blood pressure is getting higher . get urgent medical help if your doctor decides to lower your dose of fotivda . if you get high blood tension , a medicine to treat your high bloodpressure , will be used to lower the risk of it getting worse . see also section 2 warnings about the side effects below . other medicines and fotiva tell your doctor or pharmacist if any of the following side effects gets serious , or if
what fotivda contains each hard capsule of fotiva 890 mg contains tivozanib as tivolinib hydrochloride monohydrate , equivalent to 890 milligrams of tivofzanibe . the other ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( k29 / 32 ), yellow iron oxide ( е172 ), propylene glycol ( w - 171 ) and strong ammonia solution , indigolin dioxide ( the e172 ) ( containing indigone aluminium lake ). printing ink : shellac , propyl glycol and strong AMmonia resolution , containing titanium dioxide and tartrazine aluminium Lake ( i ) - shellab , propane
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvistegravar emtricitabine , which is an antiregulatory medicine known alsiatic , known as a nucleoside reverse transcriptasasse inhibitor ( nrti ) - tenofovir disoproxil , another antirétroviral medicines known as as - nucleometide reverse transcriptainse inhibitor ( nicrtis ). sttribild is available as : in a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . strebild is used
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir / tenovir disoproxil , any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking st . john ' s wort if this applies to you , tell your doctor immediately . before treatment with any medicine containing tenoffovir désoproxile , your doctor will be able to assess your kidney function . tell your physician if any of these medicines are prescribed for you : - alfuzosin ( used to treat an enlarged prostate gland ) - amiodarone , quinidine ( used for irregular heartbeats ) 47 - dabiga
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet ( 12 mg / 18 mg ) taken orally three times daily ( a total of 35 mg ). take the tablet at about the same time each day . take the tablets with food . do not chew , crush or split the tablet . you can take stribild with or without food , and with water . st john ' s wort is for oral use . taking your medicine by mouth strebild may increase the effect of the treatment . your doctor may prescribe medicines or oral supplements ( antacids and laxatives containing minerals , such as magnesium , aluminium , calcium , iron , zinc ) that you take by mouth for up to 4 weeks 
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everyone gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivie disease itself . serious side effects tell your doctor immediately : lactic acidosis ( excess lactic acids in the blood ) is a common side effect of some hiv medications . lactic Acidosity occurs more often in women who are overweight , especially those who have liver disease . the risk of lactic arrest is increased in deep , rapid , or deep - rapid
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each st - labelled sTRIbild film - coated tablet contains 150 mg of eelvitavir ; 150 mg cobicisterat ; 200 mg emmtricit abine ; and 245 mg of the active substance tenovir désoproxils ; 300 mg of active substance ( tenoffovir desoproxile fumarate ) and 136 mg of of ten ofovir . the other ingredients are croscarmellose sodium , the hydroxypropyl cellulose , lactose monohydrate and magnesium stearate ( see section 2 ). the other ingredient ( s ) are : crospo
zyprexa contains the active substance olanzapine . zy prexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , also known as symptoms of excitement or euphoria , have been reported . in some cases , it has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olapine treatment .
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swelling face , or swollen lips or shortness of breath . if this has happened to you , tell your doctor . you should have been told that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypa . the use of zypresa in elderly patients with dementia is not recommended as it may have serious side effects . medicines of this type may cause unusual movements mainly of the face or tongue . tell your dentist before taking this medicine if any of these apply to you or your child
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zypresa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zy prexa unless your doctor tells you to . you should take your zypa tablets once a day following the advice of your doctor given you zyPrexa coated tablets . do not take the zypréxa coated tablets with food . swallow the zprex a tablet whole with water . if it is difficult to swallow the tablet whole , talk to your doctor about how long to take it . patients who take more zypraxa than they should have experienced the following symptoms
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ). especially in the legs ( symptoms include swelling , pain and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , contact your doctor promptly . not known : frequency cannot be estimated from the available data . your doctor may decide to continue to prescribe zyprexa yourself . you should tell your doctors if this happens . the following side effect has been reported with zypresa : common side effects ( may affect 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should be administered within three months after its opening . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypresa tablet contains either 2 . 5 mg , 5 mg or 7 . 7 mg . the tablet can be divided into 10 mg / 15 mg or 20 mg tablets . what zeprex a tablet pack contains - the other ingredients are lactose monohydrate , hyprolose , crohn ' s cellulose , microcrystalline cellulose and magnesium stearate . - tablet coat : hypromellose ; titanium dioxide , carnauba wax . see the different zypréxa tablet strengths . they are white , oval and embossed with ' the h2o ' on one side and ' 7 / 5 '. zypa comes in blisters of 7  . 4 and
what prolia is prolivia contains denosumab , a protein ( monoclonal antibody ) that is similar to a natural protein ( a type of protein ) found in the body . prolium is used to treat another protein that causes bone loss due to osteoporosis . treatment with prolis helps to make bone stronger . it makes the bone stronger which helps to control the level of oestrogen , which is a hormone found in your bones . when you have not reached the menopause , the oesterogen level drops , and makes your bones thinner , thin and fragile . this can lead to osteoponisis , but osteoposse is not caused by the lack of testosterone or glucocorticoids . what prologia can be used for osteoporotics is used when osteopros
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if your doctor thinks you may be allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using proloa . take special care with prolide : if any of your patients have ever had a skin infection . symptoms include a swollen , red area of skin usually in your leg , feels hot or tender ( cellulitis ), and symptoms include fever . tell your doctor if : you have these symptoms because they may be the result of an allergy to latex . the needle cover on the pre - filled syringe contains a derivative of latex which is used to hold calcium . your doctor will decide if this medicine is suitable
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is one pre - filled syringe of 60 mg given every 6 weeks . it is given as a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . do not inject prolis more than once a month . your doctor will advise you if and when you may need to change your dose . also , you may find it easier to follow the instructions for use in this leaflet . always follow the directions for use exactly as described in the package leaflet ( ask your doctor , pharmacist or nurse ). the doctor may advise you to take calcium and vitamin d supplements ( see section " other medicines and prolide "). if your doctor decides that you need to take prola 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you get any of the following while being treated with prolia : skin infections ( cellulitis ). tell your dentist immediately - if any of these symptoms occur while being treatment with prollia: - the swollen , red area of skin in the upper leg suddenly feels hot and tender - symptoms include fever - when being treated for prolis - pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw - discharge , numbness or feeling of heaviness when getting up from a chair or loosening of a tooth - this may be a sign of bone damage in the bone . - swelling in the thigh , joint or bone , or joint 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . your pre  - fill sYringe may be removed from the refrigerator and left at room temperature ( below 25 ). the injection can be stored at room temperatures up to a maximum of 25 for a single period of up to 30 days . record the date from when you first remove the product from the fridge . you must record the day of the injection as well as the date removed from refrigerator . this medicine is for single use only . discard any unused product after this period . it is recommended
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg denosomab in 60 mL . - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prollia looks like and contents of the pack prolide is a clear to slightly yellow solution for infusion , supplied in a pre - filled syringe with a needle guard .
ambirix is a vaccine used in adults , adolescents and children from 1 year up to and including 15 years to prevent two diseases : hepatitis a and hepattis caused by infection with the hematitis al - a virus . the liver is swollen ( inflamed ) with the virus , and the virus can be passed from person to person infected by faeces , serum or saliva . symptoms are usually mild to moderate and usually last for 3 to 6 weeks . during early signs of infection , you may feel sick , have a fever , aches and pains and may be very painful , especially at the start of the season . ambirx is for adults . it is for use in children and adolescents aged 2 to 17 years . in adults ambirlix is for oral use . other medicines
you should not receive ambirix if you are allergic to ambirx or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if this has happened to you , tell your doctor . an allergic response to any vaccine against hepatitis a or hep b diseases is likely to occur if your child has a severe infection with a high temperature ( over 38 ). if the vaccine has been given and your child is likely will need to be delayed until you are ready to be vaccinated . your doctor may want to keep you under closer observation or review the entire list of precautions to be sure that ambiri is suitable for your child . talk to your doctor or nurse before you are given ambiris if : you have had 
you will be given ambirix as an injection into the muscle of the upper arm . ambirx will be injected into a vein . the injection will be administered into the thigh muscle . you will receive a total of two injections . if you miss a scheduled dose you will get the injections within 12 months . your doctor will decide when to give the second injection between 6 and 12 months after the first injection . there is a gap between two doses , given at least six months apart . after that , you will not receive extra doses until future booster dosing . it is recommended that you receive two injection s at the same time . not all patients may be given the same dose , but the disease may progress to worsen . as a result , your doctor may decide to give more doses as often as possible . depending on how you respond to
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects the following side effects have been reported in clinical trials with ambirix : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain in arms or legs dizziness . uncommon ( may effect up to1 in 100 people ). these effects are usually mild to moderate and go away over time . if they continue after the dose has been given , tell your baby ' s
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 720 elisa units / ml , and hepatis b surface antigen 20 - 100 / 100 - human diploid ( mrc - 5 ) cells , aluminium hydroxide , water for injections , inactivation ( 0 . 05 % w / al ). the other ingredients are , for example , sodium chloride and water for injecting ( for ph adjustment ). what amberix looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirx is a white , slightly milky liquid . each pack of ambiri contains 1 dose . the contents of one pack of pmbir
bexsero is a meningococcal group b vaccine . bexsono is used to protect against the bacteria neisseria meneningitidis group a . you will be given bexsentero , which is injected into your child ( from 2 years of age ), against disease caused by the naisseri a maningitidedis groupe b bacteria . these bacteria cause infections , including meningitis ( inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to make its own antibodies , while still protecting your child against the disease .
do not use bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given bexxserso : if : you have a severe infection with a high temperature ( over 38 ). in this case your doctor may recommend vaccination . a minor infection such as a cold should not be a problem , but talk to the doctor first . in this situation your doctor might recommend vaccination with bexsono . you have haemophilia or any other problem that may prevent your blood from clotting properly , such as the use of blood thinners ( anticoagulants ). if during treatment you have an effect on the immune system , for example , eculizumab . tell your doctor or nurse
bexsero will be given to you or your child by a doctor or nurse . it is given 5 times a month into a muscle , preferably in the thigh or upper arm . your doctor or health care professional will decide on the right dose for you or to your child . the number of injections you or the child need is 2 or 5 doses . you or someone else may receive up to three injections , depending on the dose you or a child receives : if you are unsure about the dose that is needed , talk to your doctor , pharmacist or nurse straight away . if the vaccine has been given or is due for an additional injection ( booster ) will be provided at the first injection on the first 2 weeks . please check the interval between injections at least 1 month . depending on how you respond to the booster , your child may receive 12 to
like all vaccines , this vaccine can cause side effects , although not everybody gets them . bexsero may cause the following side effects which may occur with this vaccine : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the injecting site ; swelling of the surface of the flesh at the site of injection ; hardness at site of injecting . the following other side effects may occur after receiving this vaccine ( may effect up to 1 in every 10 people in the clinic : fever / loss of appetite ; dry mouth ; rash . common ( might affect up to1 in every 100 people ), bruising and bleeding at the implant site . reporting of side effects after receiving your dose of bexson , tell your doctor or nurse . this includes any possible side effects not listed in this leaflet
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . 1 , 2 , 3 50 micrograms reconstituted naeisserinia meingitidedis - group a nada protein , 1 ml ,2 , or 3 50 reconstructed vesicles recombined nneisseia maningititidudis type b group c fusionprotein . 2 mla , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 100 microgram ( iu ) recomputed rerunant neseria ningitis group ba fhbp fusion proteins . 3 
the active substance in this medicine is nitisinone . this medicine contains the active ingredient nitisinine . you have been given this medicine because you have a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children . in this disease your body is unable to completely break down the amino acid tychine ( amino acids are building blocks of our proteins ), forming harmful substances . nitsinone helps to break down tyesine and the harmful substances are not formed . what is this medicine used for ? tyingrosine is produced by your body , in low tyerone and phenylalanine ( another amino acid in the body ).
do not take nitisinone mdk if you are allergic to nitsinone or any of the other ingredients of this medicine ( listed in section 6 ). do not use this medicine during pregnancy . warnings and precautions talk to your doctor or pharmacist before taking niisinine mk . your eyes should be checked regularly during ntisinon treatment . if red eyes appear on your eyes , contact your doctor immediately . you may need an eye examination . eye problems may occur more often in patients with inadequate dietary control ( see section 4 ) during the treatment , and during treatment if your doctor obtains blood samples to check whether the treatment is having the desired effect . blood disorders tell your doctor if the disease affects your liver , as the disease impacts your kidneys may need to be checked more frequently . tell your doctors if any of these
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight taken once daily . the recommended daily dose is 20 mg per kilogram of bodyweight taken twice daily , for a total daily dose of 20 mg . your doctor will determine the correct dose for you based on your individual needs . if this patient population is not available , you may take the capsules with or without food . swallowing the capsule whole with a small amount of water or formula diet will help you remember to take nitisinone mdk . you may find it easier to take it at the same time each day . it is important that you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . nitisinone mdk can be removed from the refrigerator and left at a temperature not above 25 for a single period of maximum 2 months . this period must not be re - used once . any unused product must be discarded .
what nitisinone mdk contains - the active substance is nitsinone ( as nitisinon ). nitchisinine mk 2 mg : each capsule contains 2 mg of nităisino . nitéisinonne mmdK 5 mg , each capsule has 5 mg of " nITisininone ". - nitzinone in mndk 10 mg - each capsule consists of 10 mg of the active ingredient nitesinone and are printed with the company logo ( ) and the company symbol ( s ) in black ink . what nicisinonce mhk looks like and contents of the pack natisinONE mzk capsules are white to off - white , opaque , gelatin , titanium dioxide ( e
the name of this medicine is docetaxel accord . docetaxil accord is a substance derived from the needles of yew trees . Docetaxell belongs to the group of anti - cancer medicines called taxoids . o docetachl accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer ; gastric cancer : head and neck cancer - for the diagnosis of advanced breast cancer in adult patients , docetcetaxela could be administered either alone or in combination with doxorubicin , trastuzumab , or capecitabine . early breast cancer and lymph node progression in the lungs , in the long term use alone . the combination of docetal accord and doxoricin has been used in the treatment or alone
docetaxel accord should not be used : - if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetachl accord ( listed in section 6 ). - because docetastel accord does not contain enough white blood cells . - in patients with a severe liver disease . warnings and precautions before each treatment with docetal accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetcetaxell accord . in case of white blood cell disturbances , your doctor may decide to carry out tests to monitor the presence of doceaxel acord . tell your doctor if : you have fever or infections . you are immediately experiencing abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool , fever
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the dose may be adjusted depending on your blood tests , your general state and your response to docetachaxel acord . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her / him results of
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . there have been reports of adverse events after the use of doceaxel . docetaxil accord may be given in combination with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions may occur . they may affect more than 1 in 10 people : flushing , headache , skin rash , hair loss . uncommon : may affect up to 1 in 100 people ; itching , red
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store below 25 . keep the vial in the outer carton in order to protect from light . after dilution , the medicine should be administered immediately in the infusion bag . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 6 hours below 25 protected from light and must not be above 25 protected . when prepared for infusion , chemical and physical in  contact with the infused solution in non - pvc bags may be stored for up to 48 hours at 2 to 8 . once the infuzation solution has been prepared it should be used immediately in order for the inflow
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetachl - each 1 mL vial of concentrated contains 20 g of doceaxel , corresponding to 4 mg / m2 of concentrate . - one 4 mlitre vial containing 80 mg of didcetaxell - every 8 m m3 of concentrate contains 160 mg of donecetaxe - - other ingredients are polysorbate 80 , anhydrous ( see section 2 ) and citric acid anhydrously ( see also section 3 ). what docetaxel accord looks like and contents of the pack docettaxell accord concentrate for solutions for infuse is a clear pale yellow to brownish - yellow solution . the concentrate is essentially free from visible particulates
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . your doctor has prescribed this medicine because you are becoming impulsive ( hyperactive ) and taking this medicine at the same time . it is used to treat a condition called ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not adequately controlled with current stimulant medication . if your current medication does not control adhd symptoms , the medicine should be administered together with a treatment programme . these include psychological therapy , educational therapy / social therapy . intunev has been shown to lower the level of adhd in adults . adhd is a serious , long - term condition that occurs when the medicine is not working properly .
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking this medicine if any of these apply to you : if your doctor has told you that you have low or high blood pressure . if the doctor has decided that you can take instunniv for any reason . heart problems tell your doctor if there are any signs of heart problems . tell your healthcare provider if : you have ever fainted recently had thoughts or feelings of suicide . you have any other psychiatric conditions . withdrawal symptoms may include increased heart rate and high blood temperature . this medicine may make you feel more anxious than usual . your doctor will decide whether you should take infunivar and will decide if it is safe for you to take
your treatment should be initiated under the supervision of a doctor experienced in the treatment of perinatal and adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your treatment will start at a low dose . the dose you will start with is 1 capsule per day . after 1 week of treatment your doctor will start you on a lower dose of 0 . 05 to 0. 12 mg per kg of bodyweight . starting treatment will continue for 1 to 7 days . intuniv should be stopped at the recommended dose of 7 mg of intunev per day for 7 days in a row . do not take intuiv if any of the above apply to you , or if your doctor decides that it is safe for you to take this medicinal product . take care
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you feel unwell while taking your medicine . serious side effects tell your healthcare professional straight away if any of the following side effects occur , as intuniv may cause feeling drowsy or feeling dizzy ( hypotension ). slow heart beat ( bradycardia ) feeling faint , loss of conciousness ( syncope ). this may be a serious withdrawal side effect . high blood pressure , with symptoms such as headaches , feeling confused , nervousness , agitation , or tremors ( hypertensive encephalopathy ). other side effects include : very common ( may affect more than 1 in 10 people ): feeling sick ( nausea ) common ( might affect up to 1 intensives )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the original package in order to protect from moisture . please return the pack to the pharmacy .
what intuniv contains the active substance is guanfacine hydrochloride . each tablet contains 1 mg of guangfaine . the other ingredients are : 2 mg guansfacina , 2 mg of " guanyfac " and 3 mg guianf acine hydrogenochloride ( see section 3 " intunev contains guandfaune " and 4 mg " of GUanfashicine hydroochlorides , 4 mg / ml "). the other ingredient ( s ) are hypromellose 2208 ( e464 ), methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone , crospovidone type a , microcrystalline cellulose .
ecalta contains the active substance andulafungin . it is used to treat adults and children and adolescents from 1 to 18 years old with a type of fungal infection that primarily affects the blood or other internal organs ( invasive candidiasis ), when the infection is causing fungal cells called candida to grow out of control . echinocandins are medicines used to prevent serious fungal infections caused by faulty fungal cell walls . by preventing these structures , eCALta helps to protect people whose fungal eggs have incomplete or defective cell walls that keep them fragile and unable to grow .
do not use ecalta : - if you are allergic to anidulafungin , other echinocandins , or caspofungin acid , any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ekalta and during your treatment . your doctor will monitor your liver function and if necessary treat you accordingly . if your doctor thinks you may have liver problems , your doctor may slow down or stop your treatment temporarily or permanently . you may be given anaesthetics during your therapy with eCALta ( see also " other medicines and ecalcta "). if any of these apply to you , tell your doctor or nurse immediately . an allergic reaction may occur as itching , wheezing or blotchy
the treatment is started and monitored by a doctor who is experienced in the use of this medicine . the recommended dose is 200 mg ( for each 100 mg dose ) given once every week . use in children and adolescents ( aged 1 year to less than 18 years ) the recommended starting dose is 3 . 0 mg ( two 200 mg doses ) per kilogram of the patient ' s weight . your doctor will decide the dose that is right for you . how ecalta is given the doctor will give you eCALta as a slow infusion through a drip into a vein over 1 . 5 to 3 hours . depending on the patient response to the treatment , the infusion time may vary depending on your weight , but it may take longer than usual for the treatment to work . duration of treatment your doctor may decide to continue to treat you for up to 14 days in order to
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are life - threatening allergic reactions , such as difficulty breathing or wheezing , or an existing rash that does not respond to ecalta . serious side effect , including convulsion ( seizure ), flushing / rash ( pruritis ), itching , hot flush , hives , sudden contraction of the muscles , wheeze , coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ): dizziness , headache , diarrhoea , vomiting , abdominal pain , nausea common side effect ( may effect up to 1 in10 people ), rash , itching rare side effects which may affect up to1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted ecalta can be stored in the original vial and should be used immediately . however , the chemical and physical stability of the reconstructed solution has been demonstrated for 24 hours at refrigerated temperature . for the infusion solution , immediate use is recommended . once reacted to the solution : chemical and biological in - use stability has been shown for 25 days at refreeze temperature and 48 hours at room temperature , with an additional 48 hours between infusions . your doctor or nurse will throw away the product correctly .
what ecalta contains the active substance is anidulafungin . one vial of powder contains 100 mg of anidULafungIN . the other ingredients are mannitol ( e421 ), polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what  eCALta looks like and contents of the pack ekalta is available in a box containing 1 ml of 100 mg concentrate for solution for infusion . not all pack sizes may be marketed .
adynovi contains the active substance rurioctocog alfa pegol and is called pegylated human coagulation factor viii . factor ixi is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a ( inborn lack of factor ii ), it is missing or not working properly . aadyingnovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older . for patients with hoemphilia alf a , it is an inherited bleeding disorder caused by lack offactor viivii .
do not use adynovi if you are allergic to rurioctocog alfa pegol or octcog altfa or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). if this applies to you , tell your doctor before using aynovin . if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using this medicine : if any of these apply to you before using the medicine , do not inject more aadonovi and tell your healthcare provider immediately : an anaphylactic reaction ( a severe , sudden allergic reaction ) to a certain type of adenovi ( see section 4 ). early signs of allergic reactions may include rash ( usually up to 95 days ), 
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . always use aadonovi exactly as your doctor has told you . check with your doctor if you are not sure . treatment of bleeding your doctor will decide on the dose of adenovi to give to you , depending on the level of factor viii you have been taking at the time of the replacement therapy . aynovis is a life - long treatment . you should continue to use this medicine until bleeding is controlled . the doses of  apynovin are different from the usual dose and may be increased every 3 - 4 weeks to 50 iu per kg body weight , for at least 2 weeks to prevent bleeding . dose of the adose of , will depend on your body weight
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have early symptoms of allergic reactions , e .g ., rash , hoops , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , coughing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath and fainting ), require prompt emergency treatment . as with previous treatment , you should be monitored carefully . tell your doctor if any of these effects cause you problems . your doctor may consider stopping the treatment if necessary . warnings and precautions adynovi is
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before the powder vial is mixed : chemical and physical in - use stability has been demonstrated for 30 days at room temperature ( 20 - 25 ) and within 3 hours at room temperatures ( 20 25 - 30 ). this medicine must be used immediately after preparation . chemical and chemical in / or chemical in in lution stability has also been demonstrated in : 3 hours when stored at roomtemperature ( 20 30 - 40 ) the powder must be dissolved and the solution must be clear and colourless .
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu rurileoctcog alegol . the solvent vial provides 5 ml of sterilised water for injections . other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminoomethane , polysorbate 80 , and sterile water for injecting . each pack contains one vial with sterils for injection . additional ingredients are water for the injections in the via
rekovelle contains follitropin delta , a faecal stimulating hormone ( fsh ), which is similar to a natural hormone produced by your body called gonadotropins . gonadotropics are involved in the reproduction and reproduction of women , and are involved with the success of assisted reproduction programmes , including in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ( ics ), in which the ovaries produce too many egg sacs , which can be crushed or crushed .
do not use rekovelle if your fertility problems are not being controlled . if you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if the tumour in your uterus is too big ( i .e . the size of the ovaries , breasts , pituitary gland or hypothalamus ), enlarged oocytes if there are cysts on your ovulation , or polycystic ovarian disease ( e - rosacea ), bleeding from the vagina if it is not reopened after an early menopause if reopens . there are malformations of the sexual organs which make a normal pregnancy impossible . it is believed that fibroids of the inuterus ( oestrogens ) play
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much rekovelle you need and for how long . the rekowelle dose will be calculated for you by your doctor for your first treatment cycle . you will receive an injection of anti - mullerian hormone ( a type of hormone that stimulates your ovaries ) and stimulation with gonadotropins that will be injected into your blood . this dose will vary depending on your body weight . if this is the case , your doctor may take a blood sample taken during the last 12 months of treatment . depending on how you respond to treatment , the dose will depend on your general condition and your bodyweight . duration of treatment your doctor and / or other healthcare professional will work out the correct dose for you , based on
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects these are due to hormones that cause infertility . you should stop using this medicine and see your doctor immediately if you experience a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . tell your doctor straight away if your symptoms get worse . a side effect that may affect up to 1 in 10 people headache and nausea ( ovulation ) have been reported in women treated with rekovelle . this may be a sign of ovary hypersimulation syndrome ( oliv ). in women it is possible that ovancy can be caused by this medicine , but it
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening the vial may be stored below 25 for up to 3 months . once opened the product should be used immediately . however , if the solution is not used immediately it can be stored up to three times in : - storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 months at 2 8 and beyond 25 years at 2oc 8oc . during the treatment any unused solution should be discarded . this product is for single use only . discard any discarded medicines via wastewater or household waste . ask your pharmacist how to dispose of medicines no
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 mg of flo3 fllo3 in 0 . 6 millilitre of solution . one pre - filled pen contains 0. 36 ml of solution or 33 . 3 mg of the active ingredient follopin delta in each milliliter of solution the other ingredients are : phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what rkovelle looks like and contents of the pack rekowelle is a clear and colourless solution for injection . it is supplied in a pack containing 1 cartridge and 3 pen injection needles , each
what revinty ellipta is revinting ellippta contains two active substances : fluticasone furoate and vilanterol . one tablet of revinthy elisa contains fluticassé furoates 92 mg and vanterol 22 mg . each tablet of fluticason furoat 184 mg and also vilantrol 22 % and 92 / 22 mg are used in adults . what rev inty is used for revintula is used in chronic obstructive pulmonary disease ( copd ) in adults ( asthma ) of 12 years and older and 184 / 23 mg , respectively , in adult patients ( asthma that is not controlled by dpd ). it is used to treat adults of 12 and 185 / 21 , exclusively for the treatment of copd in adults and adolescents
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking revinting ellippta ( see also section 4 ). warnings and precautions talk to your doctor or pharmacist before taking ellipeta and during treatment : - you should tell your physician if any of these apply to you and take rev inty carefully . - your doctor will monitor you carefully if necessary . take special care with revinny eellippt : tell your doctors if : you have liver disease , you may be more likely to get side effects . in case of moderate or severe liver disease your doctor may consider reducing the lower strength of revinity
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( 22 micrograms of fluticasone furoate and 22 microgramms of vilanterol ) once daily at the same time each day . if your doctor thinks that the medicine is not suitable for you , talk to your doctor . this dose is not for use in severe asthma . use the higher strength inhaler recommended for fluticason furoates ( 22 milligrams / kg vilantrol ). copd the recommended dosage to treat copd is one or more inhalations ( one inhaled dose of fluticsone fuoate or 22 millisone / mg vilantesrol ), once daily . revinty ellipta contains
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms after taking ellippta stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ). becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( anaphylactic reaction ). tell your anaesthetist immediately if your aneurysm ( stomatitis ) may occur . this may occur even if it occurs suddenly after taking this medicinal product . if this happens , stop taking revinty ellipinta and tell a doctor immediately as
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 : each inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticason furoat and 22 microgram of vilantrol ( as trifenatate ). 184 : every inhale provides  a deliverable dose (the dose leaving your mouthpiece is just over two microgram ) ( 22 microgramms ) fluticassén furoates and 22micrograms vilantesrol ( alstrifenat ). the other ingredients are lactose monohydrate ( see section 2 ) and magnesium stearate . what revINty is used for the ellippta device is a light grey inhaler with a yellow mouthpiece cover and 
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) emtricitabine , another nucleolar side reverse transcript
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take one tablet : twice daily by mouth . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after a meal . some side effects ( e . g . dizziness , drowsiness ) may be serious . do not change the dose of atripLA until your doctor tells you to . your doctor will tell you how long you should continue taking atriplase . the recommended dose of inripla is one tablet in the morning and one tablet at the evening . it is recommended that you take atriplava with efavirenz , emptricitabine , and tenofovir disoproxil , as well as other medicines to treat your hiv infection . you should swallow the
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects the most serious side effect is lactic acidosis ( excess lactic acids in the blood ). this is a rare ( may affect up to 1 in 1 , 000 people ) but serious side impact that can be fatal . the following side effects may be signs of lactic Acidosity : deep rapid breathing ; drowsiness ; feeling sick ( nausea ); being sick ( vomiting ); stomach pain . if you think that lactic acidosis is getting worse , contact your
what atripla contains the active substances of atriplase are efavirenz , emtricitabine and tenofovir disoproxil . each atripLA film - coated tablet contains 600 mg of eelfavirenz ( as 200 mg emmtricit abine ) and 245 mg of disoperil ( as fumarate ). the other ingredients are croscarmellose sodium , hoyprolose , magnesium stearate in the tablet core , microcrystalline cellulose and sodium laurilsulfate in the film . see section 2 " atriplag contains sodium ". the tablet film coating contains iron oxide black and iron oxide red ink . the tablets contain iron oxide yellow and iron dioxide in the coating .
what orgalutran is orgalugatran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin , which are forms of the natural gonadotropin releasing hormone ( gnrh ), which regulates the release of gonadotropics , follicle stimulating hormone ( also called fsh ). gonadomorphins are involved in the growth and development of fl - cells in the ovaries . fllollicles are small round sacs that contain the egg cells . they release the mature egg cells into the foollicle in the abdomen , where they can then be harvested and given back to the womb ( ovulation ). orgalurtran is used in assisted reproduction techniques ( in vitro fertilisation ( ivf ) and other methods .
do not take orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - are hypersensitive to gonadotrophin releasing hormone ( gnrh , a gndrh analogue ) or to any of its other ingredients . - have a moderate or severe kidney or liver disease . warnings and precautions talk to your doctor before taking orgalurtran allergic reactions . you should be aware that some patients have an active allergic condition . your doctor may recommend additional monitoring during treatment . in case of allergic reactions allergic reactions may occur . allergic reactions that may be severe include generalised ( hives ( urticaria ), swelling of the face , lips tongue and / or throat , which may cause difficulty in breathing or swallowing ( angioedema or anaphy
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine the dose of orgalutran you need and will explain the duration of the treatment . it is important that you are fully suited to the treatment described in the following assisted reproduction techniques : in vitro fertilisation ( ivf ), ovarian stimulation ( ovary stimulation ), and follicle stimulating hormone ( corifollitropin ) on day 2 or 3 of each cycle . orgalugatran is injected under the skin on days 5 to 6 of each course of treatment , depending on the day of preparation . you orgalurtran will be instructed by your doctor to prepare and inject fsh . the preparations and the injection sites will be changed at different injection sites , and then each individual cycle will have daily
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people may occur is local skin reactions , which may include redness and swelling . the local reaction usually disappears within 4 hours . uncommon is ( may affect up to 1 in 100 people ) and may cause headache , nausea , and malaise . very rare is ( could affect upto 1 in10 , 000 people ), and allergic reactions such as rash facial swelling and difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , or throat that may cause difficulty in breathing or swallowing ( dysphagia ), swelling of hands , feet , ankles or feet . not known is ( cannot be estimated from the available data ) allergic reactions including rash face - lips - tongue - and /
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the syringe label after exp . the expiration date refers to the last day of that month . sYringes should be used immediately after opening . store in a refrigerator ( 2 8 ). do not freeze . clean , particle - free solutions are available . you should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . -the other ingredients are mannitol and water for injections . to adjust the ph , the solution contains sodium hydroxide ( e524 ) and acettic acid ( a ) ( see section 2 ). what orgalutran looks like and contents of the pack orgalugatran is supplied as a clear , colourless aqueous solution for injection or subcutaneous administration . the solution is clear to slightly opalescent , and colourless to pale yellow solution . not all pack sizes may be marketed . your doctor or nurse will prepare the solution for subcutaneous use . after the needle is removed , clean the treated area with dry natural rubber / latex 
what blitzima is bitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to this cell , the cell dies . what brittle uses are the ingredients of blitima ? billetima may be used for the treatment of several different conditions in adults , adolescents and children : a ) non - hodgkin ' s lymphoma this is not a disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymphoocytes ; bishima can be given alone or with other medicines called "
do not take blitzima if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your child has a severe active infection at the moment if their child has been born with a weak immune system . warnings and precautions talk to your doctor if the child has severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not have bitzimo if any of these apply to your child . if there is a possibility that you may get a hepatitis infection . before you are given blitima your doctor will check that your child is likely to have he
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given bitzima as a drip ( intravenous infusion ). medicines given before each billetima administration before you are given a blitima , you will be provided with other medicines ( pre - medication ) to prevent or reduce possible side effects and to reduce the risk of your treatment if you have non - hodgkin ' s lymphoma if they get worse . if given : bligima alone bblitzIMa will usually be given once a week for 4 weeks . repeated treatment courses with blizima are possible . when given twice 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , chest pain , redness or itching at the site of infusion . tell your doctor immediately if you notice any of the following . other side effects very common ( may affect more than 1 in 10 people ): fever . common ( might affect up to 1 in10 people ), reactions at the start
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in blituxima is called rituximabove . the 10 ml vial contains 100 mg of ritzuximaba ( 10 mg / mL ). the 50 mml throughl contains 500 mg of
roactemra contains the active substance tocilizumab , which is a type of monoclonal antibody ( a kind of protein designed to recognise and attach to a specific target in the body ). it is used to reduce the inflammation in your body . rroaktemmr aims to reduce symptoms such as pain and swelling in your joints . by attaching to ra , it reduces the damage to the cartilage ( the bone that supports your joints and helps you to perform daily activities ) of the disease . in adult patients , rreactememrra is used for the treatment of moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough or are not tolerated .
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you have an active , severe infection , you must tell the doctor or nurse before starting the infusion . warnings and precautions talk to your doctor or healthcare professional before using rroaktemrap . allergic reactions may include chest tightness , wheezing , extreme dizziness or light - headedness ; swelling of the lips or skin rash . tell the person giving you the infected with any signs of infection . infections tell your doctor immediately if : you feel unwell . raactemara may reduce your body ' s ability to fight infections or to treat an existing infection if it gets worse . talk to a doctor if
roactemra is given into a vein by a nurse or a doctor or nurse . the intravenous infusion will be supervised by  a healthcare professional . your doctor will decide how many treatments you need . how much you receive the treatment with rroaktemran is 8 mg for every kg you weigh , 4 mg for each kg you weight . you will be given ra every 8 hours as a drip in the vein ( intraveinenous inf ) for 2 hours . rreacteemrea is diluted before it is given as 30 mg for up to 12 hours , or 30 mg infusions per kg of your body weight , depending on your bodyweight . adults the recommended dose of reactemera for adults is 2 mg / kg given as : - via a drop in
like all medicines , roactemra can cause side effects , although not everybody gets them . you can usually tell your doctor straight away if you notice any of the following side effects ( see also section 3 ) while you are taking rroaktemrapra : serious side effects common ( may affect up to 1 in 10 people ) - allergic reactions , which may cause difficulty with breathing , chest tightness , light - headedness - rash , itching , or hives - swelling of the lips , tongue or face - serious infections , such as fever and chills in the mouth and nose - abdominal pain , diarrhoea , vomiting - itching uncommon ( may effect up to1 in 100 people ). - redness or itching of the skin , lips / tongue or facial area
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viall in the outer container in order to protect from light . this medicine may pose a risk to the environment .
what roactemra contains the active substance is tocilizumab . each vial contains either : - 4 mg or 80 mg tocilizub in 20 ml solution . - 10 mg or 200 mg tozizumabe in 20 20  20 ? - 400 mg tochizumabat in 20 mg ? the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections . what if you have any questions about how rroaktemrap works or why this medicine has been prescribed for you , ask your doctor . the medicine is a concentrate for solution for infusion . infusion in raactemirra is supplied in vials containing 4 mL , 10 mmol
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier to get air in and out . onbez breezehaler is used to make breathing easier for adult patients who have breathing difficulties due to  a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the air sacs tighten . that makes breathing difficult . the active ingredient in this medicine relaxed these muscles in your lungs and made it easier for air to get in and outside the welts .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using onbez breezehaler as it may cause asthma ( see section " do not take onbriez breEZhaler "). - tell your doctor if any of these applies to you . - have heart problems . you should not be given onbrazhaler for epilepsy . tell your doctors if your thyroid gland problems ( thyrotoxicosis ). if the doctor thinks any of this applies to your case , tell your diabetes doctor before you start treatment with onbrés breezihaler and tell your physician immediately if : - you experience tightness of the chest , coughing , wh
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation of the 150 microgram capsule each day . your doctor may prescribe you a dose of 150 microgramms or 300 micrograms depending on your condition and on how you respond to the treatment . you should inhale the content of one capsule each night . inhaling the content may be inhaled at the same time each day at the the same times each day will help you to remember to use it . it will also help you remember to take it at the right time each night ( on the morning of the evening ). you should always inhalate the content in your capsules at the exact time you use it for as long as your physician has told to do so . do not use more than the recommended dosage . how to inhaler onbrez 
what onbrez breezhaler contains - each onbezhalmer 150 microgram capsule contains 150 microgramms of indacaterol as indabacaterol maleate . the other ingredients include lactose and the capsule is made of gelatin . - every onbriez breezehaler 300 microgram hard capsule contains 300 microgrammes of of indeacaterolul as indecaterol malate , as lactoses and the cap is made from gelatin and edible . what onbeezhalers looks like and contents of the pack in this pack , you will find an inhaler together with capsules in blisters . capsules are transparent and contain a white powder . onb Rez breEZhaler 150 microcapsuls are white and contain an outline of 150 microliters , with ' gs ' printed in blue ink
clopidogrel hcs contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). cloclopidagrel hocs is taken to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothromboses , and atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogreil hhcS to help prevent blood cotts from forming and prevent them from re 
do not take clopidogrel hcs : if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is too serious , or if someone in your family has severe liver disease . take special care with cloclopidagrel hocs please tell your doctor if any of these apply to you . warnings and precautions if a person is at risk of bleeding such at any time , such as having a mental condition that puts you at risk for internal bleeding ( such as such as an stomach ulcer ). it is important to tell your healthcare provider if this is the case . have a blood disorder that makes you prone to internal bleeding ("
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor has told Ihnen that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral shcS ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 - mg tablet once per day as described above . you should take clopogrell hhccs for as long as your physician
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth , skin disorders such as rashes and itching , blisters of the Skin . all of these may indicate an allergic reaction . the signs may include reddening , unusually intense pain when swallowing . you may also experience a combination of cough , sore throat and a runny nose . tell
what clopidogrel hcs contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopotogrelly ( as hydrochloride ). the other ingredients are ( see section 2 ' cloclopidel  hhcS contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 8000 ), yellow iron oxide , and talc and macrogol 3000 . what clorogre hcks looks like and contents of the pack the film  - covered tablets are pink , oval , convex
fetcroja contains cefiderocol , which is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . fеtcroJA is used for the treatment of infections caused by bacteria that have come back after they have been given other antibiotics , and for the prevention of wound healing .
do not take fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor is not sure if this applies to you , talk to your doctor before taking ffeet Croja . if - you are also allergic to other antibiotics , such as cephalosporins . warnings and precautions talk to you doctor before starting fеtcroje : if any of these apply to you as you may be at increased risk of having a severe allergic reaction to certain antibiotics ( e . ex . penicillins or carbapenems ). signs may include severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat . this may cause difficulty swallowing or breathing . stop taking e
this medicine is given by your doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours for your doctor to finish fetcroja treatment . check with your doctor if you think you may have infection . this is to make sure that you do not get any pain during the ffettingcroja infusion into , or after your vein has been opened . patients with kidney problems if your doctor thinks you may need more fеtcroJA than they should , it is very important that you receive your dose of feverja as prescribed . if a child accidentally receives more frotcroj than they were told to , tell your doctor immediately . your doctor will decide how long you need to take f et Croja . do not stop treatment with faetkroja unless your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect you may need urgent medical treatment : severe allergic reaction ( common ): sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may also be preceded by diarrhoea and stools , which may contain blood or mucus . your doctor may decide to delay or stop treatment , especially if medicines are taken to slow bowel movement . tell your healthcare professional if any of these side effects become serious . reporting of side effects 25 if your child gets any side effects talk to your doctor , pharmacist or nurse . these include : very common ( may affect more than 1 in 10 people )
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . 1 mg cefividerol . -the other ingredients are sucrose , sodium chloride , and sodium hydroxide . what et Croja looks like and contents of the pack ffetoja is a white to off - white powder for solution for infusion supplied in a vial containing 10 ml reconstituted solution .
depocyte is used to treat lymphomatous meningitis . lymphomatomus meningită is a condition in which tumour cells form on the membranes of the brain and spinal cord . depcyto is used in adults to destroy lymphoma tumour cells .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a meningeal infection . if this applies to you , tell your doctor immediately . your doctor will decide if treatment with depoocyte is right for you . severe neurological side effects have been reported with depepocyte in patients receiving depcyto . symptoms that affect the nervous system may include convulsions , pain , numbness or tingling , blindness and visual disturbances . tell your healthcare provider immediately if any of these symptoms occur . you should not take any depamethasone tablets for a long time . this is because dep cell can cause unwanted effects . talk to your doctor if these effects are severe or if they are
the use of depocyte is not recommended if you are a patient with cancer . the use in lumber sac is not necessary . depoocyte will be given to you by a doctor or nurse . your doctor or health care professional will prepare the solution for injections . it is available in two strengths . each vial contains 1 mg of dexamethasone 5 ml ( 0 . 5 g / m2 ) solution . with each depectomy dose , you will be observed closely for any side effects . once the vial has been prepared , dep cell will be transferred to a suitable temperature ( between 22 and 30 ). after withdrawing depcyto from the vially , the company will take proper precautions to avoid inhalation of this substance . since this product is a cytotoxic drug , proper handling technique and a safe
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often during your treatment . the following side effects have been reported with depocyte : very common ( affects more than 1 user in 10 ) common ( effects in 1 to 10 users in 100 ) uncommon ( affectations in 1 , 10 and 1 to ten users in 10 and less than 1 patient in 10 not known ( frequency cannot be estimated from the available data ) adverse events reported during treatment with depepocyte during treatment of depcell and other chemotherapeutic agents very common : ( affect more than1 user in 100 and more ) very common common ( impacts in more than 10 users per 10 , 000 and more than 11 users in 1 million ) not known : frequency cannot been estimated from available data adverse events observed with debocyte when dep cell is used in combination with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . depocyte should be stored in the original container in order to protect from light . store in a refrigerator ( 2 8 ). do not freeze . after first opening , dep cell should be used within 4 hours . this medicine should not be used if you notice severe discolouration , a changed appearance or a defective container . once opened , the product should be administered immediately . if the contents of the container are not clear or if there are particles in it , it should be discarded . when depcell is mixed with cytarabine , this product should not been used .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cychtarabin . one vial of 5 mL solution contains 50 mg / m2 of ccytaribine - other ingredients are cholesterol , trioline ( e339 ), dioleoylphosphatidylcholine , dipalmitoyllphosphatidicylglycerol ( е339
what bemrist breezhaler is and how it works bemreist briezhalers contains two active substances called indacaterol and mometasone furoate . inddacatrol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , making it easier for air to get in and out of the pulmonary system . this helps to open the airways and makes it easier to get air in and outside the arteries . when it is taken regularly , it helps the small lungs to remain open . mometesone furóate belongs to another group of medicine called corticosteroids ( or steroids ). corticotrooids reduce the swelling and irritation ( inflammation ) in the small aeroways in your lungs and so gradually ease breathing problems . corticoids
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without using bem.ist  Breezhalers . if the above applies to your : if your doctor has told you that you are not sure , talk to your doctor before using this medicine . warnings and precautions talk to you doctor or pharmacist before using bemmrist brezhale : tell your healthcare professional if : you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . your doctor may want to monitor you more closely . You have ever been told you have diabetes or high blood sugar . it may also cause seizures or fits . there is 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is two or three bemrist breezhaler capsules a day . you only need to use the medicine once a week . do not use more than your doctor tells you to use . it will only help control your asthma or worsen your symptoms . when to use bemist BREezhalers in the morning . how to inhale bemrast breezehaler - bemmris breezihaler is for inhalation use , and it will help you to breathe more easily throughout the day and night . - in this pack , you will find an inhaler and capsules that contain the medicine . only use the inhalers provided in this package . use the capsules with the inha
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), swelling mainly of the mouth , tongue ; lips ; face and throat ( angioedema ). other side effects include : very common ( might affect more than 1 in10 people ). common ( will affect upto 1 in every 10 people in your country ) swelling of either the tongue or lips - face or throat ( possible signs of angioneuroedemata ) other side effect common ( likely to affect upticking of the pancreas ( pancreatic pancre
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . each delivered dose of bemreist briezhalmer 125 micrograms / 62 . 5 microgram each capsule contains 173 microgram of indocaterol aate or 150 microgram ( equivalent to 80 microgram ) of indecaterol and 80 microgramm ( equivalent  to 95 microgram) of mometesone furonate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 125 milligrams of indigacaterolul and 62. 5 millilitres of momasine furoat . bemist brewing breezehaler is available in a pack containing 125 , 127 .
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zylt is taken to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothromboses , and atherophothrombitic events ( such as stroke , heart attack , or death ). you have been prescribed zyillt to help prevent blood cotts and reduce the risk of these severe thrombocytes .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is too serious , or if someone in your family has severe liver disease . do not taking zylt . warnings and precautions before you take a dose , tell your doctor if any of these apply to you . take special care with zyillt : if the risk of bleeding is increased if : you have a mental condition that puts you at risk of internal bleeding ( such as an stomach ulcer ). you have or have had a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints of your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor advises you to take it at the start of treatment , your doctor may give you 300 mg of yllt ( 4 tablets of 75 mg ) once at the beginning of treatment and then gradually increase your dose to one 75 - mg tablet once a day , depending on how you respond to treatment . then , the recommended starting dose is one75 mg tablet ( 4 tablet of the tablet ) taken or two tablets of a total of 75 tablets ( 4 capsules
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth , skin disorders such as rashes and itching , blisters of the Skin . all of these may indicate an allergic reaction . the most frequently reported side effects are listed below . side effects reported with zyllt are : very common side effects ( may affect more than 1 in 10 people ):  headache 
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopogrell ( as hydrogen sulphate ). the other ingredients are lactose ( see section 2 ' zylt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( i171 ), red iron oxide ( е172 ), talc and propylene glycol in the film . what yllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 or 50 film  screen are available . not all pack sizes may
what lamivudine teva is lam mivudines teeva is used for treatment of long term ( chronic ) hepatitis b infection in adults . lamivine toeva is an antiviral medicine that works against the hepatis - b virus , which belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). heptis is a virus that infects the liver , causes long term( chronic ), chronic , and can lead to liver damage . treatment with lamvine has been shown to improve the condition of the liver and to reduce the risk of compensated liver disease . treatments with lammivucine iteva reduces the amount of hetis ba virus in your body .
do not take lamivudine teva - if you are allergic to lamivine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor or pharmacist before taking lamvudines t Eva . taking lamevudineze e . g . with other similar medicines may cause serious side effects , especially if taken at the same time . you must be aware of all of the possible side effects of liver disease , including hepatitis c ., if your doctor determines that you are seriously overweight ( especially : if any of these apply to you ), you may need extra check - ups , and blood tests before you start taking your medication . see section 4 for more information about the risks and benefits of taking lamievudinous teeva 
always take this medicine exactly as your doctor has told you . check with your doctor lamivudine teva is for oral use . you should swallow the tablets whole , with some water . if you do not swallow the tablet whole ; you can divide and combine them with a small amount of food , or a drink , and drink it straight away . your doctor will tell you how long you need to take lamivine to take . how much to take you need lamivane is for treatment of your hepatitis b infection . depending on the severity of your infection and the severity and severity of votre illness , your doctor may prescribe lamigaudinе t Eva for you : if your doctor prescribes lamigane . lam mivudines te is usually taken with or without food . swallow the capsule whole
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in association with other conditions that may be associated with hepatitis b . it is important to talk to your doctor if you experience any of the following serious side effects during therapy with lamevudines t Eva : - tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort / pain , nausea , vomiting and diarrhoea - increases in liver enzymes . these may be signs of liver problems . - increased blood sugar , which may be a sign of liver damage . common side effects ( may affect up to 1 in 10 people ):  heart disease  liver problems during post - marketing experience during post marketing experience with lamedi
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . lamivudine teva should be stored in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . please return the pack to your pharmacist . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamium . each film - coated tablet contains 100 mg of lamivadine ( as monohydrate ). - other ingredients in the tablet core are : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film coat : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( е172 ), iron oxide red ( ă172 ). what lamevudines teeva looks like and contents of the pack orange , round , biconvex film . one side is debossed with " lilly " and plain - faced with " 32 ". lamvudince t Eva is available in aluminium blisters in pack sizes of
nespo ( an anti - anaemic ) will help you to control your anaemia . anaaemia occurs when your blood does not contain enough red blood cells . the symptoms are fatigue , weakness and shortness of breath . n espo works by reducing the amount of the natural hormone erythropoietin that your kidneys produce . this makes erythromboiettingin more effective and encourages your bone marrow to produce more red blood cell types . your doctor has prescribed naespo together with darbepoetIN alfa to treat chronic renal failure , a condition known as symptomatic anaedia . chronic renal fail in patients with kidney failure . kidney failure is a serious complication of kidney failure when the body produces too much of the naturally hormone ethropaie
do not use nespo if you have high blood pressure . take other medicines : - if your doctor is allergic to n espo ( darbepoetin alfa ) or r - hoepo . naespo should not be used to treat high blood tension caused by medicines used to thin the blood ( sickle cell anaemia , epileptic fits ( seizures ), convulsions ( fits , or seizures ) - liver disease or drugs used to thicken the blood - anaemic patients - the doctor may want to treat you for high blood temperature caused by an allergy to latex . the needle on the pre - filled yinge contains a derivative of latex and may cause symptoms such as unusual tiredness or lack of energy . pure red cell aplasia may occur in many parts of the
your doctor will carry out blood tests and decide whether you should be given nespo . the dose of nnespor you will be based on your haemoglobin level . this will be calculated by your doctor . it is usually 10 g / kg for adults . a haemeglobin value of 10 g 1/ kg will be maintained for 12 months . how is the pre - filled syringe given the doctor will decide how much n espo you need and at what time . do not inject naespo yourself if you have chronic renal failure . your doctor or nurse will give you a single injection under the skin or into a vein ( intravenous ). if your anaemia is not controlled your doctor may change your dose of the nyspo you receive . dose the dose for you will depend on your
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below has been defined using the following convention : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) associated with fluid retention ( oedema ) uncommon ( affect affects 1 to 100 users in 1 , 000 ) : blood clots ( thrombosis ) pain around the area injected rash , redness of the skin rare ( affect is 1 user in 10 ,000 ) serious allergic reactions : sudden life - threatening allergic reactions ( anaphylaxis ) including swelling of the face , lips , mouth , tongue or throat which may cause difficulty in swallowing or breathing ( angioedemosis or angioneurotic thromb
keep out of the reach and sight of children . store in the original package in order to protect from light and moisture . keep the bottle tightly closed . nespo should be used within one month of first opening the bottle . once your syringe has been removed from the bottle and has reached room temperature ( up to 30 ) it must either be used by then or be used for a maximum of 7 days in a refrigerator ( 2 to 8 ). do not freeze . do not use n espo after this period . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains the active substance is darbepoetin alfa . n espo is supplied as a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms of the active ingredient darbepepoestin alfata in the active formulation . the other ingredients are nassodium phosphate monobasic , sodium phosphat dbasic ( e331 ), sodium chloride , polysorbate 80 and water for injections . what nevespo looks like and contents of the pack nnespor is a clear to slightly pearly , colourless to slightly cloudy solution . it is available in packs containing 1 or 4 pre 
macugen is a solution given to the eye by injection . it contains the active substance pegaptanib . this medicine prevents the abnormal formation of new blood vessels in the eye . macuogen is used for the treatment of patients with macular degeneration ( amd ). this disease causes vision loss and damage to a part of the retina called the macula , which is the transparent layer at the back of the eye. the macula is the light - sensitive layer at each corner of the eyes . amd occurs when abnormal blood vessels grow out of control , and the retina becomes damaged . the development of these new blood vessel can cause vision loss or damage to the layer at back of your eye , called the cog - duct . in amd patients , abnormal blood cells grow out from the maculate . when the macusa becomes damaged over time , macu Gen
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active or suspected infection in or around your eye . warnings and precautions talk to your doctor or pharmacist before using macuogen . if this applies to you , tell your doctor immediately . macuGEN can cause an infection or bleeding in the eye , so you should not receive macu Gen injection . tell your physician immediately if , during the week following symptoms : eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , or small particles in your vision . these could happen even if the injection went well or went away . after the injection serious allergic reactions may occur . the symptoms listed below can be caused by a different type of illness .
macugen is only given by doctors who are experienced in giving injections . macuger must be given by a qualified doctor or nurse . a doctor or a nurse will give you macuogen as a single injection into your eye . it can be given every 6 to 9 days . the injection will be given into the vitreous ( part of the eye ) and will be injected slowly over a period of one month . your doctor will check whether the medicine is working and if it is working properly . before using macuGEN , your doctor may give you antibiotic eye drops to keep the eye dry , and to prevent it from becoming irritated . you may also be given some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you may have with the injection . tell your doctor if you are allergic to antibiotic eye drops ,
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction , angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting , diarrhoea ) has been reported . the frequency of these side effects is not known ( cannot be estimated from the available data ). - an infection in the internal portion of the eye has been observed in patients receiving macugen treatment . this is the symptoms described in section 2 . see also section 2 for more information . if you experience any of these symptoms , contact your doctor immediately . not known is the case in patients not yet treated . your doctor will monitor you and decide
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any suspension left in a bottle more than four weeks after it was first opened , the medicine should be disposed of .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegabib in 90 microlitres . - other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphat heptahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections , see section 2 . what macugagen looks like and contents of the pack macuGEN solution for injection is a clear , colourless solution for infusion ( injection ) in a single dose pack , containing a pouch and a pre  - loaded sYringe containing either 0. 25 ml or 0 0. 27 mL of solution . the solution is clear
kepivance contains the active substance palifermin ( which belongs to the group of bacteria called escherichia coli ). palifered by means of epithelial cells , it stimulates the growth of cells in the mouth , digestive tract and in the tissues below the skin . palifère is used to treat oral mucositis ( soreness , dryness and inflammation of the mouth as a side effect of treatments ) in adults . it is used if : your blood cancer is getting worse after you have received chemotherapy or radiotherapy , or if you have had autologous hematopoietic stem cell transplantation ( apst ).
do not use kepivance - if you are allergic to palifermin or escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions children and adolescents this medicine is not for use in children and young children below 18 years of age . other medicines and kepepivace tell your doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . this is because kepitivance may affect the way some other medicines work . also tell your pharmacist : if the child is already taking heparin . if any child has recently been given hepivancing . pregnancy and breast - feeding kekivance is not recommended if a pregnant or breast  - fed woman is pregnant , think you may be pregnant or are planning to have
kepivance should only be given by healthcare professionals experienced in cancer treatment . always use kepeivance exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose of kepativance is 60 mg . kekivance will be given to you in a single dose of one kilogram ( 0 . 5 ml ) via an intravenous injection into a vein . your doctor will decide how much keponivance you will receive . chemotherapy and radiotherapy you will be treated in ' post - marketing experience ' during the first three days of chemotherapy andradiotherapy . after the second dose , chemotherapy andRadiotherapy will be administered 24 to 48 hours before the chemotherapy and radiation . depending on the dose you receive , your doctor may decide to reduce the dose of the chemotherapy or radiotherapy 
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects reported during marketing of kepivance were skin rash , itching and redness ( pruritus or erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth OR tongue . generalised swelling ( oedema ) and swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ); altered taste ; increased levels of lipase and amylase levels . uncommon ( may effect up to1 in 100 people ), dizziness , headache , tremor or headache . not known ( frequency cannot be estimated from the available data ): allergic reactions ( e . g
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliformin -the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepepivaze is a white powder for solution for injection . it is available in packs containing 6 vials .
cinacalcet accordpharma contains the active ingredient cinakalcet , which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormon glands . the paratrons are four small glands in the neck , near the thyroid gland , that produce parathelial hormone ( paratrophy ). cinacacalcet acordpharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce calcium in the blood ( hypercalcaemia ) in patients who have parat thyroid cancer to reduce the amount of calcium inthe blood ( hypocalcaaemia the maximum amount of par athyroid cancer ) when treatment with primary hyperparatothyroidists cannot be achieved by removal of the gland . 
do not take cinacalcet accordpharma - if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). - when you are breast - feeding . - you have low levels of calcium in your blood . your doctor will monitor your blood calcium levels . do not exceed the recommended dose of cinakalcet accordchan . warnings and precautions talk to your doctor before taking cinacinacalce accordpharma and during treatment with cinaccalcet acordpharma : - tell your doctor if : you have ever had seizures ( fits or convulsions ). you have had seizures for several days or weeks . you have liver problems . or you have heart failure . using cinaCALcet accord pharmaceutical lowers calcium levels and can cause life threatening events and fatal outcomes associated with low calcium levels ( hypocalcaemia ). while
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you must take . cinacacalcet acordpharma is for oral use . you should swallow your tablet with a drink of water . the tablets are for oral usage . it is recommended that you take the tablets at the same time each day . this is to make sure that you get the best results and lowest possible efficacy . regular blood samples are taken during treatment to monitor your condition during treatment . patients with secondary hyperparathyroidism the usual starting dose of cinaCALcet accord Pharma is 30 mg per day , taken as three times per day ( morning and evening ). children and adolescents ( 3 to less than 18 years of age ) the dose is 0 . 20 mg per week 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). if this happens , you may experience swelling of the face , lips , mouth  , tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if these side effects become severe , they may be very common . common ( might affect up to 1 in every 10 people): dizziness , headache , and diarrhoea . uncommon ( may effect up to1 in every 100 people ). you may feel tired and breathless
what cinacalcet accordpharma contains - the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaccalcet ( as hydrochloride ). - tablet core : cellulose , microcrystalline - crospovidone - magnesium stearate . - coating : indigo carmine aluminium lake ( e132 ), iron oxide yellow ( i ) what caffiene looks like and contents of the pack cinacinacalce accordpharma 30 mg film  screen - covered tablets are light green colored , oval shaped , approximately 9 . 65 mm x 6 . 000 mm and biconvex , film  coated tablet . one side is debossed with ' c30 '. the other side is dubosses with
jentadueto contains two different medicines called linagliptin and metformin . linaguiptine belongs to a class of medicines called " dpp - 4 inhibitors " ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs zu the group of medicines known as biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine helps to lower the amount of sugar made by your body ' s immune system ( biguar ) and helps to control the level of sugar in the blood . this is especially important in patients with this type of diabetes . it is important that you continue to follow your food and exercise plan while taking this medicine . your doctor may prescribe this medicine together with certain other medicines for diabetes ( sul
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have severely reduced kidney function . if the doctor has advised you to take this medicine : if - you have uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acids " below ) or ketoacidosis . ketoacaidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - coma . symptoms include stomach pain , fast and deep breathing 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jentadueto is one tablet once a day . you currently take metformin in two separate tablets . your doctor may decide to increase your dose either with individual tablets of linagliptin or metformine . taking this medicine with food will help you to get the best results . swallow the tablets whole . do not crush , chew or split the tablets ; take this medicines with food to lower your chance of an upset stomach . doses of 5 mg linaguiptIN and 2 , 000 mg metforminer hydrochloride per day are available . starting dose jsentaduato is taken once daily to control your blood sugar . this medicine is taken with another oral anti - diabetic medicine , such as
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see your doctor immediately if you experience any of the following symptoms of low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypogliescaemia is a serious , potentially life - threatening condition ( frequency not known , cannot be estimated from the available data ). it is possible that if this happens you may need immediate mental attention . most cases of it happen within 1 to 10 days of administration . the most common side effect with jenteduet plus sulphonylurea is the combination jENTadueleto plus insulin . reporting of side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after " exp ". the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : this medicine does not require any special temperature storage conditions . does not use if the package is damaged or shows signs of tampering .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jsentaduеto 2 . 5 mg / 850 mg film - coated tablet contains 2 , 5 mg of linaguiptun and 850 micrograms of metformine hydroch chloride  . - each jerks - barrélia 1 , 000 mg film- coated tablets contains 2, 5 . 6 mg of lagliptingin and 1 : 000 mg of metFORMin hydrochaloride the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous . the other ingredient ( s ) are : hypromellose , titanium dioxide ( e
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection . ecedent belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is for use in adults , adolescents and children over 12 years of age who are infected with hiv and who have not used hiv medications before . your doctor will recommend the best medicines for you .
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking e during treatment with e pendant . if your doctor has told you that you do not need to take the following medicines : carbamazepine , oxcarbazepine ( e1201 ), phenobarbital and phenytoin ( medicines to treat epilepsy and prevent seizures ) rifampicin and riffapentine ( medicines used to treat some bacterial infections such as tuberculosis ) such as omeprazole / esomeprazola , lansoprazolе , pantoprazole , and rabeprazolone ( medicines for treating
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults aged 18 years and over the recommended dose is one tablet once a day with water , with or without food . edurant must be taken with food , and must not be taken after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . children and adolescents e pendant must not to be used in children and teenagers younger than 18 years as it has not been studied in this age group . there is no information on the effects of e during adult life unless your doctor has told it . 1 . take rifabutin , a medicine used to treat some bacterial infections , can replace the effects that ewährend might have on your body . talk to your doctor about
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you experience any of the following : headache , nausea , difficulty falling asleep , insomnia and dizziness , which may be due to changes in the results of your routine liver tests ( transaminase , increase in cholesterol and pancreatic amylase ) or if your blood shows signs of abnormal dreams , rash , stomach pain , depression , tiredness / vomiting , and drowsiness , decreased appetite , sleep disorders , or stomach discomfort , depressed mood , feeling unusually sleepy or sleep disorder , increased levels of uric acid or creatine phosphokinasis . rare side effects ( may affect up to 1 in 1 , 000 people ): very common side effects are : di
what edurant contains the active substance is rilpivirine ( as rilspiviine hydrochloride ). each tablet of e pendant contains rillpivirie hydrochleide equivalent to 25 mg riilpirine . the other ingredients of the film - coated tablet core are lactose monohydrate ( see section 2 ), croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . in addition , the film coat contains lactoses monohydrate , hypromellose 2910 ( 3 mpa . s ) ( equivalent to 6 mp ), titanium dioxide , macrogol 3000 and triacetin .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 diabetics either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  ''  t respond normally to the insulin their body makes . rosiziglittazon and met Formin work together so your body makes better use of the insulin it produces , and this helps reduce your blood sugar to a normal level . also avand amet can be used together with a sulphonylurea , another medicine for diabetes , which is used for preventing and controlling diabetes - related illnesses .
follow all instructions given to you by your doctor as well as your diabetes medication . do not take avandamet : if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avand amet ( listed in section 6 ). if this applies to you , tell your doctor and do not taking the tablets . if your doctor has told you that you have a heart attack , or severe angina , because your doctor may want to monitor you more closely . warnings and precautions talk to your doctor before taking avandal : " if - you have heart failure " - if someone else has had heart failure in the past - or you suffer severe breathing difficulties - your doctor knows if these apply to you ( or you are not sure ), talk to a doctor or pharmacist before taking this medicine 
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 2 mg rosiglitazone ( 800 mg metformin ). you will take this dose once a day , for 1 to 8 weeks . your doctor will decide on the right dose for you , depending on your condition . at the start of each course the dose may be increased or decreased , but the maximum dose is 4 mg . if your doctor increases the dose to 4 mg of rosilligtazon ( 1000 mg metFORMin ) once , you will receive this dose in the form of 2 mg tablet form . take a tablet at around the same time each day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . you can take ' t take tablets
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions may occur with avand amet . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact a doctor immediately if you get any of these symptoms . stop taking avandat . lactic acidosis : excess of lactic acids in the blood ( lactic Acidosity ) is an uncommon side effect , especially when treatment with metformin is not recommended for patients with severe kidney disease . symptoms of lacecidosis include rapid breathing , cold sweats and a history of blood clots in the lungs ( pulmonary oedemal ). these are usually mild and usually disappear after a few weeks 
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  't need . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . avand amet tablets come in different strengths . each tablet contains 1 mg rosyiglittingazone + 500 mg metformine . after opening the tablet compartment , you can take it with or without food . the tablet can be divided into 2 mg / 5 mg . either rossiglitabazone = 500 mg and metFORMin  the tablet must be taken in 2 mg of rosglit azone . once opened the tablet is ready to use , it can be taken with food , and the tablet itself contains 1000 mg of metforminer . every 4 weeks the tablet contains rosilligtazon = 1000 mg and meetformin the other ingredients are sodium starch glycollate , hypromellose , microcrystalline 
clopidogrel mylan contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). cloclopidоgrel meinlan is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothromboses , and atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrela mylan to help prevent blood cotts and reduce the risk of them forming again .
do not take clopidogrel mylan 31 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is too serious , or if someone in your family has severe liver disease . take special care with cloclopidоgrel Mylan : if any of these apply to you , tell your doctor before taking clopionogre  mylan . warnings and precautions talk to your doctor or pharmacist before taking the tablets : the risk of bleeding is increased if : you have a mental condition that puts you at risk of internal bleeding ( such as the stomach ulcer ) or a blood disorder that makes you prone to internal bleeding , such as bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if your doctor decides that you can take the tablet at any time of the day , you should take clopogrell mylan for as long as your physician continues to prescribe it . in case of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet (
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth , skin disorders such as rashes and itching , blisters of the Skin . all of these may indicate an allergic reaction . the signs may include reddening , unusually intense pain when swallowing . you may also experience a reaction to clopidogrel mylan . tell your doctor if your
what clopidogrel mylan contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopotogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' cloclopidel myLAN contains hydrogenated castingor oil ') and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 8000 ), yellow iron oxide , and talc and macrogol 3000 . what  Clopidogral mylant looks like and contents of the pack the film  - covered tablets are pink , oval , convex and debossed with ' 75 ' on one side
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dop Telet is used to treat chronic liver disease with low platelet count ( thrombophlebitis ) in adults who have a medical procedure to prevent bleeding , which may involve the formation of platelets . platelets are blood cells that help the blood to clot and so prevent bleeding is occurring .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - to prevent blood clots from forming in the veins or arteries . warnings and precautions talk to your doctor before taking dop Telet . blood coagulants can build up in the blood and this can be life - changing . - for example , if blood  clotes are formed in the arteries because blood sunk in the tissues surrounding the vein , or if the formation of blood - from cancer . take special care with doptelt - when you are taking the contraceptive birth control pill or hormone replacement therapy . tell your doctor if any of these apply to you . you have recently had surgery or you were injured . dopelet is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet per day . your doctor may adjust the dose to 8 mg based on your response to doptelet . take the tablet at about the same time each day , preferably at the same dose each day ( e . g . one tablet in the morning and one in the evening ). swallow the tablet whole with a glass of water . you can take dopelet with or without food . dop Telet can be taken as 20 , 40 and 60 tablets in one day ; however , your doctor will increase the dose at least 5 mg per day depending on your platelet counts . use in children and adolescents the doctor will determine the appropriate dose for you , depending on the size of the child and the size and
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse immediately if you notice any of the following side effects very common ( may affect more than 1 in 10 people ): feeling tired common ( might affect up to 1 in 100 people ), low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that connects the liver and intestines ) upper abdominal pain and swelling bone pain muscle aches fever reporting of side effects get a lot of information in the healthcare professional . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what doptelet contains the active substance is avatrombopag . each film - coated tablet contains avatotrómbopag maleate equivalent to 20 mg of avatarombog . the other ingredients are lactose monohydrate ( see section 2 ' dopelet contains lactoses '), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , poly ( vinyl alcohol ), talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( wy20 ). what dopet looks like and contents of the pack doptelt 20 mg film  s tablets are pale yellow , round and rounded . they have " t " on one side and " 20 "
rapiscan belongs to a group of medicines called ' coronary vasodilators '. they work by helping the doctor find out about the inside of the heart arteries and their function , including their function as measured by heart rate . they also contain tiny amounts of radioactivity , such as the muscles in the heart which are involved in the normal heart rhythm . rapistcan is used in adults to get a picture of the inside heart of a patient called a ' myocardial perfusion imaging ' in order to obtain clearer pictures . the scan contains a radioactive substance called , called  a' radiopharmaceutical ', which is used to obtain these images . these pictures are taken to help obtain pictures of the muscles of the human heart . it is usually done by using a treadmill or camera attached to the heart in order for a scan to
do not use rapiscan if you have : slow heart rate or a history of high degree heart block . sinus node disease . your doctor may need to use a pacemaker . chest pain ( unstable angina ) may occasionally be a problem for some patients , but it may still be reversible after a short time . if this is not treated , your doctor will decide what treatment is needed . low blood pressure ( hypotension ) or heart failure . do not give this medicine to anyone else . are allergic to regadenoson or any of the other ingredients of rapistan 6 . talk to your doctor before you receive rapissecan . warnings and precautions talk to you doctor before using rapscan : if : you have had a recent serious heart problem such as a heart attack . you have abnormal heart rhythm
rapiscan will be administered to you by a doctor or nurse who is experienced in the diagnosis and treatment of heart problems . it will be given to you in a hospital or clinic and will be performed by specialised doctors who have experience with measuring your heart and blood pressure . the recommended dose is one vial of 400 micrograms / kg of body weight given as a 5 ml solution the injection will take about 5 minutes . your doctor will decide how many doses you need . this will depend on your weight . if you are having an injection of sodium chloride 9 mg / m2 of solution for injection ( 0 . 9 %) solution for injecting , the radiopharmaceutical will be administered with rapscan . how much rapissecan you will receive your dose of rapistan will depend upon your heart rate , your heart speed and blood
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects caused by the rapistcan injection are usually mild to moderate and generally go away within 30 minutes . your doctor will discuss the side impacts with you and will explain the potential risks and benefits of any treatment . tell your doctor if you experience any of the following side effects sudden stopping of the heart or damage to the heart such as heart block , due to a disorder of the cardiac signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face , inability to speak . rapissecan may cause a stroke , or cerebrovascular accident , and an allergic reaction such as rash , wheals / weals , fits , shortness of breath , dizziness , confusion , seizures or fits . these effects
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your peni , which allows blood to enter your penisk , and allows the flow of blood into your partner ' s penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . the active ingredient in viagra is a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard , unsuitable penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). -if you take medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are prescribed for you . - for angina pectoris ( or " chest pain "). if one of the medicines is being given to you by a doctor or nurse , you may be given one or more of the medications known as nitric oxide donors such as amyl nitsitrite (" poppers "), as the combined may also lead to another dangerous fall of your blood temperature . take special care with riociguat . this drug is used to treat pulmonary arterial hypertension ( i .e ., high blood pressure in
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 50 mg . you should not take viagra more than once a day . if necessary , your doctor may tell you to take a different dose . viagra film - coated tablets are also available called viagra orodispersible tablets . take viagra about one hour before sexual activity . swallow the tablet whole with a glass of water . do not take more viagra than your doctor tells you to . this will help you to get an erection if your partner is sexually stimulated . how long to take viagra take viagra once - every day until your er erects , you should tell your doctor straight away . taking viagra will only help you get an an increase in side effects . doses above 100
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; swelling of the eyelids , face , lips or throat . chest pains - these may occur more often if taken during or after intercourse . get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections : this occurs rarely ( may effect up to1 in 1 , 000 people ). if
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildanafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( е132 ). what viagra looks like and contents of the pack viagra film - coated tablets are blue , oblong and a rounded - diamond shape with a diameter of 25 mm . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed 
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopa receptors in the brain . stimulation of the dopamamine receptors triggers nerve impulses inthe brain that help to control body movements . siffrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - help to alleviate the symptoms in moderate to severe primary restless legs syndrome in adults and children .
do not take sifrol if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sIFrol . tell your doctor if any of these applies to you . siffrol should not be used if : you have any medical conditions or symptoms that you have or have had kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucionations are visual . you have dyskinesia ( e . exaggerated , abnormal , uncontrolled movements of the limbs ). if your doctor has told you that you are at risk of advanced parkinson ' s disease and you are also taking levodopa . dyskineia is more likely in people taking 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the doctor will advise you on the right dose . sifrol is for oral use in adults , adolescents and children aged 3 years and over . during the first week , the usual dose is 1 tablet of sIFrol 0 . 088 mg three times a day ( equivalent to 0. 264 mg ). after week 1 , your doctor may increase your dose of a further 2 tablets of  0 264 until your symptoms improve . your doctor will decide which strength is best for you , and how much to take . for children less than 1 year , sfrol 0- 088 or 0: 264 tablets a week may be used to relieve your symptoms . to help you remember to take these tablets , you can take them
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in10 people uncommon may affect up to1 in 100 people rare may affect less than 1in1 , 000 people very rare may effect less than1 in 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects during treatment with sifrol : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) not known
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 35 mg tablet , equivalent to 0 7 . 7 mg pramipeexol as 0: 125 mg . 25 mg : each tablet delivers 0 5 . 5 mg pramipexoule dihydrochloride monohydrate , respectively . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what ifrol looks like and contents of the pack sIFrol 0 088mg tablets are white , round , flat , bevelled edge tablet marked with ' p6 ' on one side and ' 8 ' over
emadine is a medicine for the treatment of seasonal allergic conjunctivitis of the eye . it is used in adults to treat allergic conditions that affect the eye and can cause the allergic reaction . allergic conjonctivits may occur when exposed to some materials ( allergens ) like pollens or house dust mites . the signs of allergic reactions may include itching , redness and swelling on the surface of your eye if you feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . - children and adolescents do not give this medicine to children below the age of 3 years . warnings and precautions talk to your doctor or pharmacist before using e madine . the use of benzalkonium chloride in the treatment of patients has not been studied in clinical trials . there is no experience with the use or effects of emagine in patients with kidney or liver problems . talk to you doctor or nurse before using the medicine if any of these apply to you . other medicines and ebadine tell your doctor if your doctor has told you to take , or might take any other medicines . do not take other eye drops for at least 3 hours after using a tablet . pregnancy , breast feeding and fertility if possible
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 3 drops in each eye . you should only use this medicinal product in your eyes if your doctor tells you to . use in children and adolescents 3 . 1 2 1 2 2 get the emadine bottle out of the sight and reach of children . wash your hands before using . remove the bottle . do not remove the cap or snap collar from the bottle and place the cap back on . hold the bottle for a few seconds until it is ready to use . thumb and finger down , tilt your head back . pull down your eyelid with a clean finger , until there is a ' pocket ' between the eyelid and your eye , allowing the drop to come into contact with the eye ; if it
like all medicines , this medicine can cause side effects , although not everybody gets them . you should try to use the drops at the same time each day . if you experience any of the following , stop using emadine and see your doctor immediately : common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects these may affect more than 1 in 100 people ). effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , vision , corneal staining , increased tear producing antibodies . reporting of side effects 30 if your doctor gets any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . You can also report side effects directly via the national reporting system listed in appendix
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . to protect from infections .
what emadine contains the active substance is e madastine . each ml contains 0 . 5 mg of difumarate . the other ingredients are benzalkonium chloride , trometamol , sodium chloride and hypromellose . what ph levels are controlled with purified water , hydrochloric acid and sodium hydroxide . acidity levels are maintained ( pcs ) to maintain normal pph values . see section " ematine contains sodium ". what the emagine looks like and contents of the pack ebadine is a liquid ( a solution ) supplied in a 5 mL or 10 mlitre plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetistetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epilempepsy . epilemology is a condition where the patients have repeated fits ( seizures ). the amount of levetiratetam used depends on the type of epileptic condition in which the patient ' s brain is damaged , but it can also affect other sides of the brain ( partial onset seizure with or without secondary generalisation ). when leveti racetam has been given to you by your doctor , it has been prescribed for you to help treat : partial initiation seizures with or with secondary generalisierung in adults , adolescents , children and infants from one
do not take levetiracetam actavis - if you are allergic to leveti racetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetistetam actsavis and if your kidney problems are worsening . tell your doctor if there is any slow down in the growth or unexpected puberty development of your child . a small number of people being treated with anti - epileptics such as levetiretam actingavis have had thoughts of harming or killing themselves . do not have any symptoms of depression or suicidal ideation . ask your doctor or pharmacist for advice if any of these apply to you . other side effects include abnormal thoughts , feeling irritable or reacting more aggressively than usually , or 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis must be taken twice a day - once in the morning and once inthe evening . monotherapy dose in adults and adolescents ( from 16 years of age ): general dose : between 1 , 000 mg and 3 , 500 mg each day . when you will first start taking levetirasetam actingavis , your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose of 1 . 000 mg . add - on therapy dose in adult and adolescents (17 years of old ) weighing 50 kg or more general dose: between 2 , 800 mg and 1 iu . maximum daily dose . once you have
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction with dna ). common side effects ( may affect up to 1 in 10 people ): dizziness 
what levetiracetam actavis contains the active substance is called levetistetam . one tablet of leveti racetam actsavis 250 mg contains 250 mg of leveracetnam . each tablet of lavetiracem actavia 500 mg contains 500 mg of lavetam ( as mesilate ). one tabletof levetiretamactavis 750 mg contains 750 g of levitatiracetm . levetiratetam actingavis 1 , 000 mg contains 1  , 1000 mg of thevetiracetapam - the other ingredients are crospovidon , povidone , silica colloidal anhydrous , magnesium stearate . what levium looks like and contents of the pack stevens - johnson syndrome the medicine is a white to off - white lyophilised
what incruse ellipta is this medicine contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . what increse is used for this medicine is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs gradually become damaged and blocked by air . this can cause breathing difficulties , with difficulties in breathing due to tightening of the muscles around the air , making it difficult for air to get in and out of the pulmonary lungs . when used regularly , it can help to control your breathing difficulties and reduce the effects of copd on your everyday life . incruses ellippta should not be used to relieve a sudden attack of breathlessness
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not inhale the contents of your inhaler and talk to your doctor . warnings and precautions talk to you doctor before using this medicine : - to treat asthma before using incrussé ellippa - it is not recommended if any of these apply to you ( or you are not sure ), talk to a doctor or pharmacist before using it : 27 if : you have heart problems . you have an eye problem called narrow - angle glaucoma . - you have enlarged prostate , difficulty passing urine or a blockage in your bladder . your doctor may want to monitor you more closely . severe liver problems - immediate
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use inclusively every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . do not use this to relieve a sudden attack of breathlessness or wheezing . if this is a problem you need a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhalers see ' step - by
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta stop taking this medicine and tell your doctor immediately . if these are signs of itching skin rash ( hives ) or redness 29 other side effects may occur with this medicine : common : may affect more than 1 in 10 people faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead ( may indicate inflammation of the mucous membranes ) uncommon : might affect upto 1 in 1000 people : feeling more hungry than usual pain in your stomach or bowels abdominal pain feeling more tired than usual di
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label of your inhaler . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the inhalers in the sealed tray in order to protect from light . after first opening of the tray , the inhaled tray can be removed from the refrigerator for a maximum of 6 weeks . once you have used the inguler , do not store the tray in the fridge . write the date on the inhl in blue on the outer carton on the tray to protect it from light and keep it at room temperature . you can inhale the medicine any time before or after food or drink . if you are not sure about how to store incruse ellipta 
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromde ). - - other ingredients are lactose monohydrate ( see section 2 under ' incruses ellippta contain lactoside ') and magnesium stearate . what increse is ellipitta looks like and contents of the pack incrussant ellipinta is an inhalations powder , pre - coated , white to off - white powder . the ellipata inhaler consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged
nucala contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that recognises and attaches to a specific target substance in the body . it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . people with severe asthma have a large number of eosinophils , which are a white blood cell that mainly circulates in the lungs . eopenophilic asthma is  a serious type of asthma . nucalá is used if you have asthma attacks and you do not have medicines called high dose inhalers . to treat your asthma , these medicines may be more suitable for you . in some cases , nucalа may be used to control your asthma by using medicines called oral corticosteroids . how nucal  works when your asthma is
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . this medicine may increase your risk of worsening asthma . some patients have 58 asthma - related side effects as their asthma gets worse . nucale may increase the risk of your asthma getting worse if they continue nucalala treatment . allergic - injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions if their body is not able to fight the virus . for more information see section 4 , possible side effects . if a similar reaction occurs , please talk to a doctor or nurse before using nucal . parasitic infections nucalla may reduce your resistance to infections caused by parasites . it is possible
nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose is 12 micrograms ( 100 microgram ) given once a day in one injection , 1 dose in the pre - filled pen . your doctor will decide how much nucalá you need and for how long . if you have any further questions on the use of nucalа , ask your doctor , pharmacist or nurse . before treatment with nucal , please ask your physician , nurse or pharmacist . you will be monitored for the duration of treatment with nuclearcala . the treatment with nocala may continue after you have received no improvement in your asthma symptoms or attacks . once your asthma problems have gone away , your doctor may recommend you inject more nucalala than he / she should . it is very important that you do not miss a dose of nukala , unless your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur commonly ( up to 1 in 10 people ). they usually occur within minutes after the injection , but can sometimes develop more quickly . symptoms include chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you notice any of the following : a reaction or a similar reaction may occur with nukala . if this happens , you should contact your doctor . when nucalum is given to you , it is very important that you tell your healthcare provider immediately , if they notice any symptoms
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the nucale pre - filled pen in the original carton in order to protect from light . after first opening and dilution , store in the refrigerator ( at or below 30 ). after first use , the pen may be stored for a maximum of 7 days be sure to protect it from light and moisture . once you have removed the pen from the refrigerator you must use it within 7 days or store in an upright position . you should record the date of use on the pen label . this information will help to protect the product from light during this period .
what nucala contains the active substance is mepolizumab . 1 ml solution contains 100 mg of mepolizamab in 1 mpa . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate / polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucalala is presented as a clear and colourless solution for injection ( 1 mg / mL ). it is available as : a pack containing 1 or a multipack containing 3 packs of 1 . not all pack sizes may be marketed .
what ninlaro is ninelarro is used for ninero is not a cancer medicine . it contains the active substance ixazomib , a ' proteasome inhibitor '. nninlaaro works by preventing the growth of a tumor of the bone marrow called multiple myeloma . ixizomibe interferes with cell survival by causing the body to destroy myelama cells . by interfering with their division , the body ' s natural defences ( proteasoms ) can make proteins called proteases that are involved in their division and division . what ? ninninglararo looks like and contents of the pack nINlar0 is used to treat adult patients with multiple myelsom . when ninklarre
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking nnlarro . warnings and precautions talk to your doctor , pharmacist or nurse before taking or give nlarao : if any of these apply to you ( or you are not sure ): - if your doctor has told you that you may be at increased risk of bleeding , - persistent nausea , vomiting , diarrhoea - nerve problems , such as tingling , feeling of numbness , swelling or a persistent rash - liver or kidney problems . your doctor will decide whether you should continue treatment with ninklarre or stop treatment . before starting and during treatment
ninlaro must be given to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . ninerlarro must always be taken in combination with lenalidomide , a medicine that works in combinationwith dexamethasone , an anti - inflammatory medicine . the two active substances in nnlarre are used together with lendalidomides and dexathasone on the same day . you will receive a 4 - week course of taking nINlara once a week on the very same day of the week . during the first 3 weeks , your doctor may increase your dose to 4 weeks . lenaldomide will be given at least 25 mg twice a day
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea vomiting diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet [ peripheral oedema ] skin rash ( itchy all over the body ) rare side effects( may affect up to 1 in 1 , 000 people ). if you get any of these effects : trembling or pain in the joints or muscles ( peripheral neuropathy ) ninlaro may cause bruising or peeling of the skin ( peripheral aneuropathy or peripheral edematis ) skin rashes ( itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . does not show any signs of any damage or signs of tampering to medicine packaging . return the pack to your pharmacist . these measures will help protect the environment .
what ninlaro contains - each hard capsule contains 2 . 3 mg of ixazomib . each capsule contains 3 . 1 mg of of xazomimib citrate . - the other ingredients are microcrystalline cellulose , magnesium stearate and talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), and red iron oxide ( erasing ). - printing ink : shellac , propylene glycol , potassium hydroxide , and black iron oxide . what ' ninelara looks like and contents of the pack the hard capsule is white , capsule shaped and contains 3 mg ixazamibe . one capsule contains 33 mg xazamimibe , 3 mg and 4 mg sazomab , printed with black ink
do not use palforzia : - if you are allergic to peanuts or arachis hypoogaea , peanut or soya or any of the other ingredients of palforza . children and adolescents do not give this medicine to children and teenagers aged 4 to 17 years . warnings and precautions talk to your doctor or pharmacist before treatment . - talk to a doctor if your child has a history of peanut allergy or has been exposed to peanut ( sensitisation ) to peanut . your doctor will decide if treatment with palforziea is right for you . you may be more likely to experience allergic reactions after you have been given palforizia . talk to the doctor , pharmacist or nurse before you are given pal forzia when food allergies have been reported . the use of pal for zia has not been studied in children .
do not take palforzia if you are allergic to peanut or soya or any of the ingredients of palforza ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking palforizia : if your asthma is not controlled properly , if there is a problem swallowing , or if long term problems with your digestive system have occurred , including a severe mast cell disorder , severe or life - threatening anaphylaxis , and for 60 days after stopping treatment with your palforziea . your doctor will decide if treatment with palfor zia is suitable for you . the symptoms of peanut allergy are not known . if any of these apply to you , tell your doctor before taking Palforzi . an allergic reaction can occur during treatment with paleforzial . peanut allergy can also cause allergic reactions when taking pal
always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . this is important to you as this medicine will not cause allergy . allergic reactions ( anaphylaxis ) may occur during the first 3 weeks of treatment with palforzia . you will have initial dose escalation during these treatment phases . during the initial dose elevation and up - dosing phases , your doctor will decide exactly how much palforza you should take . if any of the above apply to you , talk to your doctor or pharmacist before taking palforcia . taking pal forzia with food , drink and alcohol , take some food . swallow the tablet whole . do not chew , crush or split the tablet . it is recommended that you take palforizia at the same time as before . initial dose evolution and up- dosesing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions . tell your doctor straight away if you get any of the following symptoms after taking palforizia . they are usually mild to moderate and go away within one hour of the reaction . - trouble breathing - throat tightness - feeling of fulness - difficulty swallowing or speaking - changes in voice - dizziness or fainting - extreme stomach cramps or pain - vomiting , diarrhoea - severely flushing or itching of the skin palforza may also cause problems with the stomach and digestive system . these include : very common side effects ( may affect more than 1 in 10 people ) - low white blood cells - fever - high blood sugar - weight loss -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store below 25 . this medicine must not be used if you notice any hard lumps of powder in the vial . your doctor or nurse will throw away the medicine . these measures will help protect the environment .
what palforzia contains the active substance is palforza 0 . 5 mg / 1 ml oral powder in capsules containing 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palforizia 100 mg : oral powderin capsules after opening microcrystalline celluloid , coloidal an hydroous siliza . magnesium sterarate palearora 300 mg ; oral powder im sachet microcrystalline ( e460 ), colloidal  anhydrOUS silicca , and magnesium STEarate . reconstituted and beige oral powder for solution for initial dose escalation ( see section 3 ). pack sizes of 1 x 13 x 5 single - dose blisters , each containing 0
zerene belongs to a class of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and tendonites to help you sleep . zere is used in adults , adolescents and children of two years and older , who are also taking sleeping problems . treatment should be started if treatment is not suitable for you , or if you have problems sleeping after your initial dose .
do not take zerene : - if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zere sleep apnoea syndrome ( see section 4 ). warnings and precautions talk to your doctor or pharmacist before taking zerente if any of these apply to you . if for any reason you have been told by your doctor that you have zerenne sleep aponooeal syndrome , stop taking it and tell your doctor straight away . you have severe kidney or liver problems . your doctor may want to change your dose . have myasthenia gravis ( very weak or tired muscles , severe breathing or chest problems ). children and adolescents under 18 years of age should not take this medicine . it is not known whether zerence has any undesirable effects . this is because it has not been studied
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day , if your doctor thinks you have difficulty falling asleep . do not take cerene if : you are over 65 years of age and you have mild to moderate liver problems . your doctor will advise you on the dose that is right for you : 65 if the dose is right , you take one 5 mg capsule . if there is mild to medium liver problems you may take one five mg capsule ( 40 mg capsules ) once . after the first dose , the capsule may become cloudy . in the case of an overdose you may become increasingly drowsy , leading to a coma . try to take your capsule at the same time , and do not stop taking
like all medicines , zerene can cause side effects , although not everybody gets them . any other changes in your health should be considered . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( impacts 1 to 10 users in 100 ) uncommon ( impacts between 1 to 100 users in 1 , 000 ) rare ( impacts less than 1 to 5 users in 10 000 ), very rare ( effects 1 to 15 users in10 ,000 ) not known ( frequency cannot be estimated from the available data ). as with all medicines you should tell your doctor if you experience side effects or any other change in your healthcare . tell your healthcare professional immediately if any of the following side effects gets serious : drowsiness ; memory difficulties ; sensations like tingling in the extremities ; trembling
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( i - 171 ). the printing ink contains gelatin , titanium dioxide . printing ingen : red iron oxide ( е172 ), yellow iron oxide and black iron oxide [ e172 ], sodium laauryl steulphate and silicon dioxide ( is s - 13350 ). printing ingelheim ink : shellac , lecithin , simethicone , yellow iron dioxide ( the e - 12350 ) what zeene looks like and contents of the
